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Summary 
Legionella pneumophila is a bacterial pathogen present in natural and man-made 
freshwater environments that can cause a severe, and often fatal, pneumonia called 
Legionnaires’ disease. Molecular epidemiology based on the application of typing methods is 
essential to determine the genetic relatedness between bacterial strains and understand the 
transmission and evolution of this pathogen. This thesis aimed to contribute to a more profound 
understanding of the genetic diversity of L. pneumophila strains and its clonal populations in 
different habitats and biogeographic regions. Furthermore, it aimed to get insights into the 
growth physiology and virulence of the most relevant clonal representatives. For this purpose, 
the high resolution genotyping method Multi Locus Variable number of tandem repeats 
Analysis (MLVA) was established and validated by comparison with the standard Sequence 
Base Typing (SBT). A total of 133 clinical and 478 environmental isolates of L. pneumophila 
from Germany, Israel and the West Bank were subjected to serological analysis and MLVA 
genotyping. Since temperature is one of the major factors that affect the growth of L. 
pneumophila in water systems, the growth in liquid medium of a subset of 63 isolates was 
examined at a range of temperatures from 15°C to 45°C in order to further understand the role 
that plays this environmental parameter in the physiology of clinical and environmental strains. 
Finally, the virulence of 85 strains was assessed by various in-vitro assays using THP-1 human 
macrophages like-cells. 
MLVA genotyping presented higher discriminatory power than SBT yet, both methods 
were highly congruent. Genotyping analysis revealed the clonal nature of the populations of L. 
pneumophila. At genotype level high genetic diversity of the strains was observed. Only three 
MLVA genotypes, were common between Europe and the Middle East and only two were 
shared by Israel and the West Bank despite of the proximity of the two areas. Among the 
common genotypes, genotype Gt4(17) was generally the most frequently isolated and  
corresponded to the globally widespread Sequence Type 1 (ST1). However, the great majority 
of isolates from the different areas were genetically related as they appeared enclosed in VNTR 
Analysis-based clonal complexes (VACC). Analysis of growth at different temperatures 
revealed that the multiplication of clinical strains was enhanced at high temperatures (30ºC, 
43ºC) in comparison to environmental strains, which appeared to be more adapted to lower 
temperatures (15ºC, 22ºC). In addition, temperature influenced the growth of specific genotypes 
differently. In particular, genotype Gt4(17) exhibited higher ability to grow at colder 
temperatures. The assessment of the pathogenicity in human macrophages indicated the high 
virulence potential of certain genotypes and clonal complexes. Overall, these findings may 
assist the understanding of the epidemiology of L. pneumophila strains and provide insights into 
the ecology of this opportunistic pathogen.  
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Zusammenfassung 
Legionella pneumophila ist ein pathogene Bakterienart, die in natürlichen und 
technischen Süßwassersystemen vorkommt und schwere, oft tödliche, Lungenentzündungen 
verursacht, die Legionärskrankheit genannt werden. Für die molekulare Epidemiologie von L. 
pneumophila, die auf der Anwendung von Typisierungsmethoden basiert, ist es wichtig die 
genetische Verwandtschaft zwischen einzelnen Stämmen zu bestimmen, um seine 
Übertragungswege und Evolution zu verstehen. Die vorliegende Doktorarbeit zielt darauf hin 
ein tieferes Verständnis der genetischen Vielfalt von L. pneumophila Stämmen zu erlangen und 
ihre klonalen Populationen in verschiedenen Habitaten und geographischen Regionen zu 
bestimmen. Darüber hinaus sollte die Wachstumsphysiologie und Virulenz der relevantesten 
klonalen Repräsentanten bestimmt werden. Zu diesem Zweck wurde die hochauflösende 
Genotypisierungsmethode MLVA (Multi Locus Variable number of tandem repeats Analysis) 
etabliert und validiert und mit der gegenwärtigen Standardmethode SBT (Sequence Base 
Typing) verglichen. Insgesamt wurden 133 klinische und 478 Umweltisolate von L. 
pneumophila aus Deutschland, Israel und der West Bank serotypisiert und mit MLVA 
genotypisiert. Die Temperatur stellt für L. pneumophila einen der wesentlichsten Faktoren dar, 
die sein Wachstum in aquatischen Systemen beeinflussen. Daher wurde das Wachstum von 63 
Isolaten in Flüsskultur im Temperaturebereich von 15°C bis 45°C untersucht, um die Rolle der 
Temperatur für die Physiologie von klinischen und Umweltisolaten aufzuklären. Abschließend 
wurde die Virulenz einer Reihe von Stämmen mit Hilfe verschiedener in-vitro Assays basierend 
auf humanen Zellkulturen (THP-1 human macrophages like-cells) bestimmt. 
Die auf MLVA-basierende Genotypiserung zeigte eine höhere 
Unterscheidungsfähigkeit als die SBT-basierte, allerdings waren beide Methoden in hohem 
Maße kongruent. Auf der Ebene einzelner Genotypen wurde eine hohe genetische Diversität 
festgestellt. Nur drei MLVA Genotypen wurden sowohl in Europa als auch im Nahen Osten 
gefunden; nur zwei Genotypen fanden sich gemeinsam in Israel und der West Bank, trotz der 
großen räumlichen Nähe. Der Genotyp Gt4(17) wurde überall am häufigsten isoliert und 
entspricht auch dem global verbreiteten Sequenztypt 1 (ST1). Darüber hinaus bestand der 
Großteil der Isolate aus genetisch verwandten klonalen Komplexen. Die Analysen des 
Wachstums bei verschiedenen Temperaturen zeigten, dass das Wachstum der klinischen 
Stämme bei hohen Temperaturen (30-43°C) im Vergleich zu Umweltstämmen erhöht war, 
während Letztere besser bei niedrigen Temperaturen wuschen (15-22°C). Die Temperatur 
beeinflusste das Wachstum verschiedener Stämme eines spezifischen Genotyps unterschiedlich. 
Besonders der Genotyp Gt4(17) wuchs besser bei kalten Temperaturen. Die Bestimmung der 
Virulenz zeigte ein hohes Virulenz-Potential bei bestimmten Genotypen und klonen 
Komplexen. Insgesamt führen diese Ergebnisse zu einem umfassenderen Verständnis der 
Epidemiologie und Ökologie von L. pneumophila Stämmen.
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Chapter I 
 
General Introduction 
 
 
1.1 Legionella pneumophila: environmental bacterium and opportunistic pathogen 
The provision of safe drinking water has been one of the most successful developments 
in public health of all times. Yet, inappropriate management of the drinking water supply 
systems (DWSS) and ignorance of the potential risks can lead to waterborne single infections 
and disease outbreaks. Some microorganisms, defined as opportunistic premise plumbing 
pathogens, are responsible for a significant number of waterborne infections and represent an 
emerging disease problem with major economic costs (1). Legionella species are one of the 
leading causes of drinking water associated individual infections and outbreaks, accounting for 
58% of the cases in 2010 in the United States (2). 
The genus Legionella was first described during the investigation of a major pneumonia 
outbreak among members of the American Legion attending a convention in Philadelphia in 
1976. The causative agent was identified as a Gram-negative bacterium that was consequently 
named Legionella pneumophila. The name given to the infection was Legionnaires´ disease 
(LD), which denotes the pneumonic form of legionellosis. There is a non-pneumonic form of 
legionellosis, called Pontiac fever, which is a milder and non-fatal infection that usually goes 
undiagnosed due to lack of consensus on diagnostic criteria. After isolating the bacterium for 
first time many serogroups of L. pneumophila and other Legionella species have since then been 
discovered. Currently, there are 59 different Legionella species and 70 serogroups described and 
all can be considered potential human pathogens (3). 
LD is an atypical pneumonia, whose incubation period is roughly 2–14 days and the 
symptoms range from mild disease to severe pneumonia that require hospital admission. 
Transmission is usually by inhalation of contaminated aerosols with Legionella spp generated 
by showers, faucets, air-conditioning systems or cooling towers (Figure 1). The amount of 
bacteria needed to result in disease, the infectious dose, is still not clear (4). It is thought that no 
person-to-person transmission exists. However, recently the first probable case of person-to-
person transmission has been reported (5). Of all Legionella species, L. pneumophila 
(particularly, L. pneumophila serogroup 1) is the most virulent and most the common cause of 
disease, accounting with 87% of culture-confirmed cases of LD in Europe and 70-80% in 
United States (6, 2).  The global incidence of LD worldwide is unknown and it is likely to be 
under-recognised, primarily because countries differ in diagnosis methods, common definitions 
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and reporting rates. In 2013, 5851 cases of Legionnaires’ disease were reported to the European 
Legionnaires’ Disease Surveillance Network, with the highest number of reported cases located 
in France, Italy and Spain. LD shows a seasonal pattern, having higher prevalence in the late 
summer to autumn. Some studies have associated this increase to warm and humid weather 
conditions (7, 8).  
 
Figure 1. Route of distribution of L. penumophila from its natural freshwater habitats to the development of disease. 
L. pneumophila that inhabits freshwater environments (1) is spread through units of water treatment and purification 
plants (2) and ends up colonizing downstream water supply networks (3). Under appropriate environmental 
conditions the bacteria multiply (4) and disseminate by means of small aerosols droplets. (5). Aerosols reach the 
human population, which include individuals with different susceptibility (6). The outcome of the infection depends 
on the susceptibility of the individuals. [Modified from Mercante & Winchell 2015 (3)]. 
 
One of the major concerns about LD disease is the occurrence of outbreaks that affect a 
high number of people, including fatal cases. In the late summer of 2013, a large outbreak of LD 
occurred in the German city of Warstein. An industrial cooling tower was the source of the 
outbreak, which ended with 159 suspected and 78 laboratory-confirmed cases of LD, including 
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one death (9). In November 2014, again an industrial wet cooling system was the source of a 
LD outbreak in Northern Portugal, in which a total of 334 cases were confirmed, including ten 
deaths (10). The most recent LD outbreak in Europe took place in December 2015 in Spain. 
This outbreak accounted for 237 cases were laboratory-confirmed and four deaths. Unlike the 
previous outbreaks, in this case the source of infection seemed to be an ornamental fountain. 
The case-fatality ratio of LD has been reported in average as 10% (6). Yet, it might be higher in 
elderly people and people who have pre-existing medical conditions or smoke. Antibiotic 
resistance has never been reported for L. pneumophila and the treatment in case of infection are 
the commonly prescribed antibiotics recommended for other community and hospital-acquired 
infections of Gram-negative bacteria (e.g. macrolides or fluoroquinolones) (11). 
 
1.2 Ecology and life cycle of L. pneumophila 
L. pneumophila are aerobic Gammaproteobacteria that inhabit natural and 
anthropogenic freshwater environments. They have been found in rivers, lakes, hot springs and 
subsurface waters. However, infections are always traced back to man-made freshwater 
systems, such DWSS, cooling towers, whirlpool spas or even decorative fountains (12). Due to 
the low concentrations of nutrients in their oligotrophic natural habitats, L. pneumophila has 
adapted to live in biofilms, where they can obtain amino acids and carbon sources that they need 
for survival and replication. In biofilms, they are part of complex microbial communities (13) 
where they are subjected to predation by protozoa (14). However, living in the constricted 
environment of biofilms has evolved in the development of strategies to parasitize and multiply 
inside numerous protozoa species. They are able to parasitize at least 20 different species of 
amoeba, two species of ciliated protozoa, and one slime mold (15, 16), but are associated most 
frequently with amoeba belonging to the genera Acanthamoeba, Hartmanella, and Naegleria 
(17). The association with amoeba, in the cyst or the vegetative form, or just the presence in the 
biofilm, entail numerous benefits for L. pneumophila, such as protection from bactericidal or 
harsh  environmental conditions (high temperatures, acidity, high osmolarity, chlorine) and 
assistance in dispersion (18).  
Growth inside amoeba is considered a fundamental process in the life cycle of L. 
pneumophila. Although this bacterium is able to replicate in biofilm outside the host, this 
extracellular replication represents a minor contribution to maintain its populations in the 
environment (19, 20). The life cycle of L. pneumophila was primarily described as a biphasic 
cycle combining an intracellular replicative form and an extracellular infective form ready to 
infect new hosts (14). Nonetheless, currently the cycle is understood as a complex network in 
which the host interacts with several different developmental forms of the bacterium, such as 
exponential and stationary phase forms (EPF, SPF), mature infectious forms (MIFs), 
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filamentous and VBNCC (Viable But Non-Culturable cell) forms, among others (21). 
Regardless of the type of host, after invasion, L. pneumophila evades being transported to the 
lysosome and stablishing a unique endoplasmic reticulum-derived compartment where it is 
protected from degradation, known as Legionella containing vacuole (LCV). To remodel this 
compartment, the bacterium makes use of its major essential virulence factor, the Dot/Icm type 
IVB translocation system, which allows the translocation of effectors into the host-cell cytosol. 
The translocated effectors are responsible of manipulating the host cell functions (e.g. 
disrupting vesicle transport) and reprogramming the endosomal-lysosomal degradation pathway 
of the host to ensure its survival. Within the protected vacuole, L. pneumophila replicates until 
nutrients become limited. Nutrient limitation then leads to transition to the infectious forms, 
which will be ready to infect a new host after being released (22, 23).  
 
1.3 Typing methods for L. pneumophila  
Bacterial typing is an essential public health tool important for disease surveillance and 
outbreak investigation, for determining relatedness between bacterial strains and understanding 
pathogen transmission and evolution. The fundamental concept of bacterial typing is the ability 
to differentiate bacterial strains based on their phenotypes and genotypes. Classical typing 
methods focused on phenotypic characteristics, such as serotypes and nutrient demands. 
Molecular typing methods based on bacterial genotypes have increased and improved in the last 
decades, leading to enhanced methods for strain classification, assessment of clonal relatedness, 
detection of virulence genes, and drug resistance markers, as well as for the study of genetic 
evolution over time across geographic regions.  
For almost 30 years the 16S ribosomal RNA gene (24) has provided a general 
framework for molecular studies of taxonomic relationships and the identification of bacterial 
diversity. However, despite its achievement in defining higher taxa, the 16S ribosomal RNA 
classification system lacks the resolution required to distinguish among closely related bacteria 
(25). The need for higher resolution characterization of isolates has led to the development of a 
wide range of strain typing methods (26), such as multilocus sequence typing (MLST), which 
has become a popular method for typing many organisms (27, 28). 
MLST is used to study bacterial populations by investigating multiple housekeeping 
gene loci along the bacterial genome. MLST is based in the comparison of alleles instead of 
nucleotide sequences. In allele-based comparisons, each allelic change is considered a unique 
genetic event, independently of the number of nucleotide polymorphisms involved. Thus, direct 
comparison of alleles allow to study bacterial diversification combining vertical and horizontal 
genetic transfer events (29). Usually, most of MLST schemes are composed of seven MLST 
loci, for which each unique sequence is assigned to an arbitrary allelic number. The allelic 
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numbers of each locus are grouped together into an allelic profile or sequence type (ST), which 
is also designated using a numerical code. Sequence types are used to designate bacterial strains 
and can be grouped into clonal complexes or lineages to improve the understanding of the 
development of the bacterial population structure. The use of MLST housekeeping genes, 
however, does not provide enough discrimination for all typing purposes, including tracing back 
outbreaks or resolving differences among variants of single-clones. More recently, the advances 
in the sequencing technologies have facilitated whole-genome sequencing (WGS) of a wide 
variety of bacterial species (30). Several approaches have been used to detect variation among 
bacterial samples using WGS, for example, the analysis of single nucleotide polymorphisms, 
which has been successfully used in evolutionary and epidemiological studies of closely related 
and single-clone pathogens (31). Alternatively, variation can be also measured using a gene-by-
gene approach, similar to MLST schemes (28). 
In the case of L. pneumophila, several typing methods have been applied to subgroup 
and classified this bacterium. Monoclonal antibody (MAb) subgrouping and Sequence Based 
Typing (SBT) are the most common typing methods used in routine and reference clinical 
laboratories to distinguish between environmental and clinical strains during epidemiological 
investigations to identify the possible common environmental source. Monoclonal antibody 
subgrouping is a phenotypic method related to the lipopolysaccharide (LPS) characteristics of L. 
pneumophila (32, 33). Although the index of discrimination is low in comparison to other 
molecular typing methods, MAb is an ideal screening tool due to its low price and its ease of 
performance. SBT is considered the gold standard typing method for L. pneumophila. It is a 
molecular typing technique based in the sequencing of seven virulence-associated genes 
(flaA, pilE, asd, mip, mompS, proA and neuA) (34, 35). The combination of alleles is 
summarized as sequence type, as in the case of MLST. STs are allelic profiles that include the 
ordered string of allele numbers. In contrast to MLST, SBT uses genes subjected to selective 
pressures instead of housekeeping genes so it has a high index of discrimination. SBT can be 
applied directly as a culture-independent method in clinical samples when no isolates are 
available (36). Other molecular typing methods applied in the characterization of L. 
pneumophila strains are Pulse-field Gel Electrophoresis (PFGE), Amplified Fragment Length 
Polymorphism (ALFP) and a more recently described spoligotyping tool based on the diversity 
of the CRISPR (Cluster Regularly Interspaced Palindromic Repeats) locus for the subgrouping 
of the L. pneumophila serogroup 1 ST1 (37). While CRISPR spoligotyping is a complementary 
genotyping tool, PFGE and ALFP have been extensively used as main method for genotyping of 
L. pneumophila. (38–40). PFGE and ALFP are based in the digestion of genomic DNA with 
restriction enzymes and comparison of the resulting fragment patterns. Although both 
techniques possess high index of discrimination and can be applied not only to L. pneumophila 
but also to other Legionella species, they have the disadvantages of difficult intra- and inter-
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laboratory standardization and have been gradually replaced by SBT. In the last years, the great 
improvements in sequencing technologies have made the application of Whole Genome 
Sequencing (WGS) possible to study retrospective LD outbreaks and the structure of L. 
pneumophila populations (31, 41, 42). WGS has shown to have greater resolution compared to 
the traditional genotyping techniques described above and has demonstrated the feasibility of 
this technique for outbreak investigations.Therefore, WGS has the potential to replace current 
diagnostic and molecular epidemiological tools due to its multiple advantages (43, 44). 
 
1.3.1 Multi Locus Variable number of tandem repeats (VNTR) Analysis (MLVA) 
Multi locus variable number of tandem repeats analysis (MLVA) has emerged more 
recently as a method for genotyping foodborne bacterial pathogens and has been adopted for the 
typing of L. pneumophila (45–47). This method is based on the variation in the number of 
tandem repeated DNA sequences found in many different loci in the genome of 
microorganisms. DNA replication errors, such as slipped-strand mispairing, generate diversity 
in the number of tandem repeats observed between the strains. This method determines the 
number of tandem repeats, or copy units, at multiple variable number of tandem repeat (VNTR) 
loci along the genome. Normally, multiplex PCR amplification of the repeat and flanking 
regions is followed by amplicon sizing using capillary electrophoresis. The number of repeats 
units, or allele numbers, at each locus is calculated from the measured amplicon size. The string 
of alleles from multiple loci generates the MLVA profile, which is specific of each strain. 
High resolution is the main advantage of MLVA genotyping, followed by reduced 
typing time, cost and throughput. These features make it suitable for outbreak investigations and 
surveillance of L. pneumophila (48) as well as for population studies (47, 49). Moreover, 
MLVA has been applied directly to DNA obtained from drinking water (46). MLVA can be 
applied as a complementary method to SBT, due to the increased resolution and the high 
concordance with the gold standard. Furthermore, studies comparing MLVA and WGS 
techniques carried out in other bacteria, such as Escherichia coli or Clostridium difficile, have 
revealed a high correlation between both genotyping methods, despite that MLVA only analyses 
a small part of the bacterial genome (50, 51). The analysis of MLVA genotypes through the 
construction of phylogenetic Minimum Spanning Trees (MSTs) allows inferring genetic 
relationships between the isolates and understanding their clonal relatedness (52). In addition to 
the application of genotyping methods to understand the clonal structure of L. pneumophila 
populations it is also important for the searching of possible ecological features responsible for 
the distinction of the different clonal complexes or lineages. Correlations between genetic 
clusters and ecology has been identified in other bacteria, such as species of the genus Vibrio 
(53, 54). The clonal complexes identified by MLVA can provide the basis for further ecological 
research. 
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Figure 2. A) Typical organization of a variable number of tandem repeat (VNTR) locus. The arrows point to the 
annealing sites for polymerase chain reaction (PCR) primers in the conserved region flanking the repeats. B) Example 
of the variation of the number of repeats in a particular VNTR locus (VNTR3) in two different strains (Strain 1 and 
2). C) Variation in the number of repeats in eight VNTR (VNTR1 to VNTR8) loci along the genome of the two 
strains. The different number of repeats in the loci (numbers inside the genomes) is reflected in the MLVA profiles, 
which are specific for each strain.  
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1.4 Molecular epidemiology and infectivity of L. pneumophila 
Epidemiological typing data collected from multiple studies have shown that most cases 
of LD have been caused by a small subset of serogroup 1 L. pneumophila strains. As previously 
mentioned, L. pneumophila serogroup 1 is the responsible of 70-90% of culture-confirmed cases 
of LD in Europe and the United States (6, 2). However, the proportions of serogroup 1 in 
clinical isolates do not really reflect the environment. In the natural environment, the diversity 
of serogroups is higher and serogroup 1 is less frequently isolated (55). Likewise, the 
prevalence of monoclonal subgroup MAb 1/3 positive or MAb2, which are serogroup 1 strains 
characterized by presenting a virulence-associated epitope, is very high in clinical strains but 
less frequent in the environment (56). As it occurs with serogroup 1 strains, there is little 
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overlap between clinical and environmental sequence types (STs) and common clinical STs are 
rarely isolated from the environment. In the study by Harrison et al. (2009) (55), where clinical 
and environmental populations of L. pneumophila in England and Wales were compared, it was 
reported that 98% of clinical isolates were serogroup 1; 92% were MAb 3/1 positive; and ST47, 
ST37, and ST62 accounted for 46% of all clinical isolates. Of the environmental isolates, only 
56% were serogroup 1, 8% were MAb 3/1 positive, and 34% were ST1 or ST79. In addition, of 
all sequence types (STs) described by SBT, only a few of them appear usually responsible of 
most cases of LD. In England and Wales were predominantly ST47, ST37 and ST62, while in 
Unites States ST1, ST35, ST36, ST37, and ST222 were responsible for most of the cases of 
both outbreak-associated and sporadic cases (57). Several authors have suggested that clinical 
and environmental isolates cannot be distinguished on the basis of coding gene sequences (58). 
The same predominant clinical STs in England and Wales have been found to be common in 
other European countries, such as France (59). Despite that some of the most common strains 
appear restricted to specific regions, other are widespread distributed and have been found in 
very different geographic areas, e.g. ST1. Population studies applying MLVA genotyping have 
also revealed the presence of the same genotypes in very different environments and climatic 
areas, as Northern Europe and the Middle East (47, 49). At clonal level, the largest MLVA 
clonal complex (VACC) described in France, VACC1, which includes the pathogenic strain L. 
pneumophila Paris, was as well the predominant clonal complex observed in Israel. The broad 
distribution of clones suggests that geographical barriers would not be relevant for the 
development of the clones. Instead, adaptation to specific ecological niches could influence their 
distribution (60). Further research would be needed to better understand what ecological factors 
drive the adaptation of global and local clones to specific niches.  
Although some in-vitro studies, using both their natural hosts and human macrophages, 
have shown the enhanced infectivity and persistence of serogroup 1 isolates in comparison to 
other serogroups (61), there is not a clear explanation for the different distribution of serogroups 
and STs in environmental and clinical populations. Besides the effect of the LPS, the virulence 
of L. pneumophila is mainly triggered by the activity of the Dot/Icm Type IVB secretion 
system. As indicated before, this system delivers approximately 300 effector proteins into the 
host cell, which manipulate the normal host cell activity in order to allow bacterial growth (62). 
Differences in pathogenicity between strains may be due to the differential functions of the 
different effectors. Therefore, determining the function of the multiple translocated proteins is 
essential to understand the virulence of L. pneumophila. However, high redundancy in the 
effectors has been reported so that the deletion of single proteins does not impair the replication 
of the bacterium inside the host (63). Standard genetic mutation analyses were unable to identify 
the function of many of these proteins in intracellular growth because the manipulation of 
multiple pathways by the bacterium masks defects resulting from loss of a single pathway. In 
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addition to the Dot/Icm Type IVB secretion system, L. pneumophila utilizes a type II secretion 
system, which also delivers proteins inside the host (64). It has been reported that mutants 
lacking the type II secretion system are defective of growth in amoeba, macrophages and mice, 
indicating that these proteins play an important role in the infectivity of the strains (65). The 
involvement of different secretion systems and the functional effector redundancy could be a 
strategy to preserve the ability to replicate in a wide host range. 
 
1.5 Effect of temperature in the ecology of L. pneumophila. 
Temperature represents a critical environmental factor that can mediate changes in 
growth, development, and pathogenesis of bacteria. In the case of L. pneumophila, temperature 
plays an essential role in its ecology. Temperature is crucial for the growth and abundance of 
this bacterium in natural and man-made freshwater systems. L.pneumophila are mesophilic 
bacteria, able to survive in a wide range of temperatures (20°C to 55°C), having their optimum 
growth temperature between 20°C to 40°C (66, 67). Due to the enhanced growth at warm 
temperatures, warm water systems (showers, air conditioners or cooling towers) have had 
always a high relevance in public health measures controlling Legionella infections. Outbreaks 
of LD have often been linked to contaminated freshwater systems. Therefore, heating the water 
above 50°C is a highly recommended disinfection measure to decrease the risk of outbreaks. 
However, several studies have observed that high temperatures (between 50°C and 60°C) can be 
associated with Legionella spp and L. pneumophila colonization. Kusnetsov et al. (1996) (68) 
demonstrated that the growth in liquid medium of all tested strains of L. pneumophila decreased 
at temperatures above 44-45°C, although the growth-limiting temperature was between 48.4°C 
and 50°C. Despite the decrease and the stop of cell multiplication, the strains produced carbon 
dioxide up to 51.6°C, indicating that the bacteria retained their metabolic activity even beyond 
the maximum temperature for cell multiplication. A recent study (69) has shown by molecular 
techniques, that the abundance of  Legionella species and, in particular L. pneumophila, in a 
local freshwater system increased above 50°C. The increase of temperature from 49.2°C to 
57.9°C correlated positively with the increase of Legionella cells per ml of water. Furthermore, 
Farhat et al. (2012) (70) reported in a pilot-scale hot water distribution system that Legionella 
could persist and recolonize the biofilm of the system after multiple rounds of heat shock at 
70°C for 30 min. Heat shocks used to disinfect water systems usually entail the transformation 
of the cells into a VBNC (Viable But Non Culturable) state. VBNC is a physiological state in 
which bacteria cannot grow on standard growth media but retain certain features of viable cells, 
such as membrane integrity, metabolic activity or virulence. The physiological significance of 
the VBNC state is mostly thought to be an adaptive response to favour the long term survival 
under adverse environmental conditions (71). Cells in VBNC state can produce virulence 
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proteins (72). However, they only become infectious after its resuscitation on their natural hosts 
(73). On the other hand, in order to avoid the growth of L. pneumophila in cold water systems, 
the recommended temperature for storage and distribution of cold water is ideally below 20°C. 
Temperature does not only affect the multiplication of L. pneumophila in the environment but 
also affects its virulence (74, 75). In both studies it was demonstrated that strains grown at high 
temperatures (37°C and 41°C) were significantly more infective to guinea pigs than strains 
which were had been grown at lower temperatures (25°C). 
 
1.6 Research approach 
Understanding the clonal structure of population by using genotyping methods is 
necessary not only to identify the source of infection in case of outbreaks but also to understand 
overall the epidemiology of L. pneumophila and to assist the development of public health 
control strategies. Moreover, population studies covering distinct geographic areas help to 
identify global and local clones, which is essential for the establishment of molecular 
surveillance. The study of the physiological response of strains of these clones to environmental 
factors, as important as the temperature, is essential in order to understand their distribution in 
the environment and to get insights into their ecology. Finally, the assessment of the infectivity 
using human cells is crucial to evaluate the relevance of the clones for human health. 
In this study, four main points were addressed.  First, a biogeography of clinical and 
environmental strains in Germany; second, a biogeography and comparison of clinical and 
environmental strains between the two different climatic regions Germany and Middle East; 
third, an analysis of a representative subset of strains to characterize the temperature adaptation 
of relevant genotypes from Germany and the Middle East, and fourth, to assess the infectivity of 
relevant genotypes from Germany and Middle East. 
The MLVA genotyping method was selected due to its highly discriminatory power and 
performance to type environmental and clinical strains isolated from different habitats (biofilm, 
bulk water, cooling tower water) and different geographical regions (central Europe and the 
Middle East). The MLVA genotyping profiles obtained from isolates of these areas were 
compared with an international database (http://bacterial-genotyping.igmors.u-psud.fr/ 
Legionella2006) in order assess the biogeography of major genotypes and the respective clonal 
complexes. The major strains were physiologically characterized by studying their growth at a 
wide range of temperatures, and special interest was given to infer growth differences between 
clinical and environmental isolates. Finally, the infectivity of the clones to human macrophages 
was studied through different in vitro approaches.  
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1.6.1 Objectives of the thesis 
Three objectives were defined in order to address the overall goal of the thesis, which is 
to better understand the biology of environmental and clinical isolates of L. pneumophila by the 
study of their clonal population structure in different environments using high resolution 
genotyping techniques, their growth behaviour in relation to the temperature and their 
interaction with human host cells. Therefore, the following objectives were approached: 
 Chapter II: to establish and validate Multi Locus Variable number of tandem 
repeats Analysis (MLVA) genotyping method by comparing with the gold standard 
Sequence Based Typing (SBT) genotyping and to examine the genetic diversity 
and population structure of environmental and clinical L. pneumophila isolates in 
Germany by both techniques.  
 Chapter III: to study the population structure and the distribution of genotypes of 
L. pneumophila in the Middle East, and its relation with the populations from 
Germany and the rest of Europe by comparing to the international L. pneumophila 
MLVA database.  
 Chapter IV: to study the effect of the temperature in the growth of clinical and 
environmental isolates as well as of the most relevant clones. And finally, to assess 
the pathogenicity of the clones to human cells.  
 
Figure 3. Project scheme of the current study. Molecular and physiological analyses were carried out to a large 
dataset of L pneumophila strains isolated in Europe and the Middle East. After the characterization of the isolates by 
MLVA genotyping, the growth at different temperatures was studied in order to investigate the role of this parameter 
in the ecology of the genotypes. Finally, in vitro assays were used to evaluated the infectivity potential of the main 
genotypes to human macrophages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infectivity assessment of the 
clones to human 
macrophages-like cells   
Isolation of L. pneumophila strains in different 
habitats from different geographic regions 
Clonal identification of isolates by MLVA genotyping 
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12 
 
1.7 References 
1.  Ashbolt NJ. 2015. Microbial Contamination of Drinking Water and Human Health from 
Community Water Systems. Curr Environ Heal Reports 2:95–106. 
2.  CDC. 2011. Legionellosis — United States, 2000–2009. MMWR Morb Mortal Wkly 
Rep. 60:1083–6. 
3.  Mercante JW, Winchell JM. 2015. Current and Emerging Legionella Diagnostics for 
Laboratory and Outbreak Investigations. Clin Microbiol Rev 28:95–133. 
4.  Whiley H, Keegan A, Fallowfield H, Ross K. 2014. Uncertainties associated with 
assessing the public health risk from Legionella. Front Microbiol 5:501. 
5.  Correia AM, Ferreira JS, Borges V, Nunes A, Gomes B, Capucho R, Gonçalves J, 
Antunes DM, Almeida S, Mendes A, Guerreiro M, Sampaio DA, Vieira L, Machado 
J, Simões MJ, Gonçalves P, Gomes JP. 2016. Probable Person-to-Person Transmission 
of Legionnaires’ Disease. N Engl J Med 374:497–498. 
6.  European Centre for Disease Prevention and Control. 2015. Legionnaires ’ disease in 
Europe, 2013. ECDC Surveillance report. 
7.  Fisman DN, Lim S, Wellenius GA, Johnson C, Britz P, Gaskins M, Maher J, 
Mittleman MA, Haas CN, Newbern C. 2005. It ’ s not the heat, it ’ s the humidity: wet 
weather increases legionellosis risk in the greater Philadelphia metropolitan Area. J 
Infect Dis 1013:2066-2073. 
8.  Karagiannis I, Brandsema P, Van der Sande M. 2009. Warm, wet weather associated 
with increased Legionnaires’ disease incidence in The Netherlands. Epidemiol Infect 
137:181–187. 
9.  Maisa A, Brockmann A, Renken F, Lück C, Pleischl S, Exner M, Jurke A. 2015. 
Epidemiological investigation and case – control study : a Legionnaires’ disease 
outbreak associated with cooling towers in Warstein, Germany, August – September 
2013. Euro Surveill 20:1–9. 
10.  Shivaji T, Pinto CS, Serra LAO, Valente J, Machado J, Marques T. 2014. A large 
community outbreak of Legionnaires ’ disease in Vila Franca de Xira, Portugal, October 
to November. Euro Surveill 19:1–4. 
11.  Phin N, Parry-Ford F, Harrison T, Stagg HR, Zhang N, Kumar K, Lortholary O, 
Zumla A, Abubakar I. 2014. Epidemiology and clinical management of Legionnaires’ 
disease. Lancet Infect Dis 14:1011–21. 
12.  van Heijnsbergen E, Schalk J a. C, Euser S, Brandsema PS, den Boer JW, De Roda 
Husman AM. 2015. Confirmed and potential sources of Legionella reviewed. 
Environmental Science & Technology 49:4797-815. 
13.  Declerck P. 2010. Biofilms: the environmental playground of Legionella pneumophila. 
Environ Microbiol 12:557–66. 
13 
 
14.  Rowbotham TJ. 1980. Preliminary report on the pathogenicity of Legionella 
pneumophila for freshwater and soil amoebae. J Clin Pathol 33:1179–83. 
15.  Hägele S, Ko R, Merkert H, Wu D, Mu D. 2000. Dictyostelium discoideum : a new 
host model system for intracellular pathogens of the genus Legionella 2:165–171. 
16.  Lau HY, Ashbolt NJ. 2009. The role of biofilms and protozoa in Legionella 
pathogenesis: Implications for drinking water. J Appl Microbiol 107:368–378. 
17.  Fields BS. 1996. The molecular ecology of Legionella. Trends Microbiol 4:286–290. 
18.  Molmeret M, Horn M, Wagner M, Santic M. 2005. Amoebae as Training Grounds for 
Intracellular Bacterial Pathogens. Appl Enviromental Microbiol 71:20–28. 
19.  Temmerman R, Vervaeren H, Noseda B, Boon N, Verstraete W. 2006. Necrotrophic 
growth of Legionella pneumophila. Appl Environ Microbiol 72:4323–4328. 
20.  Declerck P, Behets J, Margineanu A, van Hoef V, De Keersmaecker B, Ollevier F. 
2009. Replication of Legionella pneumophila in biofilms of water distribution pipes. 
Microbiol Res 164:593–603. 
21.  Robertson P, Abdelhady H, Garduno RA. 2014. The many forms of a pleomorphic 
bacterial pathogen - the developmental network of Legionella pneumophila. Front 
Microbiol 5:1–20. 
22.  Steinert M, Heuner K, Buchrieser C, Albert-Weissenberger C, Glöckner G. 2007. 
Legionella pathogenicity: Genome structure, regulatory networks and the host cell 
response. Int J Med Microbiol 297:577–587. 
23.  Newton HJ, Ang DKY, van Driel IR, Hartland EL. 2010. Molecular pathogenesis of 
infections caused by Legionella pneumophila. Clin Microbiol Rev 23:274–98. 
24.  Woese CR. 1987. Bacterial Evolution. Microbiol Rev 51:221–271. 
25.  Clarridge J. 2004. Impact of 16S rRNA Gene Sequence Analysis for Identification of 
Bacteria on Clinical Microbiology and Infectious Diseases. Clin Microbiol Rev 17:840–
862. 
26.  Sabat AJ, Budimir A, Nashev D, Dijl JM Van, Laurent F, Grundmann H, Friedrich 
AW. 2013. Overview of molecular typing methods for outbreak detection and 
epidemiological surveillance. Euro Surveill 8:1–15. 
27.  Maiden MCJ. 2006. Multilocus Sequence Typing of Bacteria. Annu Rev Microbiol 
60:561–588. 
28.  Maiden MCJ, Jansen van Rensburg MJ, Bray JE, Earle SG, Ford SA, Jolley KA, 
McCarthy ND. 2013. MLST revisited: the gene-by-gene approach to bacterial 
genomics. Nat Rev Microbiol 11:728–36. 
29.  Didelot X, Maiden MCJ. 2014. Impact of recombination on bacterial evolution. Trends 
Microbiol 18:315–322. 
30.  Medini D, Serruto D, Parkhill J, Relman DA, Moxon R, Falkow S, Rappuoli R. 
14 
 
2008. Microbiology in the post-genomic era. Nat Rev Microbiol 6:419–430. 
31.  Underwood AP, Jones G, Mentasti M, Fry NK, Harrison TG. 2013. Comparison of 
the Legionella pneumophila population structure as determined by sequence-based 
typing and whole genome sequencing. BMC Microbiol 13:302. 
32.  Helbig RH, Kurtz JB, Pastoris MC, Pelaz C, Lu PC, Medizinische I. 1997. Antigenic 
Lipopolysaccharide Components of Legionella pneumophila Recognized by Monoclonal 
Antibodies : Possibilities and Limitations for Division of the Species into Serogroups. J 
Clin Microbiol 35:2841–2845. 
33.  Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, 
Lindsay D, Lück PC, Marques T, Mentula S, Peeters MF, Pelaz C, Struelens M, 
Uldum S a., Wewalka G, Harrison TG. 2002. Pan-European study on culture-proven 
Legionnaires’ disease: Distribution of Legionella pneumophila serogroups and 
monoclonal subgroups. Eur J Clin Microbiol Infect Dis 21:710–716. 
34.  Gaia V, Fry NK, Afshar B, Luck CP, Meugnier H, Etienne J, Peduzzi R, Harrison 
TG. 2005. Consensus Sequence-Based Scheme for Epidemiological Typing of Clinical 
and Environmental Isolates of Legionella pneumophila. J Clin Microbiol 43:2047–2052. 
35.  Ratzow S, Gaia V, Helbig JH, Fry NK, Lück PC. 2007. Addition of neuA, the gene 
encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of 
the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 
strains. J Clin Microbiol 45:1965–8. 
36.  Coscollá M, González-Candelas F. 2009. Direct sequencing of Legionella pneumophila 
from respiratory samples for sequence-based typing analysis. J Clin Microbiol 47:2901–
2905. 
37.  Ginevra C, Jacotin N, Diancourt L, Guigon G, Arquilliere R, Meugnier H, 
Descours G, Vandenesch F, Etienne J, Lina G, Caro V, Jarraud S. 2012. Legionella 
pneumophila sequence type 1/Paris pulsotype subtyping by spoligotyping. J Clin 
Microbiol 50:696–701. 
38.  Luck PC, Helbig JH, Hagedorn HJ, Ehret W. 1995. DNA fingerprinting by pulsed-
field gel electrophoresis to investigate a nosocomial pneumonia caused by Legionella 
bozemanii serogroup 1. Appl Environ Microbiol 61:2759–2761. 
39.  Scaturro M, Losardo M, De Ponte G, Ricci ML. 2005. Comparison of three molecular 
methods used for subtyping of Legionella pneumophila strains isolated during an 
epidemic of Legionellosis in Rome. J Clin Microbiol 43:5348–50. 
40.  Nhu Nguyen TM, Ilef D, Jarraud S, Rouil L, Campese C, Che D, Haeghebaert S, 
Ganiayre F, Marcel F, Etienne J, Desenclos J. 2006. A Community‐Wide Outbreak of 
Legionnaires Disease Linked to Industrial Cooling Towers—How Far Can Contaminated 
Aerosols Spread? J Infect Dis 193:102–111. 
15 
 
41.  Reuter S, Harrison TG, Köser CU, Ellington MJ, Smith GP, Parkhill J, Peacock SJ, 
Bentley SD, Török ME. 2013. A pilot study of rapid whole-genome sequencing for the 
investigation of a Legionella outbreak. BMJ Open 3:1-6. 
42.  Raphael BH, Baker DJ, Nazarian E, Lapierre P, Bopp D, Kozak-Muiznieks NA, 
Morrison SS, Lucas CE, Mercante JW, Musser KA, Winchell JM. 2016. Genomic 
resolution of outbreak-associated Legionella pneumophila serogroup 1 isolates from 
New York State. Appl Environ Microbiol 82:3582-90. 
43.  Leopold SR, Goering R V., Witten A, Harmsen D, Mellmann A. 2014. Bacterial 
Whole-Genome Sequencing Revisited: Portable, Scalable, and Standardized Analysis for 
Typing and Detection of Virulence and Antibiotic Resistance Genes. J Clin Microbiol 
52:2365–2370. 
44.  Chui L, Li V. 2015. Technical and software advances in bacterial pathogen typing. 
Current and emerging technologies in microbial diagnostics, 1st ed. Elsevier Ltd., 
Amsterdam, The Netherlands. 
45.  Pourcel C, Visca P, Afshar B, D’Arezzo S, Vergnaud G, Fry NK. 2007. Identification 
of variable-number tandem-repeat (VNTR) sequences in Legionella pneumophila and 
development of an optimized multiple-locus VNTR analysis typing scheme. J Clin 
Microbiol 45:1190–9. 
46.  Kahlisch L, Henne K, Draheim J, Brettar I, Höfle MG. 2010. High-resolution in situ 
genotyping of Legionella pneumophila populations in drinking water by multiple-locus 
variable-number tandem-repeat analysis using environmental DNA. Appl Environ 
Microbiol 76:6186–95. 
47.  Visca P, D’Arezzo S, Ramisse F, Gelfand Y, Benson G, Vergnaud G, Fry NK, 
Pourcel C. 2011. Investigation of the population structure of Legionella pneumophila by 
analysis of tandem repeat copy number and internal sequence variation. Microbiology 
157:2582–94. 
48.  Sobral D, Le Cann P, Gerard  a, Jarraud S, Lebeau B, Loisy-Hamon F, Vergnaud 
G, Pourcel C. 2011. High-throughput typing method to identify a non-outbreak-
involved Legionella pneumophila strain colonizing the entire water supply system in the 
town of Rennes, France. Appl Environ Microbiol 77:6899–907. 
49.  Rodríguez-Martínez S, Sharaby Y, Pecellín M, Brettar I, Höfle M, Halpern M. 
2015. Spatial distribution of Legionella pneumophila MLVA-genotypes in a drinking 
water system. Water Res 77:119–132. 
50.  Eyre DW, Fawley WN, Best EL, Griffiths D, Stoesser NE, Crook DW, Peto TEA, 
Walker AS, Wilcox MH. 2013. Comparison of Multilocus Variable-Number Tandem-
Repeat Analysis and Whole-Genome Sequencing for Investigation of Clostridium 
difficile Transmission. J Clin Microbiol 51:4141–4149. 
16 
 
51.  Holmes A, Allison L, Ward M, Dallman TJ, Clark R, Fawkes A, Murphy L, 
Hanson M. 2015. The utility of Whole Genome Sequencing of Escherichia coli O157 
for outbreak detection and epidemiological surveillance. J Clin Microbiol 53:3565-73. 
52.  Teixeira AS, Monteiro PT, Carriço J a, Ramirez M, Francisco AP. 2015. Not seeing 
the forest for the trees: size of the minimum spanning trees (MSTs) forest and branch 
significance in MST-based phylogenetic analysis. PLoS One 10:e0119315. 
53.  Fraser C, Alm EJ, Polz MF, Spratt BG, Hanage WP. 2009. The Bacterial Species 
Challenge: making sense of genetic and ecological diversity. Science 323:741–746. 
54.  Hunt D, David L, Gevers D, Preheim S, Alm E, Polz M. 2008. Resource partitioning 
and sympatric differentiation among closely related bacterioplankton. Science 320:1081-
5. 
55.  Harrison TG, Afshar B, Doshi N, Fry NK, Lee J V. 2009. Distribution of Legionella 
pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in 
recent clinical and environmental isolates from England and Wales (2000-2008). Eur J 
Clin Microbiol Infect Dis 28:781–91. 
56.  Kozak N a., Benson RF, Brown E, Alexander NT, Taylor TH, Shelton BG, Fields 
BS. 2009. Distribution of lag-1 alleles and sequence-based types among Legionella 
pneumophila serogroup 1 clinical and environmental isolates in the United States. J Clin 
Microbiol 47:2525–2535. 
57.  Kozak-Muiznieks N a, Lucas CE, Brown E, Pondo T, Taylor TH, Frace M, 
Miskowski D, Winchell JM. 2014. Prevalence of sequence types among clinical and 
environmental isolates of Legionella pneumophila serogroup 1 in the United States from 
1982 to 2012. J Clin Microbiol 52:201–11. 
58.  Aurell H, Farge P, Etienne J, Jarraud S, Bernard C. 2005. Clinical and 
Environmental Isolates of Legionella pneumophila Serogroup 1 Cannot Be 
Distinguished by Sequence Analysis of Two Surface Protein Genes and Three 
Housekeeping Genes. Society 71:282–289. 
59.  Doleans A, Aurell H, Reyrolle M, Lina G, Freney J, Vandenesch F, Etienne J, 
Jarraud S, Ce L. 2004. Clinical and Environmental Distributions of Legionella Strains 
in France Are Different. J Clin Microbiol 42:458–460. 
60.  Cohan FM, Koeppel AF. 2008. The Origins of Ecological Diversity in Prokaryotes. 
Curr Biol 18:1024–1034. 
61.  Messi P, Patrizia M, Bargellini A, Annalisa B, Anacarso I, Immacolata A, Marchesi 
I, Isabella M, de Niederhäusern S, Bondi M, Moreno B. 2013. Protozoa and human 
macrophages infection by Legionella pneumophila environmental strains belonging to 
different serogroups. Arch Microbiol 195:89–96. 
62.  Brüggemann H, Cazalet C, Buchrieser C. 2006. Adaptation of Legionella 
17 
 
pneumophila to the host environment: role of protein secretion, effectors and eukaryotic-
like proteins. Curr Opin Microbiol 9:86–94. 
63.  Ensminger AW. 2016. Legionella pneumophila, armed to the hilt: Justifying the largest 
arsenal of effectors in the bacterial world. Curr Opin Microbiol 29:74–80. 
64.  Cianciotto NP. 2005. Type II secretion: A protein secretion system for all seasons. 
Trends Microbiol 13:581–588. 
65.  Tyson JY, Pearce MM, Vargas P, Bagchi S, Mulhern BJ, Cianciotto NP. 2013. 
Multiple Legionella pneumophila Type II Secretion Substrates, Including a Novel 
Protein, Contribute to Differential Infection of the Amoebae Acanthamoeba castellanii, 
Hartmannella vermiformis, and Naegleria lovaniensis. Infect Immun 81:1399–1410. 
66.  Wadowsky RM, Wolford R, McNamara  a. M, Yee RB. 1985. Effect of temperature, 
pH, and oxygen level on the multiplication of naturally occurring Legionella 
pneumophila in potable water. Appl Environ Microbiol 49:1197–1205. 
67.  Ohno A, Kato N. 2003. Factors influencing survival of Legionella pneumophila 
serotype 1 in hot spring water and tap water. Appl Environ Microbiol 69:2540–2547. 
68.  Kusnetsov, J.M., Ottoila, E., and Martikainen, P.J. 1996. Growth, respiration and 
survival of Legionella pneumophila at high temperatures. J Appl Bacteriol 81: 341–347. 
69.  Lesnik R, Brettar I, Höfle MG. 2016. Legionella species diversity and dynamics from 
surface reservoir to tap water: from cold adaptation to thermophily. ISME J 10:1064-80. 
70.  Farhat M, Moletta-Denat M, Frère J, Onillon S, Trouilhé M-C, Robine E. 2012. 
Effects of disinfection on Legionella spp., eukarya, and biofilms in a hot water system. 
Appl Environ Microbiol 78:6850–8. 
71.  Ducret A, Chabalier M, Dukan S. 2014. Characterization and resuscitation of “non-
culturable” cells of Legionella pneumophila. BMC Microbiol 14:3. 
72.  Alleron L, Khemiri A, Koubar M, Lacombe C, Coquet L, Cosette P, Jouenne T, 
Frere J. 2013. VBNC Legionella pneumophila cells are still able to produce virulence 
proteins. Water Res 47:6606–17. 
73.  Epalle T, Girardot F, Allegra S, Maurice-Blanc C, Garraud O, Riffard S. 2014. 
Viable but Not Culturable Forms of Legionella pneumophila Generated After Heat 
Shock Treatment Are Infectious for Macrophage-Like and Alveolar Epithelial Cells 
After Resuscitation on Acanthamoeba polyphaga. Microb Ecol 69:215–224. 
74.  Edelstein PH, Beer KB, Deboynton ED. 1987. Influence of Growth Temperature on 
Virulence of Legionella pneumophila. Infect Immun 55:2701–2705. 
75.  Mauchline WS, James BW, Fitzgeorge ROYB, Dennis PJ, Keevil CW. 1994. Growth 
Temperature Reversibly Modulates the Virulence of Legionella pneumophila. Infect 
Immun 62:2995–2997. 
 
18 
 
 
 
Chapter II 
 
Molecular diversity of clinical and environmental isolates of L. 
pneumophila across Germany based on Sequence Based Typing and 
Multi Locus Variable number of tandem repeats (VNTR) analysis 
(MLVA) 
 
 
Marina Pecellín1, Christian Lück2, Ingrid Bretar1, Manfred Höfle1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection 
Research, Braunschweig, Germany 
2Institute of Medical Microbiology and Hygiene, National Consulting Laboratory for 
Legionella, Technical University of Dresden, Dresden, Germany 
19 
 
2.1 Abstract 
Typing methods are essential for the study of the distribution of clinical and 
environmental L. pneumophila, which is necessary in order to establish control measures and 
investigate the sources of outbreaks. In this study, Multi Locus Variable number of tandem 
repeats Analysis (MLVA) was established as a high resolution genotyping method and validated 
by comparing to Sequence Based Typing (SBT), the standard method for typing of L. 
pneumophila. Different MLVA schemes using eight (MLVA-8), 12 (MLVA-12) and 13 
(MLVA-8(12)) VNTR loci were used. MLVA and SBT were applied to evaluate the genetic 
diversity of 311 environmental and clinical L. pneumophila isolates for different parts of 
Germany. All different MLVA schemes presented high reproducibility and typeability. In 
general, the discriminatory power of three MLVA schemes was higher than that of SBT. In 
MLVA genotyping, the resolution improved when increasing the number of VNTR studied. 
Therefore, MLVA-8(12) scheme showed the highest resolution. The majority of isolates (70%) 
were identified as single genotypes. However, certain genotypes, i.e. Gt4(17) and other closely 
related strains differing in a single locus, were frequently observed. These genotypes 
corresponded to worldwide distributed sequence types, such as ST1 and ST23, and were found 
across different regions of Germany. Little overlap was detected between environmental and 
clinical isolates and the same genotypes, as Gt4(17), were dominant in both groups of isolates. 
Clonal analysis of the strains of L. pneumophila in Germany indicated that the population 
structure of L. pneumophila isolated from Germany resulted from the combined action of 
widespread clonal complexes and genotypes, i.e. clonal complex VACC1 and Gt4(17), along 
with genetic differentiation at shorter geographic distances. 
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2.2 Introduction 
The incidence of Legionnaires´ disease (LD) has been increasing during the last years in 
Germany (1, 2). Most of the cases that contributed to the increase were attributed to infections 
in the community, with a minor number of travel-associated and nosocomial cases. 
Additionally, major outbreaks have occurred since 2010 in Warstein, Ulm and Zweibrücken (3–
5).  
In cases of LD, it is crucial to detect the source of the infection as promptly as possible 
by comparing clinical and environmental strains of L. pneumophila to apply decontamination 
measures to control and prevent further cases. With this purpose, and in general, for the study of 
the genetic diversity and distribution of L. pneumophila strains, which could be important for 
public health control strategies, numerous genotypic typing methods have been applied to the 
typing of L. pneumophila in the last years. These methods include amplified fragment length 
polymorphism (AFLP), pulsed-field gel electrophoresis (PFGE) (6), sequence-based typing 
(SBT) (7, 8) or more recently whole genome mapping (WGM) (9) and whole genome 
sequencing (WGS) (10). PFGE and SBT have been widely used but SBT is still considered the 
current gold-standard assay for epidemiological investigations, due to its high typeability, 
interlaboratory reproducibility and epidemiologic concordance (11). Moreover, the European 
Society for Clinical Microbiology Study Group on Legionella Infections (ESGLI) maintains an 
active and continually updated allele database. In a study where L. pneumophila phylogenies 
were compared by SBT and WGS approaches, it was shown that STs could reflect precisely the 
whole genome genotypes (12). However, WGS remains to be challenging to substitute SBT as 
routine and outbreak investigation genotyping due to high costs and lack of standadised 
sequence analysis. 
Multilocus variable number of tandem repeats (VNTR) analysis (MLVA) has been 
largely used to type different pathogens (13–15). VNTRs consist of relatively short DNA 
fragments repeated in tandem that can vary in copy number among strains. MLVA assays have 
exhibited high level of discrimination among strains and reduced typing time and costs. Several 
studies have used MLVA for the genotyping of L. pneumophila strains (16–18). They showed 
the high correspondence between MLVA genotypes and sequence types (STs) and an important 
increase of the resolution when applying MLVA, which is relevant for understanding clonal 
populations. Due to its advantages, MLVA could be used to complement SBT and gain insights 
in the clonal structure population of L. pneumophila as well as to help selecting strains for 
further whole genome sequencing. 
The populations of L. pneumophila isolates in Germany have been previously studied 
by SBT (19, 20). However, so far no such studies using MLVA or WGS have arised. The aim of 
this study was to investigate the clonal population structure of L. pneumophila in Germany by 
using MLVA genotyping. To this purpose, two MLVA typing assays previously proposed for L. 
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pneumophila strains were optimized and validated and a total of 311 environmental and clinical 
isolates from across Germany were MLVA genotyped. The MLVA genotypes were compared 
with those genotypes from the MLVA Legionella database containing strains from Europe and 
multiple reference strains. MLVA genotypes were compared to SBT and aspects of diversity, 
geographical distribution and differences of clinical and environmental isolates were assessed. 
The results obtained in this study have been used as a base to select genotypes for whole 
genome sequencing. 
 
2.3 Material and methods  
2.3.1 Isolation of Legionella spp. and strain collection 
Water and biofilm samples were taken monthly between June 2013 and July 2014 from 
a cooling tower located at the HZI campus (E building) as part of a routine sampling plan. 
During the same period, hot water samples were taken from a shower in the men toilets (D0.21). 
Moreover, biofilm samples were taken from two faucets of two kitchens of the HZI (D2 
building) that were replaced on June 28th 2013.  
Isolation of Legionella from water samples was performed by culture using a 
modification of the International Standard method ISO 11731:1998 (International Organization 
for Standardization, 1998), based on a filtration procedure and cultivation of bacteria on 
selective media. 300 ml of water collected from the sump of the cooling tower, a chamber where 
water flows to facilitate pump suction, were concentrated by filtration on a sterile 47 mm, 0.2 
µm pore size, polycarbonate membrane (Whatmann Nucleopore, UK). After filtration, bacteria 
collected on the membrane were resuspended in 15 ml of sterile water and vortexed for 10 min. 
1:10 dilutions of the concentrate were made and three plates of GVPC (Glycine-Vancomycin- 
Polymyxin- Cycloheximide medium, Oxoid Thermoscientific, Germany) were plated with 1 ml 
and 0.1 ml of 1:10 concentrate, respectively. In the case of hot water, two liters were filtered as 
described above and bacteria resuspended in 10 ml of sterile water. 1 ml and 0.1 ml of a 10-fold 
dilution of this concentrated water were plated onto three plates of BCYE (Buffered Charcoal 
Yeast Extract Agar, Oxoid Thermoscientific, Germany). Plates were incubated for 7 to 10 days 
at 37°C under aerobic conditions and humidified atmosphere. Round, white, purple or greenish 
colonies with smooth edges and with the centre usually brighter than the borders, were 
suspected to be Legionella spp. and were counted as positive and subcultured in BCYE and 
BCYE without L-cysteine to be confirmed. The isolated colonies growing only on BCYE agar 
but not on BCYE without L-cysteine were considered to be Legionella colonies according to 
ISO 11731:1998.  Five colonies of each plate were selected when possible. Isolates were kept in 
YEB (Yeast Extract Broth) supplemented with 10% glycerol at -80°C. 
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Biofilm samples were taken in the cooling tower from the bottom and the walls of the 
chamber containing the drift eliminators when the surfaces were moist by using nylon swabs 
(FLOQSwabs, Copan Flock Technologies, Italy). Swaps were suspended in 1 ml of sterile water 
and vortex gently. 0.1 ml was plated in three GVPC plates and 0.1 ml of 1:10 diluted suspension 
was plated in three BCYE plates. The incubation, examination of the plates and preparation of 
isolates were done as described above for the water samples. 
A total of 283 L. pneumophila strains from the period 1998-2013 were kindly provided 
by the National Reference Laboratory for Legionella Infections in Dresden, Germany (Table 
A1). 81 strains were received by post in an insulated storage container as living biomass plated 
in BCYE plates. Isolates kept at -80°C as described above. From the rest of the strains, DNA 
was received in 1.5 ml screw cap Eppendorf tubes, which was kept at -20°C until later analysis. 
 
2.3.2 Identification of Legionella spp. isolates  
Bacterial DNA was extracted using the DNeasy-Kit (Qiagen; Hilden, Germany). 
Briefly, four to five colonies were suspended in phosphate buffer saline (PBS) and centrifuged 
for 10 min at 7500 rpm (Heraeus Biofuge, Germany). The pellet was suspended in 180 µl of 
ATL lysis buffer from the kit and 20 µl of Proteinase K and was incubated at 56°C for 30 min. 
200 µl of AL-Buffer and 200 µl absolute ethanol were added to the mix and all volume was 
transferred to a spin column. After 1 min centrifugation at 8000 rpm, the columns were washed 
with 500 µl AW1 and AW2 buffer. DNA was eluted in 50µl of AE elution buffer after a final 
centrifugation step of 1 min at maximum speed and finally quantified by Nanodrop 
spectrophotometer (NanoDrop, Thermo Scientific, Germany). 
PCR amplifications of parts of the bacterial 16S rRNA gene were performed to test at 
the molecular level the genus and the species of the isolates. A Legionella genus-specific PCR 
was carried out using the primers 17F (5´-GGCCTACCAAGGCGACGATCG-3´) and 28R (5´-
CACCGGAAATTCCACTACCCTCTC-3´) (21).  PCR was done using 50 ng of DNA of the 
isolates in a final volume of 25 μl, starting with an initial denaturation for 15 min at 95°C. A 
total of 35 cycles (30 sec at 95°C, 30 sec at 66.5°C, and 30 sec at 72°C) was followed by a final 
elongation for 10 min at 72°C. A L. pneumophila species-specific PCR was performed using the 
primers Lp-16S_246-248F (5´-CCTGGGCTTAACCTGGGAC-3´) and Lp-16S_246-248R (5´-
CTTAGAGTCCCCACCATCACAT-3´) (21) and 50 ng of DNA in a final volume of 25 µl. An 
initial denaturing step of 15 min at 95°C was followed by 35 cycles (45 min at 95°C, 45 min at 
60°C and 45 sec at 72°C) and a final elongation step of 10 min at 72°C. 1.5 and 1 U of 
HotStarTaq DNA polymerase were used respectively (Qiagen, Hilden, Germany). Isolates were 
further characterized by complete sequencing of the 16S rRNA gene. To amplify the complete 
gene (about 1500 bp) a PCR was carried out using the primers 27F (5´-
AGAGTTTGATCMTGGCTCAG-3´) and 1492R (5´-TACGG YTACCTTGTTACGACTT -3´) 
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(21). 50 ng of DNA were amplified in a total volume of 50 µl by a denaturing step of 15 min at 
95°C, followed by 30 cycles (60 sec at 95°C, 40 sec at 56°C and 60 sec at 72°C) and an 
elongation step of 10 min at 72°C. 3.75 U of HotStarTaq DNA polymerase was used for the 
amplification. PCR products were purified using MinElute PCR Purification kit (Qiagen, 
Hildem, Germany) and purified amplicons were amplified in a sequencing reaction (ABI 
PRISM BigDye Terminator Cycle Sequencing Ready Reaction kit; Applied Biosystems, UK) 
using an additional primer 1087R (5´-CTCGTTGCGGGACTTAACCC -3´) to full cover the 
sequence of the 16S rRNA gene.  Products were purified again using MinElute PCR 
Purification kit (Qiagen, Hildem, Germany) following manufacturer instructions and analyzed 
by Sanger sequencing using capillary electrophoresis with fluorescence detection (ABI Prism 
3100 Genetic Analyzer). 
The serogroup of L. pneumophila isolates obtained at the HZI campus were identified 
using a latex agglutination test (Oxoid, UK) following manufacter´s instructions. This test is 
specific for the especies L. pneumophila and allowed a separated identification of L. 
pneumophila serogroup 1 and serogroups 2-14. All isolates were subjected to the test, however, 
other non-pneumophila Legionella species were expected to be negative in the agglutination 
reaction. Some of the isolates (n=24) were subjected to monoclonal subgrouping using the 
Dresden panel (22, 23). Information regarding serogroups, monoclonal subgroups and sequence 
types was provided for the isolates obtained from the Reference Laboratory in Dresden.  
 
2.3.3 Multi Locus Variable number of tandem repeats (VNTR) Analysis (MLVA) of L. 
pneumophila isolates 
Two MLVA protocols were previously published for L. pneumophila (16, 18). One 
protocol comprised eight VNTR marker genes (MLVA-8) and the second one was composed of 
12 VNTR genes (MLVA-12). The MLVA-8 typing scheme carried out in this study consisted of 
two multiplex PCR (multiplex 1, multiplex 2) using the set of primers previously described (16, 
21) (Table S1). In each multiplex reaction, four VNTR loci were amplified. 25 µl PCR 
reactions contained one to two ng of DNA template, 1x Multiplex PCR Master Mix (Qiagen, 
Hilden, Germany) and 1.25 pmol of each fluorescently labelled primer (VIC-, NED-, FAM- and 
NET- labelled forward primers from Applied Biosystems, Foster City, CA). The PCR program 
comprised an initial denaturation step of 95 ºC for 15 minutes, 35 cycles of 30 seconds at 94 ºC, 
90 seconds at 60 ºC and 60 seconds at 72ºC, followed by a final elongation step for 30 minutes 
at 60 ºC. 
The MLVA-12 scheme for typing L. pneumophila strains consisted of an optimized 
multiplex touchdown PCR where 12 VNTRs markers were amplified using the set of primers 
previously described (18) (Table S1). Amplification was carried out by using 5 to 10 ng of 
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template DNA in a final volume of 25 µl, comprising 1x Multiplex PCR Master Mix (Qiagen, 
Hilden, Germany) and 1.25 pmol of each primer. Forward primers were labelled with VIC, 
PET, 6-carboxyfluorescein (FAM), and NED dyes (Applied Bio- systems, Foster City, CA) 
(Sobral et al 2011). PCR comprised an initial denaturation cycle for 15 min at 95°C followed by 
a first phase of 15 cycles (30 sec at 95°C, 120 sec at 78°C with a decrease in this step of 1.2°C 
in every cycle, and 70 sec at 72°C), a second phase of 15 cycles (30 sec at 95°C, 120 sec at 
60°C and 70 sec at 72°C, with an increase of 5 sec per cycle in this last step) and a final step of 
15 min at  68°C. PCR products of both protocols were checked in 1.5% agarose-gel 
electrophoresis and later purified on filter columns (MSB HTS PCRapace/C (96) kit, Stratec 
Molecular, Germany) according to the manufacturer instructions. Purified PCR products were 
diluted 1:10 with molecular grade water (Roth, Germany) and 1µl of the dilution was added to 
8.8µl of highly deionized formamide (Applied Biosystems, UK) and 0.2µl of GeneScan 1200 
LIZ Size Standard (Applied Biosystems, USA). The mixture was denaturated for 3 min at 95°C 
in a thermoblock, cooled down on ice for at least 1 min and spun down briefly in a Multifuge 1 
centrifuge (Heraeus, Germany). VNTRs were analyzed by fluorescent capillary electrophoresis 
using a 3730xL sequencer (Applied Biosystems) with pre-run voltage of 8.0 kV, run voltage of 
8kV, injection voltage of 1.8kV and injection time of 15 sec. 
Both typing schemes were stablished in our laboratory, however, MLVA-12 protocol, 
less time-consuming and providing more information than MLVA-8, was primarily used for the 
typing of L. pneumophila isolates. To obtain additionally the MLVA-8 scheme and further 
create a combination of both MLVA typing schemes, MLVA-12 multiplex PCR was carried out 
as described and Lpms17, the only locus contained in the protocol MLVA-8 but missing in 
MLVA-12, was amplified separately in a singleplex PCR. The singleplex PCR was performed 
by using 1 to 2 ng of DNA in a final volume of 50 µl, 6 pmol of primer (forward primer 
fluorescent labelled) and 1.5 U of HotStarTaq DNA polymerase (Quiagen). Each dNTP and 
MgCl2 was added in a concentration of 0.1 µM and 2 µM, respectively. Amplification was 
achieved by 15 min denaturation at 95°C, followed by 35 cycles (30 sec at 95°C, 30 sec at 62°C 
and 30 sec at 72°C) and a final step of 10 min at 72°C. Products purification and capillary 
electrophoresis was done as described above for MLVA-12. Additionally, all 13 VNTR markers 
were sequenced (forward primers non-fluorescent labelled) for L. pneumophila Philadelphia-1 
reference strain by cycle sequencing (ABI PRISM BigDye Terminator Cycle Sequencing Ready 
Reaction kit; Applied Biosystems) as a quality control measure. 
 
2.3.4 Data analysis 
Sequences analyses were carried out using the software Sequencer version 5.2.4 
(Genecodes, USA). Capillary electrophoresis data were analysed using GeneMapper software 
(version 3.7, Applied Biosystems) to perform sizing and to calculate the number of repeats in 
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the PCR fragments. Each locus was identified according to colour. Data Fragment sizes were 
converted into repeat numbers based on the formula:  
number of repeats (bp) = fragment size (bp) − flanking regions (bp) /repeat size (bp). 
A null allele (“0”) was assigned when no amplicon was detected. The number of repeats was 
rounded to the nearest integer value. An allele number string (MLVA profile), based on the 
number of repeats at each locus, was assigned to all isolates. An arbitrary numerical code was 
assigned to each MLVA-8 and MLVA-12 genotype. To designate MLVA-8(12) genotypes 
(containing all 13 VNTR) a joint code, including the code in MLVA-8 and in MLVA-12, was 
used. Identical profiles were named with the same code and null alleles were taken into account 
when defining the profiles. Suggestions for optimized panels of VNTRs were determined using 
the Automated Selection of Typing Target Subsets (AuSeTTS) Analysis (24).  
To quantitatively compare and evaluate the congruence among different typing methods 
(MLVA-8, MLVA-12 and SBT), Simpson's Index of Diversity, Adjusted Rand and Wallace 
coefficients were calculated using the online tool provided on 
http://darwin.phyloviz.net/ComparingPartitions. To measure the variation of the number of 
repeats at each VNTR locus, the Hunter-Gaston Discrimination Index (HGDI), which is a 
modification of the Simpson's Index of Diversity, was calculated using http://www.hpa-
bioinfotools.org.uk/cgi-bin/DICI/DICI.pl. Data with the calculated number of repeats were 
imported into Bionumerics (version 5.0, Applied Maths) and the unweighted pair group method 
with the arithmetic mean (UPGMA) clustering method was applied using the categorical 
coefficient and a cut-off value of 60% similarity was applied to define clusters. MLVA-8 allelic 
profiles available at the international Legionella database (http://bacterial-genotyping.igmors.u-
psud.fr/ Legionella2006) were downloaded and imported to Bionumerics for comparison. 
Minimum spanning trees using categorical coeficients and scaling with member number were 
also produced in Bionumerics. Fisher’s exact test was performed to check statistical significance 
(GraphPad Prism, v. 5.0, USA). 
 
2.4 Results 
2.4.1 Isolation and identification of Legionella spp. isolates 
The ISO 11731-2:2004 isolation protocol was initially selected and used for the 
Legionella isolation from the hot water on a shower in the men toilets (room D0.21) and the 
cooling tower water at the HZI campus. However, isolation was not successful using this 
method and no isolates could be obtained from any of the two systems. By using a modification 
of the ISO 11731:1998 standard protocol, a total of 74 Legionella isolates were obtained during 
June 2013 to July 2014 (Table S2). 66 isolates were obtained from the cooling tower, 61 were 
isolated from the cooling tower water and 5 from biofilm. Only 3 Legionella isolates could be 
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obtained from hot water in April 2014 and five isolates were obtained from the dismantled 
faucets (June 2013), from the cooling tower water and 5 from biofilm. Isolation was not 
possible during the summer months of 2013 and in June 2014, probably due to an increase in 
the biocide concentration applied to prevent Legionella growth in the cooling tower during the 
warm months.  
Analysis of the 16S rRNA gene showed that 53 isolates matched strains L. 
pneumophila, as Philadelphia-1, Paris, Corby, Lorraine or Los Angeles. 21 isolates showed a 
negative result in the L. pneumophila species-specific PCR as well as in the latex agglutination 
reaction for serogroup 1 and serogroups 2-14. According to the 16S rRNA analysis these 
isolates corresponded to the species L. longbeacheae. 
 
2.4.2 Validation of MLVA genotyping assays 
The robustness and performance of the MLVA assays described for L. penumophila has 
already been demonstrated when it was initially established (16, 18). Nevertheless, the modified 
protocols were validated in our laboratory as recommended in standard guidelines for 
development and application of MLVA methods (25, 26). For validation, a set composed of 36 
environmental and clinical isolates (outbreak-associated and sporadic isolates), as well as 
reference strains, was used. 
The stability of the VNTRs markers along passages in vivo and in vitro systems was 
already shown to be very high (S=1.00) in both MLVA-8 and MLVA-12 typing schemes and 
was therefore, not tested again in our laboratory. MLVA markers were originally selected based 
on their specificity for L. pneumophila strains (27), nonetheless, this was assessed additionally 
for a larger set of Legionella species (L. anisa ATCC 35292T, L. feeleii ATCC 35072T, L. 
jordanis ATCC 33623T, L. hackeliae ATCC 35250T, L. bozemanii ATCC 33217T, L. erythra 
ATCC 35303T, L. longbeache ATCC 33462T, L. micdadei ATCC 33218T , L. oakridgensis 
ATCC 33761T and L. wadsworthii ATCC 33877T). None of the loci were amplified in the 
multiplex PCR for any of the Legionella species tested. The absence of PCR products was 
confirmed by agarose-gel and by capillary electrophoresis, whose sensitivity is greater, and no 
peaks could be detected (Figure 1). 
The reproducibility of MLVA-8 scheme was tested by comparing the profiles obtained 
for three L. pneumophila reference strains (L.pn. Philadelphia-1, L.pn. Paris and L.pn. Lens) 
with their published profiles (16) (Table S3). For the MLVA-12 scheme, the reproducibility 
was confirmed by comparison with the previously published profile of L.pn. Philadelphia-1 
(18). Furthermore, the 13 alleles of L.pn. Philadelphia-1 were sequenced in order to verify the 
copy number and the accuracy of size determination by capillary electrophoresis (CE). The 
sequencing of the markers showed sizes comparable to the sizes expected and same number of 
repeats and, consequently, same profile. However, a difference of few base pairs for all VNTRs 
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was observed. This difference was especially larger for Lpms31 (8 bps). The same phenomenon 
was observed among the expected or theoretical sizes and the actual sizes of the amplicons 
obtained using CE. Both sizes differed in a few base pairs and for most of the alleles the sizes 
determined by CE were smaller than the theoretical size. Size differences between CE and 
sequencing  have already been shown in other studies (28–30). The differences in the number of 
base pairs increased with the size of the amplicon, regardless of the dye (VIC®-, NED®-, 
FAM- or NET) used for labelling. The maximum difference observed was 21 bp (Lpms31). In 
this case, this difference of size affected the number of repeats, which decreased from 17 to 16.  
 
Figure 1. Representative electropherograms of the MLVA-8 and MLVA-12 PCR products separated by CE and 
identified according to their sizes and colors. Electropherograms correspond to MLVA-8 PCR products of panel 1 
and panel 2 of a) L. pneumophila Philadelphia-1 and b) the environmental isolate from the cooling tower H16; 
MLVA-12 PCR products of c) L. pneumophila Philadelphia-1 and d) L. pneumophila isolate H16. 
 
The repeatability of PCRs (MLVA-12 multiplex and Lpms17-singleplex PCR) and the 
size measurement of the alleles by capillary electrophoresis were validated by typing twice a 
panel of 36 non-related and epidemiologically related isolates (panel I). The results showed a 
complete agreement of the deduced repeat number at all loci (Table S4). Panel l was besides 
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used to assess typeability. Results showed 100% typeability, since all isolates tested were able 
to be assigned to a MLVA type. The typeability of some loci (Lpms1, Lpms19, Lpms38, 
Lpms40) where null alleles (no fragments were amplified by PCR) were observed, was 
confirmed using singleplex PCR reactions in order to rule out suboptimal multiplex conditions 
as a cause for amplification failure. Singleplex PCR showed no amplification for any of the loci 
so PCR failure was rejected. The presence of null alleles could be considered to be sequence 
mismatches in the primer binding region. 
 
2.4.3 Individual VNTR marker evaluation 
The VNTR markers used in both typing schemes were analyzed individually using a 
larger set of 149 isolates (Table S5). This group of 149 isolates was comprised of 73 MLVA-
8(12) genotypes (D=0.964, 95% CI 0.949-0.980). The Hunter Gaston diversity index was 
calculated for each of the 13 VNTR markers (Table 1). Four VNTRs were considerably more 
discriminative than the rest: Lpms13, Lpms31, Lpms35 and Lpms39 (Figure 2). These markers 
could discriminate more than 10 alleles, being Lpms35 the most variable one (19 alleles). Three 
of them were minisatellites (Lpms13, Lpms31, Lpms35) and only one a microsatellite 
(Lpms39). Eight markers showed occurrence of null alleles, due to non-amplification of the loci 
during PCR. The markers presenting a higher percentage of null alleles were the four 
microsatellites (6 to 8 bp units) and Lpms19, one of the VNTR with smallest repeat unit size (21 
bp). 
 
Table 1. Characteristics of the 13 VNTR markers analyzed in panel II based on 149 isolates.  
VNTR 
designation 
Repeat unit 
size (bp) 
No. of alleles 
% of null 
alleles 
HGDI1 CI2 (95%) 
Lpms1 45 5 0 0.508 (0.450-0.567) 
Lpms13 24 10 1.34 0.748 (0.692-0.803) 
Lpms17 39 2 0 0.04 (1.000-0.084) 
Lpms19 21 6 7.38 0.375 (0.282-0.467) 
Lpms3 96 2 0 0.487 (0.458-0.516) 
Lpms31 45 15 1.34 0.873 (0.855-0.892) 
Lpms33 125 5 0 0.689 (0.648-0.729) 
Lpms34 125 4 0.67 0.555 (0.501-0.609) 
Lpms35 18 19 0 0.853 (0.817-0.889) 
Lpms38 8 8 3.36 0.214 (0.124-0.304) 
Lpms39 6 12 6.71 0.815 (0.782-0.849) 
Lpms40 6 3 18.12 0.584 (0.527-0.641) 
Lpms44 6 3 16.78 0.519 (0.444-0.593) 
1Hunter Gaston diversity index, 2 Confidence interval of HGDI. 
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Figure 2. Representation of the number of alleles and the Hunter Gaston diversity index (HGDI) index of the 13 
VNTR markers. 
 
 
Both, the presence of null alleles, and the characterization of these four markers as the 
most discriminative VNTRs, was already shown (18). However, the 13 VNTR markers were 
evaluated by the software AuSeTTS (Automated Selection of Typing Target Subsets) to 
determine the combination of loci that maximizes the discriminatory power (Table 2).  
 
Table 2. Combination of VNTRs markers that maximize discriminatory power 
No. of 
VNTR 
ID (95% CI)1 
No. of 
genotypes 
VNTR Targets 
0 0 1 
 
1 0.873 (0.855-0.892) 15 Lpms31 
2 0.944 (0.928-0.96) 36 Lpms13, Lpms31 
3 0.955 (0.94-0.97) 52 Lpms13, Lpms19, Lpms31 
4 0.959 (0.944-0.974) 58 Lpms13, Lpms19, Lpms31, Lpms38 
5 0.961 (0.946-0.977) 65 Lpms13, Lpms19, Lpms31, Lpms35, Lpms38 
6 0.962 (0.948-0.978) 66 Lpms13, Lpms19, Lpms31, Lpms33, Lpms35, Lpms38 
7 0.963 (0.949-0.979) 69 Lpms13, Lpms19, Lpms31, Lpms33, Lpms35, Lpms38, Lpms40 
8 0.964 (0.949-0.979) 72 
Lpms13, Lpms19, Lpms31, Lpms33, Lpms35, Lpms38,  
Lpms39, 
   
Lpms40 
9 0.964 (0.949-0.98) 73 Lpms13, Lpms17, Lpms19, Lpms31, Lpms33, Lpms35, Lpms38, 
   
Lpms39, Lpms40 
10 0.964 (0.949-0.98) 73 Lpms1, Lpms13, Lpms17, Lpms19, Lpms31, Lpms33, Lpms35, 
   
Lpms38, Lpms39, Lpms40 
11 0.964 (0.949-0.98) 73 Lpms1, Lpms3, Lpms13, Lpms17, Lpms19, Lpms31, Lpms33, 
   
Lpms35, Lpms38, Lpms39, Lpms40 
12 0.964 (0.949-0.98) 73 Lpms1, Lpms3, Lpms13, Lpms17, Lpms19, Lpms31, Lpms33, 
   
Lpms34, Lpms35, Lpms38, Lpms39, Lpms40 
13 0.964 (0.949-0.98) 73 Lpms1, Lpms3, Lpms13, Lpms17, Lpms19, Lpms31, Lpms33, 
   
Lpms34, Lpms35, Lpms38, Lpms39, Lpms40, Lpms44 
1Simpson Index of Diversity and Confidence Interval   
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A combination using a total of 9 markers would be able to discriminate the same number of 
genotypes that were obtained using the 13 markers. This optimal combination of markers would 
be formed by the four most discriminative markers mentioned above and other group of 5 
markers that include mini- and microsatellites (Lpms17, Lpms19, Lpms33, Lpms38 and 
Lpms40). Interesting, by using a subset of 6 markers (Lpms13, Lpms19, Lpms31, Lpms33, 
Lpms35, Lpms38) would allow to differentiate 90% of the genotypes. According to the results 
by AuSeTTS, markers Lpms3, Lpms13, Lpms34 and Lpms38 could be excluded. The use of a 
protocol containing less number of VNTR but same efficiency could reduce the price of the 
typing and facilitate the optimization of the multiplex PCR. 
 
2.4.4 Comparison of Multi Locus Variable number of tandem repeats Analysis (MLVA) 
and Sequence Based Typing (SBT) 
A panel of 149 isolates (panel II, Table S5), comprising 112 clinical and 37 
environmental isolates with known STs and different epidemiological background, was used to 
test the discriminatory power of the different MLVA schemes and to compare with the “gold 
standard” SBT as recommended in the guidelines for application of MLVA methods. Overall, 
the resolution showed by MLVA-12 (ID=0.964, 95% CI 0.948-0.979) scheme was greater than 
the resolution showed by MLVA-8 (ID=0.948, 95% CI 0.929-0.966) (Table 3).  
 
      Table 3. Simpson’s Index of Diversity of the different typing methods 
 
 
 
 
 
 
 
 
Twenty-one genotypes more were obtained when a higher number of loci was used. 
Nevertheless, discrimination was in both cases equal or higher than 0.95, which is the 
thereshold generally used to consider a typing method as “ideal” (25). In addition, both MLVA 
schemes showed higher discrimination than SBT (ID=0.931, 95% CI 0.910-0.953), which could 
discriminate only 45 genotypes out of the 149 isolates in contrast to 50 genotypes obtained by 
MLVA-8 and 71 by MLVA-12. This higher discrimination of MLVA in comparison to SBT is 
consistent with previous results (16, 18, 31).  The combination of 13 loci using the 12 loci 
included MLVA-12 plus Lpms17, the only locus present in the MLVA-8 but not in the MLVA-
12 scheme, was generated and designated using a joint nomenclature as MLVA-8(12). Yet, only 
Typing method No. of genotypes Simpson's ID1 CI2 (95%) 
ST 45 0.931 (0.910-0.953) 
MLVA-8 50 0.948 (0.929-0.966) 
MLVA-12 71 0.964 (0.948-0.979) 
MLVA-8(12) 73 0.964 (0.949-0.980) 
1 Index of Diversity, 2 Confidence interval 
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two genotypes more were found when using in addition Lpms17 (ID=0.964, 95% CI 0.949-
0.980). Therefore, the discriminatory power of this new combination did not differ considerably 
of the MLVA-12 resolution. 
 
The congruence between MLVA and STB was quantified using the adjusted Wallace 
coefficient (32) (Table 4). This coefficient indicates the probability that a pair of isolates which 
are assigned to the same type by one typing method are also typed as identical by the other 
method. A good directional correlation between MLVA and SBT results was observed: the 
probability of two isolates having the same MLVA-8(12) type also sharing the same SBT type 
(ST) was 86.9%. This probability was smaller for MLVA-12 (84.8%) and for MLVA-8 
(76.4%). By contrast, the possibility that two isolates sharing the same ST also shared the same 
MLVA type was 57.3% for MLVA-8, 43.6% for MLVA-12 and 43.6% for MLVA-8(12). These 
differences can be explained by the higher discriminatory power of MLVA compared to SBT. 
 
Table 4. Congruence between typing methods expressed by adjusted Wallace coefficients and analytical 95% 
confidence interval. 
Typing method ST MLVA-8 MLVA-12 MLVA-8(12) 
ST 
 
0.573 (0.454-0.692) 0.436 (0.308-0.563) 0.436 (0.309-0.564) 
MLVA-8 0.764 (0.657-0.870)1 
 
0.669 (0.530-0.808) 0.669 (0.531-0.808) 
MLVA-12 0.848 (0.771-0.924) 0.976 (0.945-1.000) 
 
0.977 (0.946-1.000) 
MLVA-8(12) 0.869 (0.798-0.940) 1.000 (1.000-1.000) 1.000 (1.000-1.000) 
 1 Confidence interval 
    
A minimum spanning tree of the MLVA-8(12) data, grouped by SBT using colors 
(Figure 3), shows the typing resolution of both methods and how clustering with MLVA 
correctly aggregates, in most of the cases, isolates with similar sequence types (ST). In general, 
MLVA-8(12) allowed further differentiation of isolates with identical STs, although was also 
possible to find some cases where a MLVA-8(12) type corresponded to 2 or up to 3 distinct 
STs. An example of it is ST1, which can be subtyped into 8 different MLVA-8(12) types 
(indicated by * in Figure 3). On the contrary, one of MLVA-8(12) type does not match 
exclusively with ST1 but also with ST7 and ST23. This could occur due to the presence of 
recombination, a genetic mechanism that has been shown to occur in L. pneumophila (33). 
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Figure 3. Minimum spanning tree of 149 L. pneumophila isolates typed by MLVA and SBT. Each circle represents a 
MLVA-8(12) type; the size of the circle is scaled according to the number of isolates within a given MLVA-8(12) 
type. The numbers in the different lines connecting the MLVA-8(12) types represent the VNTRs variants. Each color 
represents an ST and STs appear numbered. Asterisks denote MLVA-8(12) genotypes matching more than one ST. 
Due to the large number of STs, some of the MLVA-8(12) types containing only a single strain are left white. 
 
 
 
2.4.5 Phylogeography and population structure of L.  pneumophila isolates in Germany 
using MLVA analysis 
2.4.5.1 Diversity of L. pneumophila in Germany  
A total of 249 L. pneumophila strains from the period 1998-2013 was provided by the 
National Reference Laboratory for Legionella Infections in Dresden, Germany. Specifically, 
147 strains were of clinical origin and 102 were from environmental sources. Environmental 
strains were isolated during routine surveillance programs for Legionella control as well as 
during outbreak investigations whilst clinical strains were isolated from patients that represented 
cases of nosocomial or community infections as well as outbreaks. Environmental and clinical 
strains related to cases of nosocomial or community infections were obtained from 57 cities 
across Germany spanning 16 regions. Strains that represented travel-associated cases of 
legionellosis (n=19) were as well provided, in addition to four reference strains and five strains 
for which important information, as their location, was missing. A total of 311 L. pneumophila 
isolates, collected at the HZI and obtained from the Legionella National Reference Laboratory, 
was MLVA-8(12) genotyped. However, a reduced group of isolates (n=179) was used for 
diversity and population structure analysis of L. pneumophila in Germany. Travel-associated 
isolates, reference strains and strains with missing information were excluded from the study. 
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Furthermore, in order to avoid redundancy due to sample bias, the number of isolates obtained 
at the HZI (n=62) was reduced to the minimum number of genotypes found (n=20). Isolates 
obtained after the legionellosis outbreak occurred in Warstein, 2013 (n=71), were as well 
reduced to the minimum of genotypes (n=9) for the same reason.  
The 179 isolates, 122 from clinical origin and 57 environmental isolates, were typed in 
60 MLVA-8 genotypes (ID=0.954, 95% CI 0.939-0.969), 91 MLVA-12 genotypes (ID=0.972, 
95% CI 0.96-0.984) and 92 MLVA-8(12) genotypes (ID=0.973, 95% CI 0.962-0.984) The 29% 
(n=27) of MLVA-8(12) genotypes were found at least twice, and the rest 71% (n=66) were 
singletons. About 30% of the isolates (n=51) belonged to only 4 genotypes. Among the most 
frequent isolated genotypes were Gt4(17) (n=16, 8.9%) and Gt36(45) (n=7, 3.9%), which 
belonged to ST1 (1,4,3,1,1,1,1) and ST23 (2,3,9,10,2,1,6), two worldwide highly abundant 
sequence types. 
MLVA-8 genotypes were clustered together with the MLVA-8 genotypes of the 
Legionella MLVA database using UPGMA analysis and 60% similarity in order to define the 
groups as previously done (18, 31). Nine MLVA Clonal Complexes or VACCs (VACC1, 
VACC2, VACC3, VACC4, VACC5, VACC6, VACC8, VACC10 and VACC11), which were 
consistent with the clusters existing at the database, were formed (Figure 4). When using the 
combination of 13 loci of MLVA-8(12), adding the markers of MLVA-12 scheme (Lpms31, 
Lpms38, Lpms39, Lpms40, and Lpms44), few changes were observed in the clusters. Strain 
L07-590 was not included in VACC1, L08-378, L10-091 and L12-317 formed a group 
dissociated from VACC1 (VACC1-A) and another group of nine clinical isolates was 
dissociated from VACC1 and formed an independent cluster (VACC1-B). Strains L08-444, 
L10-525, W13-872-2, W13-874-13, W13-845-1 and W13-845-11 were dissociated from 
VACC5. The last four genotypes formed a separated group (VACC5-A). So, three new clonal 
complexes were observed with the addition of the MLVA-12 markers. In total, 92.2% of 
isolates (n=165) were clustered in 12 VACCs (Figure 4) and the rest 7.8% (n=14) were found 
as singletons. VACC2 was the largest cluster including 49 isolates (27.4%), followed by 
VACC1 (36 isolates, 20.0%) and VACC6 (26 isolates, 14.5%). The majority of strains from 
these clonal complexes were Sgp1 (88.9% in VACC1, 87.8% in VACC2, 69.2% in VACC6%). 
VACC1 and VACC2 were characterized by epidemic strains such as Paris and Philadelphia-1, 
respectively.  
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Figure 4. Categorical UPGMA analysis deduced from the clustering of 179 environmental and clinical L. 
pneumophila isolates from panel III using MLVA-8(12) genotyping. MLVA clonal complexes (VACC) of three or 
more genotypes are shown in different colors. 
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2.4.5.2 Geographical structure of L. pneumophila isolates in Germany 
L. pneumophila isolates were obtained from all 16 federal states of Germany, although, 
the number of isolates was not even distributed across the states. Most isolates (n=124, 69.3%) 
were obtained from five states (Niedersachen, Baden Würtemberg, Berlin, Nordrhein-Westfalen 
and Bayern). Several genotypes showed a wide distribution across the states (Figure 5, Figure 
6A), with genotype Gt4(17) (VACC1) being the most widespread profile (8/16 states). It 
corresponds to ST1, a well-known worldwide distributed genotype. In general, the geographical 
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distribution of VACCs was varied (Figure 5, Figure 6B). The largest clonal complexes showed 
to be broadly distributed. In the case of VACC1 (ID=0.811, 95% CI 0.693-0.929), present in 
10/16 states), the wide distribution was due to the wide spreading of its most abundant genotype 
Gt4(17). For VACC2 (ID=0.815, 95% CI 0.703-0.928, 12/16 states) and VACC6 (ID=0.902, 
95% CI 0.809-0.994, 9/16 states) extensive distribution could be due to the higher genotype 
diversity. Only one small cluster, VACC5-A, formed by 4 isolates of 4 distinct genotypes, was 
exclusively found in the city of Warstein, during the legionellosis outbreak in August 2013.  
 
Figure 5. Minimum spanning tree obtained with Bionumerics on the MLVA-8(12) profiles of 179 L. pneumophila 
strains. MLVA clonal complexes (VACC) appear shaded. Pie charts represent the 92 different MLVA-8(12) 
genotypes of Germany with size proportional to genotype frequencies and the different colours refer to the 16 
different states of Germany (see legend). Thicknesses of the branches represent the number of different of loci. 
 
 
To better evaluate the levels of genetic diversity in Germany, results from this study 
were compared to the variability in Europa reported to the Legionella MLVA database. Isolates 
clustered into the largest clonal complexes VACC1 and VACC2, were also reported in several 
countries across Europe (Greece, England, Sweden, Portugal, Spain or Denmark among other). 
VACC6 was reported in Sweden and France, where one of its genotypes was colonizing most 
parts of the hot water system in the French city of Rennes (18). Several VACC6 genotypes 
corresponded to ST332 (7,10,17,6,14,11,3) and ST424 (7,10,17,3,13,14,9), which were reported 
according to the L. pneumophila Sequence-Based Typing database only from Germany.  
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Figure 6. Geographical distributions of MLVA-8(12) genotypes (A) and clonal complexes (B) across Germany. Each 
colour represents a genotype or clonal complex (see legend). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.4.3 Comparison of environmental and clinical isolates 
Serogroup and, when possible, monoclonal antibody (MAb) subgroup of the clinical 
(n=122) and environmental (n=57) isolates are shown in Table 5. Overall, 90.2% of clinical 
isolates were sgp1 (serogroup 1) compared to 71.9% of environmental isolates (P<0.05). Sgp3 
and sgp5 were exclusively found in clinical isolates (4.1% and 0.8%, respectively). Likewise, 
sgp4 was only found in environmental isolates (10.5%). All three serogroups (sgp3, sgp5 and 
sgp4) were found in cases of nosocomial and community acquired infections as in routine 
samplings in different countries according to the SBT Legionella database (3.5%, 1.8% and 
0.9% of the isolates reported to the database).  
Likewise, according to the MAb serotyping, 68% of the clinical isolates were confirmed 
to be part of the virulence-associated ‘MAb3/1 positive’ subgroup [also known as MAb2+ ve’ 
subgroup or “Pontiac” (34)], compared to 33.3% of the environmental isolates (P<0.05). 
Clinical isolates obtained from the three large Legionella outbreaks that have been occurred in 
the past years in Germany (Ulm, 2010; Zweibrücken, 2012 and Warstein, 2013) were typed as 
sgp1 MAb3/1 positive. 
 
A B 
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    Table 5. Distribution of clinical isolates (n=122) and environmental isolates (n=57) of 
    L. pneumophila by phenotype (serogroup and MAb subtype) in Germany. 
Serogroup 
(sgp) 
MAb subtype 
Clinical isolates Environmental isolates 
No. Frequency (%) No. Frequency (%) 
1 Philadelphia 19 15.6 4 7.0 
1 Allentown/France 11 9.0 3 5.3 
1 Benidorm 12 9.8 5 8.8 
1 Knoxville 41 33.6 7 12.3 
 
MAb 1/3 +ve 83 68.0 19 33.3 
1 OLDA 15 12.3 10 17.5 
1 Oxford 2 1.6 1 1.8 
1 OLDA/Oxford 1 0.8 0 
 1 Bellingham 6 4.9 6 10.5 
1 Denver 2 1.6 2 3.5 
 
MAb 1/3 -ve 26 21.3 19 33.3 
1 Oxford/Philadelphia 1 0.8 0 
 1 Unknown 0 
 
3 5.3 
 
Total sgp1 110 90.2 41 71.9 
3 
 
5 4.1 0 
 4 
 
0 
 
6 10.5 
5 Dallas 1 0.8 0 
 6 Chicago 3 2.5 2 3.5 
6 Dresden 2 1.6 1 1.8 
10 
 
1 0.8 5 8.8 
(2-14) 
 
0 
 
2 3.5 
 
Total non-sgp1 12 9.8 16 28.1 
Total 
 
122 100.0 57 100.0 
 
 
Table 6 shows the distribution of MLVA-8(12) genotypes and STs of clinical and 
environmental isolates. As shown before, 92 MLVA-8(12) genotypes were observed among the 
179 isolates (ID=0.973, 95% CI 0.962-0.984). Among the 122 clinical isolates, 67 genotypes 
were identified (ID=0.970, 95% CI 0.954-0.985) while 38 genotypes were identified among the 
57 environmental isolates (ID=0.969, 95% CI 0.946-0.992). Only 13 genotypes were common 
to the two groups (Figure 6A), 54 genotypes were exclusively found among clinical isolates 
and 25 among environmental isolates. In both groups, the distribution frequency of the 
genotypes was skewed (Table 6). The common genotypes were the most abundant ones in each 
group (frequency of >5%), in particular, two genotypes, Gt4(17) and Gt23(63), accounted for 
20.5% and 21% of clinical and environmental isolates, respectively. The majority of genotypes 
in each group were found only once. Gt4(17), as already mentioned, corresponds to ST1. 
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Figure 6. A) Venn diagram of the number of MLVA-8(12) genotypes shared among clinical and environmental L. 
pneumophila isolates. B) Minimum spanning tree of the MLVA-8(12) profiles of 179 L. pneumophila strains. MLVA 
clonal complexes (VACC) appear shaded. Clinical isolates are represented in red and environmental isolates in green 
in both graphics.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical  
isolates (n=122) 
Environmental 
 isolates (n=57) 
13 common 
genotypes 
54 unique genotypes 
ID 0.9695 (0.9536, 0.9855) 
25 unique genotypes 
ID 0.9693 (0.9463, 0.9923) 
A 
B 
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ST1 is usually very frequent in the environment (36) but it can also be associated to nosocomial 
and community acquired infections as well ((37, 38). Gt23(63) corresponds to ST182, a sgp1 
genotype isolated predominantly in Germany, particularly in the area of Berlin and Brandenburg 
responsible for multiple infections. Gt47(56), the third more frequent genotype among 
environmental isolates (8.8%), was also present among the clinical genotypes (2.5%). It 
matches ST334, a sequence type subtyped as MAb3/1 negative found primarily in the 
environment in Germany. Figure 6B shows the clonal relatedness between clinical and 
environmental isolates. Several clonal complexes were formed exclusively by clinical isolates 
(VACC1-A, VACC1-B, VACC5), while VACC5-A was composed only by environmental 
isolates. The rest of clonal complexes shared both types of isolates. VACC2, despite of 
containing environmental isolates was formed mostly by numerous clinical genotypes.  
According to the epidemiology, most isolates were related to cases of LD (nosocomial 
and community-acquired infections). Only the isolates obtained from the cooling tower in the 
HZI campus were not considered to be related to any case of infection. No correlations were 
found between the MLVA 8(12) genotypes, serogroup or MAb subgroups and the origin of the 
isolates. 
 
 
 
Table 6. Distribution of MLVA-8(12) genotypes among clinical (n=122) and environmental isolates (n=57) of L. 
pneumophila.  
  
Clinical isolates Environmental isolates 
ST  MLVA- 8(12) No. Frequency (%) No. Frequency (%) 
ST182 Gt 23(63) 17 13.9 4 7.0 
ST1  Gt 4(17) 8 6.6 8 14.0 
ST23/ST177 Gt 36(45) 7 5.7 0 
 ST62 Gt 29(27) 4 3.3 0 
 ST62 Gt 75(49) 4 3.3 0 
 ST47/ST82 Gt 37(46) 4 3.3 1 1.8 
ST9/ST561/ST737 Gt 64(115) 3 2.5 0 
 ST62/ST169 Gt 71(135) 3 2.5 0 
 ST387 Gt 48(60) 3 2.5 2 3.5 
ST334 Gt 47(56) 3 2.5 5 8.8 
ST1 Gt 18(4) 3 2.5 2 3.5 
ST9/ST440 Gt 64(74) 2 1.6 0 
 ST59 Gt 22(64) 2 1.6 0 
 ST46/ST82 Gt 37(62) 2 1.6 0 
 ST424 Gt 83(121) 2 1.6 0 
 ST332 Gt 44(54) 2 1.6 0 
 ST189 Gt 23(73) 2 1.6 0 
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  Clinical isolates Environmental isolates 
ST  MLVA- 8(12) No. Frequency (%) No. Frequency (%) 
ST182 Gt 23(71) 2 1.6 0 
 ST93 Gt 24(117) 1 0.8 0 
 ST93 Gt 24(68) 1 0.8 0 
 ST93 Gt 84(116) 1 0.8 0 
 ST93 Gt 86(118) 1 0.8 0 
 ST92 Gt 80(65) 1 0.8 0 
 ST9 Gt 52(122) 1 0.8 0 
 ST9 Gt 54(77) 1 0.8 0 
 ST9 Gt 87(120) 1 0.8 0 
 ST9 Gt 88(90) 1 0.8 0 
 ST87 Gt 30(137) 1 0.8 0 
 ST81 Gt 8(132) 1 0.8 0 
 ST8 Gt 28(24) 1 0.8 1 1.8 
ST788 Gt 41(52) 1 0.8 0 
 ST736 Gt 53(85) 1 0.8 0 
 ST68 Gt 24(116) 1 0.8 0 
 ST62 Gt 67(22) 1 0.8 0 
 ST562 Gt 34(136) 1 0.8 0 
 ST46 Gt 37(55) 1 0.8 0 
 ST45 Gt 32(41) 1 0.8 1 1.8 
ST444 Gt 72(66) 1 0.8 0 
 ST44 Gt 77(139) 1 0.8 0 
 ST437 Gt 9(129) 1 0.8 0 
 ST435 Gt 69(69) 1 0.8 0 
 ST425 Gt 27(133) 1 0.8 0 
 ST424 Gt 82(127) 1 0.8 0 
 ST42 Gt 31(37) 1 0.8 1 1.8 
ST42 Gt 76(140) 1 0.8 0 
 ST407 Gt 79(125) 1 0.8 0 
 ST347 Gt 54(123) 1 0.8 0 
 ST345 Gt 39(48) 1 0.8 0 
 ST34 Gt 52(75) 1 0.8 1 1.8 
ST334 Gt 81(128) 1 0.8 0 
 ST332 Gt 82(126) 1 0.8 0 
 ST292 Gt 40(47) 1 0.8 1 1.8 
ST20 Gt 33(40) 1 0.8 0 
 ST182 Gt 64(119) 1 0.8 0 
 ST182 Gt 82(124) 1 0.8 0 
 ST18 Gt 73(51) 1 0.8 0 
 ST15 Gt 66(131) 1 0.8 0 
 ST1403 Gt 32(70) 1 0.8 1 1.8 
ST1352 Gt 64(114) 1 0.8 0 
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  Clinical isolates Environmental isolates 
ST  MLVA- 8(12) No. Frequency (%) No. Frequency (%) 
ST1327 Gt 78(130) 1 0.8 0 
 ST1292 Gt 69(67) 1 0.8 0 
 ST1 Gt 28(25) 1 0.8 0 
 ST1 Gt 4(14) 1 0.8 2 3.5 
ST1 Gt 4(59) 1 0.8 0 
 ST1 Gt 68(19) 1 0.8 0 
 ST1 Gt 70(21) 1 0.8 0 
 
 
Gt 85(138) 1 0.8 0 
 ST9 Gt 53(76) 0 
 
1 1.8 
ST788 Gt 42(53) 0 
 
1 1.8 
ST600 Gt 30(32) 0 
 
1 1.8 
ST600 Gt 30(33) 0 
 
1 1.8 
ST600 Gt 30(34) 0 
 
1 1.8 
ST600 Gt 30(35) 0 
 
1 1.8 
ST48 Gt 7 (26) 0 
 
1 1.8 
ST334 Gt 46(58) 0 
 
1 1.8 
ST334 Gt 50(57) 0 
 
1 1.8 
ST182 Gt 54(56) 0 
 
1 1.8 
ST1431 Gt 14(31) 0 
 
1 1.8 
ST1 Gt 18(5) 0 
 
1 1.8 
ST1 Gt 4(61) 0 
 
1 1.8 
 
Gt 14(30) 0 
 
1 1.8 
 
Gt 22(100) 0 
 
1 1.8 
 
Gt 22(102) 0 
 
2 3.5 
 
Gt 22(113) 0 
 
1 1.8 
 
Gt 4(16) 0 
 
1 1.8 
 
Gt 43(104) 0 
 
2 3.5 
 
Gt 49(101) 0 
 
1 1.8 
 
Gt 5(11) 0 
 
1 1.8 
 
Gt 5(12) 0 
 
1 1.8 
 
Gt 51(103) 0 
 
1 1.8 
 
Gt 56(86) 0 
 
1 1.8 
 
Gt 62(10) 0 
 
1 1.8 
Total 
 
122 100 57 100.0 
 
 
2.5 Discussion 
2.5.1 Validation of MLVA assays 
Germany is fourth in the EU with respect to the total cases of LD according to the last 
surveillance report of the European Center for Disease prevention and Control (39). Previous 
studies have suggested that the incidence of LD may increase under warm and wet 
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meteorological conditions, which could be due to the global climate change (40–42). Therefore, 
surveillance of environmental sources and proper maintenance of man-made freshwater systems 
are key in the prevention of legionellosis. Surveillance of Legionella in the environment is also 
indispensable to validate the efficacy of decontamination procedures, for risk assessment, when 
evaluating the potential transmission or amplification sources at a facility, and for tracking the 
sources of outbreaks. Cultivation is still considered the gold standard for detection of Legionella 
in the environment yet other non-culture methods are available, as serology or nucleic acid-
based detection methods, especially qPCR (43). Cultivation can be inaccurate as a result of 
overgrowth by other microorganisms on the agar plates, can generate false positives (44) and 
can be ineffective due to the presence of viable but non culturable (VNBC) Legionella cells 
(45). However, cultivation allows obtaining isolates that can be identified and characterized 
phenotypically and genetically which is essential for epidemiological studies. 
Several typing methods have been applied for subgrouping of Legionella species. In 
particular, most of them were applied for subtyping of L. pneumophila since this species is the 
responsible for more than 90% of the cases of LD. Among the typing methods, such as Pulse-
Field Gel Electrophoresis (PFGE) or Amplified Fragment Length Polymorphism (ALFP), 
monoclonal antibody subtyping (MAb) and sequence-based typing (SBT) are the preferred 
epidemiological typing methods for comparison of clinical and environmental isolates. 
Monoclonal antibody subtyping is easy to perform and although its index of discrimination is 
not as high as for other methods, it is still useful to distinguish environmental isolates not 
related to the clinical isolates during outbreak investigations. SBT has high typeability, 
interlaboratory reproducibility and generally a high index of discrimination (46). However, 
some STs are very common (ST1) and when those STs are responsible for causing LD higher 
discrimination is needed in order to find out the source of the infection. (40, 47, 48). Therefore, 
the use of a combination of typing methods is recommended (49).  
Multiple Locus Variable number of tandem repeats Analysis (MLVA) has emerged as a 
method for the subtyping of bacterial pathogens. Studies performing MLVA genotyping with 
other pathogens showed the increase of resolution of MLVA when it was compared to other 
typing methods (13, 50, 51). MLVA methods are in addition rapid and and not as expensive and 
laborious as SBT. Nevertheless, besides these advantages, MLVA usually lacks standardization 
that can complicate the comparison and interpretation of results. For instance, a single bacterial 
pathogen can be studied by different MLVA protocols generated by different laboratories or 
there may be differences in the sizing of amplicons due to different platforms or chemicals, in 
the nomenclature used to designate the genotypes or in the interpretation of incomplete repeats. 
Therefore, validation of the protocol, as recommended in recognized guidelines (26, 25) is 
crucial during the implementation of MLVA in a new laboratory. In the case of L. pneumophila, 
two MLVA protocols had been previously described (16, 18). The MLVA-8 protocol consisted 
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of a combination of eight VNTR markers formed by longer repeat sequences or minisatellites 
(Lpms1, Lpms3, Lpms13, Lpms19, Lpms33, Lpms34 and Lpms35). MLVA-12 protocol 
included 12 VNTR markers, of which seven were comprised in MLVA-8 and five new ones 
were added, one minisatellite (Lpms31) and four microsatellites (Lpms38, Lpms39, Lpms40 
and Lpms44). Overall, general, the validation of the MLVA protocol in our laboratory 
confirmed the reproducibility and repeatability of the protocol, the specificity of the VNTR 
markers for L. pneumophila and the high discriminatory power. 
The reproducibility of MLVA-8 and MLVA-12 schemes was tested by comparing the 
profiles of reference strains using capillary electrophoresis and sequencing of the PCR products 
for each marker. The sizes of the amplicons and therefore, the number of repeats for each 
marker, analyzed by sequencing corresponded with the expected sizes, or sizes observed in 
silico when the primers were designed. However, the sizes of the amplicons obtained by 
capillary electrophoresis differed in few basepairs from the expected sizes. This was observed in 
other studies (29, 30, 52, 53). The differences in basepairs increased with the number of repeats, 
specifically there was a difference of 21 bp less for Lpms31, which is the marker with highest 
number of repeats. The size differences were consistent and did not interfer when calculating 
the number of repeats, except for marker Lpms31. This could be due to large size of the 
amplicon that could have sequence-specific migration performance. Other reasons for 
differences between the observed and the theoretical sizes could be the size standard, type of 
polymer, or the instrument used. Since this only occurred with Lpms31 it appears to be intrinsic 
to this marker. It could be suggested that markers whose size differ from their expected size and 
can lead to inaccurate calculation of number of repeats could be excluded of the typing scheme, 
despite the high index of diversity. 
A very good repeatability was determined for the MLVA-8 and MLVA-12 schemes 
after duplicate typing of 36 strains were carried out (Table S4). Usually, less than one basepair 
variation in fragment size was observed between different runs and therefore, the number of 
repeats was concordant for all markers. The typeability, or possibility of assign an isolate to a 
certain MLVA type, was as well very good since all isolates could be genotyped. Null alleles 
were observed for the VNTR markers Lpms1, Lpms19, Lpms38, Lpms40, at frequencies 
ranging from 0.67% in Lpms34 (microsatellite) to 18.12% in Lpms40 (minisatellite). However, 
no correlation has been found between null allele frequency and microsatellite repeat length nor 
motif complexity (54). Null alleles are considered a common genotyping error (55, 56). 
Although many studies using MLVA and microsatellites have reported the presence of null 
alleles (57–59). They are due to mutations in the annealing sequence, which produce poor 
amplicon or no amplification of the marker at all.  
Regarding the index of discrimination of both MLVA typing schemes, MLVA-12 
showed greater resolution than MLVA-8, as expected, due to the introduction of five highly 
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discriminative markers, especially Lpms31, Lpms38 and Lpms39, with 15, 8 and 12 alleles 
respectively. The combination of both schemes using in total 13 markers, so called MLVA-
8(12), did not reveal a big improvement of the resolution compared to MLVA-12, since only 
two new genotypes were observed. Thus, typing separately Lpms17, the VNTR included in 
MLVA-8 but absent in MLVA-12, could be abandoned. The analysis of the 13 VNTRs 
regarding their index of diversity suggested a combination of nine markers that would maximize 
the discriminatory power and would resolve the same number of genotypes than using all 13 
VNTRs. Nevertheless, the use of the 12 loci of the MLVA-12 scheme showed the highest 
congruence with SBT, a requirement for two typing methods that are used in a complementary 
manner.  
An important fact to point out is the general lack of consensus about the type of 
rounding that should be selected for allele assignment. While some studies take into 
consideration half repeats to assign new alleles (18, 59), most of the MLVA studies preferred to 
make use of the rounding to the nearest whole integer, or to round down to consider exclusively 
complete repeats (13, 60–62). The second rounding strategy could be less biased and easier to 
reproduce than the rounding considering half sizes, unless it is well specified how to determine 
a half repeat. In this study half repeats have not been considered, in contrast to the previous 
MLVA protocols for L. pneumophila (18). However, to compare the newly obtained genotypes 
with the profiles downloaded from the database; those were as well rounded to the nearest 
integer and then compared. The instructions to follow for the allele assignment should be clearly 
specified when new MLVA protocols are designed to make them truly efficient and comparable.  
In conclusion, it was demonstrated that the combined MLVA method described in this 
study was an appropriate typing method for L. pneumophila isolates due to the upright 
performance for the criteria discussed above. Nonetheless, its rapidity, costs efficiency, 
accessibility to technical resources (availability of a capillary sequencer) and the portability of 
the results make MLVA very suitable as genotyping method. 
 
2.5.2 L. pneumophila diversity and population structure in Germany using MLVA analysis 
In Germany, the population genetics of L. pneumophila isolates have been previously 
studied by using PFGE (63), SBT (1, 19) or by Variable genetic Element Typing (VET) (64). 
Nonetheless, no studies using MLVA genotyping for L. pneumophila have been reported in 
Germany. Thus, the study of the diversity of L. pneumophila isolates in Germany by MLVA 
could help to obtain insight into the population structure and consequently improve the 
surveillance and disease control for LD. 
As shown before during the validation of the MLVA protocols, the discriminatory 
power of the combined scheme MLVA-8(12) was higher than the discrimination given by 
MLVA-8 when both protocols were applied to the population of L. pneumophila isolates in 
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Germany. By MLVA-8(12), and the same phenomenon was seen by MLVA-8, the majority of 
genotypes (70%) appeared as singlentones, while few genotypes, specifically four genotypes, 
among them Gt4(17) or Gt36(45), appeared very frequently. These genotypes correspond to 
ST1 and ST23, and represent globally distributed sequence types. The high diversity or number 
of singletones observed in L. pneumophila could be a consequence of the great capability that 
this bacterium has to exchange genetic material. The genome of L. pneumophila is highly 
dynamic, with recombination and horizontal gene transfer of mobile genetic elements as the two 
important factors in its evolution (33).  L. pneumophila are naturally competent bacteria (65, 66) 
and comparative genome analysis have shown that the genome of L. pneumophila can contain 
integrative plasmids, genomic islands and conjugation elements (67). It has been reported that 
L. pneumophila can interchange DNA not only within the species L. pneumophila (68) but also 
within the genus Legionella (69) and with their eukaryotic hosts (70). An example of exchange 
within the species is the gene cluster coding for the synthesis of the lipopolysaccaride (LPS) 
responsible of the serogroup 1, which has been detected in different L. pneumophila strains of 
different lineages, suggesting that the serogroup 1 LPS cluster can be transferred horizontally 
(69). Recombination is another mechanism that shapes the population structure and evolution of 
L. pneumophila (71, 72). However, besides the evidence for recombination and horizontal gene 
transfer, the population structure of L. pneumophila has been considered to be clonal due the 
high linkage disequilibrium showed by studies using typing methods (73, 74) and due to the 
presence of strains or clonal complexes with a global distribution. Visca et al. (2011) (31) 
showed signs of recombination in a study of the populations of L. pneumophila carried out by 
using MLVA genotyping. ST1, which corresponds to Gt4(17) and is represented by the strain 
Paris, is the most abundant strain in VACC1. It has been isolated very frequently from the 
environment as well as from patients of LD throughout France (75) and other European 
countries (76–78)  including Germany (19) . It has been found in very different environments, 
such as hot springs, cooling towers or freshwater systems in Asian countries (79) and it is one of 
the most abundant strains found in Canada (37, 80). ST23 is usually reported together with ST1. 
The results obtained by MLVA in this study support the hypothesis of a clonal population of 
these previous studies. Not only few genotypes, as Gt4(17) (ST1), are distributed across the 
country but also the clonal complexes or VACCs appeared broadly distributed. In general, the 
VACCs did not show any correlation with sampling locations, with exception of the small 
VACC5-A, which was exclusively found in Warstein. The lack of correlation between the 
strains that comprise the clonal complexes and geographical characteristics was observed by 
Cazalet et al. (2008) (69). The overall results indicated that the population structure of L. 
pneumophila isolates from Germany results from the combined action of widespread clonal 
complexes and genotypes, i.e. Gt4(17) along with genetic differentiation at shorter geographic 
distances (VACC5-A).  
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To better implement satisfactory control measures that prevent and limit new infections, 
it is necessary to know the scope of variation among clinical and environmental L. pneumophila 
strains. In this respect, this study was concordant with earlier results. The percentage of sgp1 
among clinical isolates was significantly higher than among environmental isolates and the 
majority of clinical isolates were subgrouped as MAb3/1 positive, in contrast to the 
environmental isolates, where MAb3/1 negative were more predominant. The same proportions 
were demonstrated for L. pneumophila populations in the UK (76, 81), France (82) and in the 
US (83). Until now, there is no complete explanation for the enhanced ability of sgp1 strains, 
and in particular MAb3/1 positive strains, to cause disease. Hypothetically, some strains of L. 
pneumophila could be especially virulent to humans, easily aerosolized, or more suited to 
colonization of freshwater distribution systems (84). In this study,  the diversity observed in 
clinical and environmental isolates was very similar, in contrast to a previous analysis (81) that 
showed that diversity of the clinical isolates was significantly less than that of the 
environmental isolates. The same group published later how these differences, although still 
present, were smaller (76). 
Another important point that was shown by using MLVA genotyping methods and 
agreed with what it was shown by SBT, was the little overlap between the two populations, 
clinical and environmental isolates. Only 13 out of 92 MLVA-8(12) genotypes were common 
among clinical and environmental isolates. The same effect was observed with the sequence 
types. Usually, common clinical STs are rarely found in the environment and viceversa (23, 76). 
Harrison et al. (2009) (76) suggested that well-managed freshwater systems present little risk to 
the human population, due to the low incidence of isolation of clinical strains from the 
environment. With the data set used in this study it is not possible to make the same suggestion. 
Among the common genotypes, Gt4(17), and therefore, ST1, was the most abundant in the two 
populations. Environmental and clinical Gt4(17) were related to community acquired and 
nosocomial cases of LD. Borchard et al. (2008) (19) described that ST1 was, by far, the most 
common ST in Germany among isolates from patients, although they noted that their sample of 
isolates was probably not representative of Germany as a whole, as nosocomial cases were very 
over-represented. The dataset used in this study might be biased due to the random selection of 
isolates but it pointed out that ST1 is also frequently present in different environments in 
Germany. Not only in Germany but in many other countries ST1 appeared as the most prevalent 
ST for both clinical sporadic and environmental L. pneumophila sgp1 group isolates.  
Until today, there is no confirmed explanation to the presence of globally distributed 
clones. A hypothesis could be that these clones are easier cultured than other strains, indicating 
bias in the isolation procedures. However, Sánchez-Busó et al. (2014) (72), showed a high 
congruence in the level of diversity detected by molecular methods and by SBT based on 
isolates. Geographical barriers do not appear to be significant for the formation of the clones. It 
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could be more suitable that the strains or group of strains that form the extensively distributed 
clonal complexes would be adapted to specific ecological niches. Amemura-Maekawa et al. 
(2005) (85) and Cohan et. Al (2007) (86) reported the presence of possible stable ecotypes 
adapted to specific ecological environments. More recently, in a study where environmental 
strains of L. peumophila were genotyped by MLVA-8 by Rodríguez-Martínez et al. (2015) (87), 
it was suggested that distinct genotypes (Gt4 and Gt6) included within clonal complex VACC1 
could be perceived as different ecotypes with features rendering them competent in different 
niches. Furthermore, whole genome analyses and physiological studies open new research 
avenues to reveal if specific genes could contribute to improved fitness in the specific 
environment. 
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2.7 Supplementary material 
Table S1. Characteristics of the VNTR loci and primer sequences used in this study. 
        
VNTR Primer sequence (5´-3´) 
Repeat unit 
size (bp) 
Position 
(bp)1 
MLVA 
scheme 
Associated 
gene 
Function Reference 
Lpms01 GCATATGACAAAGCCTTGGC 45 3231393 MLVA-8/ lpg2854 Hypothetical protein Sobral et al. 2011 
 
NED-TGAATTTCTCCCTCTTGCTTG 
  
MLVA-12 
   Lpms03 TGATGGTCTCAATGGTTCCG 96 3145527 MLVA-8/ lpg2793 Protein LepA, onserved gene Sobral et al. 2011 
 
 VIC-GGACAAACAACCAATGAAGC 
  
MLVA-12 
   Lpms13 GCATCGGACTGAGCAAAGTA 24 1645025 MLVA-8/ lpg1488 Conserved protein, surface antigen Sobral et al. 2011 
 
NED-CTCACCAGGATGCTTTGTCG 
  
MLVA-12 
   Lpms17 TAACATCAATGACCGCGAAA 39 931165 MLVA-8 lpg0854 Hypothetical protein Pourcel et al. 2007 
 
VIC-CAGCTCACCCCGTATCACTT 
      Lpms19 TCCAGAGGCTCTGGATTATC 21 913445 MLVA-8/ Intergenic 
 
Sobral et al. 2011 
 
VIC-GAACTATCAGAAGGAGGCGA 
  
MLVA-12 
   Lpms31 ATCGCCTAATTGCCGCCTA  45 2991504 MLVA-12 
  
Sobral et al. 2011 
 
FAM-CCTCGCAAGCCTATGTGG 
      Lpms33 CGAGGAAATCTTCTTCAGCC 125 2578937 MLVA-8/ Intergenic 
 
Sobral et al. 2011 
 
VIC-GACACCACAGCAGTTTGAAC 
  
MLVA-12 
   Lpms34 ATGCAGGATGTTTGCGCATG  125 2662138 MLVA-8/ lpg2356 Transmembrane protein Sobral et al. 2011 
 
FAM-AAGGAATAAGGCGCAGCAC  
  
MLVA-12 
   Lpms35 TATCAACCTCATCATCCCTG 18 1428473 MLVA-8/ lpg1299 Protein FimV, Sobral et al. 2011 
 
PET-GAATCTGAAACAGTTGAGGATG 
  
MLVA-12 
 
transmembrane Tfp pilus assembly 
 Lpms38 GGATTGCCTTGGGCATTAAT  8 857393 MLVA-12 lpg0692 ABC type transport, ATPase component Sobral et al. 2011 
 
NED-CCTATCAACAGATGACGCTT 
      Lpms39 CCAACTCCTCAACGCAACAA 6 3219356 MLVA-12 lpg2844 Hypothetical histidine-rich protein Sobral et al. 2011 
 
PET-CTTGACGAAGTAGGTGTGGG 
      Lpms40 TTACCCAAGCCCTTATTGCG  6 29936 MLVA-12 lpg0023 Transmembrane protein Sobral et al. 2011 
 
FAM-TAGATCTCTTGCCGAGCTTC 
      Lpms44 TTATGCGAGAGTTTCATGA 6 3009948 MLVA-12 lpg0321 50S ribosomal protein Sobral et al. 2011 
  NED-GCTACTGCAGCAACATCC             
1 Position on the L.pneumophila Philadelphia-1 genome 
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Table S2. Legionella strains isolated at the HZI campus between June 2013 and July 2014. 
Strain 
Designation 
Sgp 
Leg. genus  
16S rRNA 
PCR 
L.pn. 16S 
rRNA PCR 
Site of isolation Type of sample 
Isolation 
date 
Closest described bacterial species (% similarity, accession no.) 
H16 2-14 + + Cooling tower Bulk water 19/06/2013 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H17 2-14 + + Cooling tower Bulk water 19/06/2013 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H18 1 + + Cooling tower Biofilm 19/06/2013 100% Legionella pneumophila str. Paris complete genome CR628336.1 
H19 2-14 + + 
HZI (Kitchen faucet 
D2) Biofilm 28/06/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H20 2-14 + + 
HZI (Kitchen faucet 
D2) Biofilm 28/06/2013 99%  Legionella pneumophila subsp. pneumophila str. Lorraine chromosome, FQ958210.1 
H21 1 + + 
HZI (Kitchen faucet 
D2) Biofilm 28/06/2013 99% Legionella pneumophila str. Paris complete genome CR628336.1 
H22 2-14 + + 
HZI (Kitchen faucet 
D2) Biofilm 28/06/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H23 2-14 + + 
HZI (Kitchen faucet 
D2) Biofilm 28/06/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H24 2-14 + + Cooling tower Biofilm 01/11/2013 100%  Legionella pneumophila subsp. pneumophila str. Lorraine chromosome, FQ958210.1 
H25 1 + + Cooling tower Biofilm 01/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H26 2-14 + + Cooling tower Biofilm 01/11/2013 100%  Legionella pneumophila subsp. pneumophila str. Lorraine chromosome, FQ958210.1 
H27 1 + + Cooling tower Biofilm 01/11/2013 100%  Legionella pneumophila subsp. pneumophila str. Lorraine chromosome, FQ958210.1 
H28 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H29 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H30 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H31 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H32 2-14 + + Cooling tower Bulk water 28/11/2013 99% Legionella pneumophila str. Corby, complete genome CP000675.2 
H33 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H34 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H35 1 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H36 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H37 2-14 + + Cooling tower Bulk water 28/11/2013 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H38 1 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila str. Paris complete genome CR628336.1 
H39 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H40 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
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H41 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H42 1 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H43 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H44 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H45 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H46 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H47 2-14 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila str. Corby, complete genome CP000675.2 
H48 1 + + Cooling tower Bulk water 28/03/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H49 negative + - 
HZI (Men´s toilet 
D0.21) Hot water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence  AY444741.1 
H50 2-14 + + 
HZI (Men´s toilet 
D0.21) Hot water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H51 2-14 + + 
HZI (Men´s toilet 
D0.21) Hot water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H52 1 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H53 1 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H54 negative + - Cooling tower Bulk water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H55 negative + - Cooling tower Bulk water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H56 negative + - Cooling tower Bulk water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene,partial sequence   AY444741.1 
H57 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H58 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H59 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H60 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H61 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H62 1 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H63 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H64 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H65 negative + - Cooling tower Bulk water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H66 negative + - Cooling tower Bulk water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H67 negative + - Cooling tower Bulk water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H68 negative + - Cooling tower Bulk water 08/04/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H69 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H70 2-14 + + Cooling tower Bulk water 08/04/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H71 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
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H72 1 + + Cooling tower Bulk water 25/06/2014 100% Legionella pneumophila str. Lens complete genome CR628337.1 
H73 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H74 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H75 2-14 + + Cooling tower Bulk water 25/06/2014 99% Legionella pneumophila subsp. fraseri strain Los Angeles-1 16S ribosomal RNA gene NR_104921.1 
H76 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H77 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H78 2-14 + + Cooling tower Bulk water 25/06/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H79 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H80 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H81 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H82 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H83 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H84 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H85 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H86 negative + - Cooling tower Bulk water 25/06/2014 99% Legionella longbeachae strain ATCC 33484 16S ribosomal RNA gene, partial sequence   AY444741.1 
H90 2-14 + + Cooling tower Bulk water 13/07/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H91 2-14 + + Cooling tower Bulk water 13/07/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
H92 2-14 + + Cooling tower Bulk water 13/07/2014 100% Legionella pneumophila subsp. pneumophila str. Philadelphia 1 AE017354.1 
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Table S3. Reproducibility test by comparison PCR product length inferred by capillary electrophoresis and sizes from 
the L. pneumophila allele assignment table previously published. MLVA-8 markers (plus Lpms31) were compared for 
L. pn. Paris and L. pn. Lens. MLVA-12 markers were compared for L. pn. Philadelphia-1. VNTR markers of L. pn. 
Philadelphia-1 were as well sequenced and compared. 
 
  L.pn. Philadelphia-1   L.pn. Paris   L.pn. Lens 
VNTR 
Expected size 
(bp) (no. of 
repeats)1,3 
Sequencing 
(bp) (no. of 
repeats)2 
CE (bp) 
(no. of 
repeats)2 
 
Expected 
size (bp) 
(no. of 
repeats)3 
CE (bp) 
(no. of 
repeats)2 
 
Expected 
size (bp) (no. 
of repeats)3 
CE (bp) 
(no. of 
repeats)2 
Lpms01 498 (8) 494 (8) 503 (8) 
 
520 (7) 516 (7) 
 
475 (6) 476 (6) 
Lpms03 942 (8) 941 (8) 930 (8) 
 
845 (7) 843 (7) 
 
845 (7) 840 (7) 
Lpms13 793 (11) 793 (11) 784 (11) 
 
404 (10) 400 (10) 
 
260 (4) 262 (4) 
Lpms17 278 (2) 275 (2) 274 (2) 
 
278 (2) 275 (2)  
 
278 (2) 276 (2) 
Lpms19 128 (4) 128 (4) 128 (4) 
 
173 (4) 171 (4) 
 
173 (4) 171 (4) 
Lpms31 1043 (17) 1035 (17) 1017 (16)  
 
615 (9.5) 610 (10)* 
 
795 (13.5) 797 (14)* 
Lpms33 317 (1) 314 (1) 313 (1) 
 
604 (4) 603 (4) 
 
352 (2) 350 (2) 
Lpms34 265 (1) 266 (1) 259 (1) 
 
334 (2) 337 (2) 
 
460 (3) 460 (3) 
Lpms35 205 (3) 204 (3) 203 (3) 
 
454 (17) 459 (17) 
 
562 (23) 558 (23) 
Lpms38 264 (3) 258 (3) 260 (3) 
      
Lpms39 79 (6) 77 (6)  80 (6) 
      
Lpms40 198 (4) 196 (4) 196 (4) 
      
Lpms44 173 (9) 174 (9) 169 (8)             
1 As published by Sobral et al. 2011 sand Pourcel et al. 2007 
2 Result obtained in this study 
       3 As published by Pourcel et al. 2007 
       * The number of repeats are rounded to the nearest integer value in this study 
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Table S4. Repeatability test of the MLVA-12 multiplex PCR and  Lpms17 singleplex PCR and allele size measurement (bp) by capillary electrophoresis using 36 
strains included in panel I.  
Strain designation Test Lpms1 Lpms3 Lpms13 Lpms17 Lpms19 Lpms31 Lpms33 Lpms34 Lpms35 Lpms38 Lpms39 Lpms40 Lpms44 
L. pn. Philadelphia-1  PCR1 503.55 930.14 784.00 274.09 122.80 1017.80 313.29 259.10 202.98 260.33 80.55 196.00 169.21 
ATCC 33152T PCR2 503.39 930.35 784.22 274.68 122.97 1018.08 313.37 259.18 202.99 259.09 80.60 196.32 169.24 
L. pn. Bloomington-2 PCR1 504.20 930.99 760.54 274.03 144.80 0.00 684.51 260.62 344.80 504.20 104.80 196.53 169.39 
 ATCC 33155 PCR2 503.58 930.17 761.19 273.90 144.02 0.00 684.45 260.37 344.18 503.87 105.09 196.15 169.23 
L. pn. Paris  PCR1 457.48 835.60 761.60 275.54 122.90 693.10 687.40 383.70 450.60 260.40 128.40 202.60 151.30 
CIP 107629 PCR2 457.50 835.48 761.26 275.98 123.92 692.34 687.23 383.51 450.93 260.21 128.22 202.45 151.10 
L. pn Chicago-2  PCR1 503.50 929.90 784.10 273.73 143.60 1018.00 313.50 259.20 203.10 260.00 80.60 196.50 169.20 
ATCC 33215 PCR2 503.39 930.06 784.22 274.49 144.26 1018.08 313.37 259.18 202.99 259.09 80.60 196.32 169.24 
L. pn. Corby PCR1 0.00 930.00 737.00 274.98 124.00 817.30 685.50 260.20 573.00 260.00 127.70 196.20 169.00 
  PCR2 0.00 929.62 736.35 274.65 123.67 816.81 684.98 260.87 572.97 260.67 128.15 196.49 169.45 
L13-435 PCR1 503.80 930.27 713.17 274.00 143.64 879.80 437.37 384.54 256.40 260.17 105.13 196.24 169.27 
  PCR2 504.02 930.02 713.45 275.68 143.61 879.49 437.42 384.58 256.39 260.24 105.05 196.17 169.33 
L13-444 PCR1 503.85 930.12 713.53 273.43 143.64 879.61 437.40 384.59 256.43 260.21 105.13 196.27 169.27 
  PCR2 504.34 930.67 713.47 274.19 143.33 879.85 437.34 384.02 256.76 260.29 105.85 196.86 169.03 
L13-445 PCR1 503.82 930.09 713.50 274.68 143.61 879.58 437.37 384.56 256.40 260.18 105.10 196.24 169.24 
  PCR2 504.28 930.61 713.41 274.35 143.27 879.79 437.28 383.96 256.70 260.23 105.79 196.80 168.97 
L13-446 PCR1 504.47 930.47 713.69 273.70 143.78 879.83 437.11 384.09 256.24 260.16 105.47 196.01 169.14 
  PCR2 504.56 930.56 713.78 275.38 143.87 879.92 437.20 384.18 256.33 260.25 105.56 196.10 169.23 
W13-845-1 PCR1 457.00 929.83 713.45 274.29 144.72 816.93 437.32 384.58 344.53 260.21 0.00 196.26 169.28 
  PCR2 457.49 929.26 713.79 274.78 144.81 817.06 437.32 384.63 344.64 260.32 0.00 196.60 169.35 
W13-845-2 PCR1 503.32 929.82 736.45 274.45 123.53 879.60 437.08 384.36 520.56 259.79 104.80 195.75 168.87 
  PCR2 503.77 930.27 736.90 275.02 123.98 880.05 437.53 384.81 521.01 260.24 105.05 196.20 169.32 
W13-845-3 PCR1 456.97 929.80 713.42 274.30 144.69 816.90 437.29 384.55 344.50 260.18 0.00 196.23 169.29 
  PCR2 457.45 929.29 712.98 274.18 144.45 817.63 436.82 384.08 343.13 260.39 0.00 195.67 169.03 
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W13-845-4 PCR1 503.62 930.10 713.36 274.06 143.46 879.04 437.23 384.29 256.36 260.12 105.10 195.94 169.11 
  PCR2 503.95 929.95 713.38 273.94 143.54 879.42 437.35 384.51 256.32 260.17 104.98 196.10 169.26 
W13-845-5 PCR1 456.94 929.77 713.39 274.52 144.66 816.87 437.26 384.52 344.47 260.15 0.00 196.20 169.22 
  PCR2 457.49 929.26 713.79 273.87 144.81 817.06 437.32 384.63 344.64 260.32 0.00 196.60 169.35 
W13-845-6 PCR1 503.88 930.20 736.94 274.37 122.85 879.72 437.41 383.96 520.87 260.25 105.09 196.22 169.27 
  PCR2 503.80 930.12 736.86 273.72 122.55 879.12 437.34 383.34 521.90 260.23 104.78 198.39 170.69 
W13-845-7 PCR1 504.67 931.24 737.35 273.93 124.65 881.13 438.15 385.00 522.47 261.80 106.29 197.84 170.62 
  PCR2 503.77 930.34 736.45 274.14 123.75 880.23 437.25 384.10 521.57 260.90 105.39 196.94 169.72 
W13-845-8 PCR1 457.50 930.06 713.44 274.35 144.76 817.30 437.34 384.57 344.59 260.20 0.00 196.20 169.27 
  PCR2 457.49 929.26 713.79 274.56 144.81 817.06 437.32 384.63 344.64 260.32 0.00 196.60 169.35 
L13-438 PCR1 504.01 929.97 713.49 274.77 143.49 879.78 437.34 384.58 256.43 260.21 105.05 196.23 169.23 
  PCR2 504.02 930.02 713.45 274.98 143.61 879.49 437.42 384.58 256.39 260.24 105.05 196.17 169.33 
L13-443 PCR1 503.89 930.15 783.96 275.19 0.00 1017.80 313.29 259.10 202.99 0.00 80.56 196.51 169.21 
  PCR2 503.72 930.20 784.30 274.81 0.00 1018.32 313.50 259.33 203.06 0.00 80.50 196.42 169.35 
W13-845-11 PCR1 457.35 929.77 713.22 274.65 143.50 816.02 437.08 384.34 344.46 260.00 129.36 196.20 169.10 
  PCR2 457.56 929.34 713.87 274.49 143.34 816.86 437.20 384.39 344.29 260.89 128.98 196.83 169.89 
W13-845-12 PCR1 457.45 930.94 713.34 274.33 144.09 817.34 437.72 384.98 346.00 260.22 0.00 196.03 169.00 
  PCR2 457.52 929.29 713.82 274.44 144.84 817.09 437.35 384.66 344.67 260.35 0.00 196.63 169.38 
W13-845-13 PCR1 503.80 930.13 736.75 274.55 122.80 879.88 437.47 383.91 520.95 260.21 105.05 196.22 169.23 
  PCR2 503.12 930.83 736.01 274.57 122.63 878.92 437.29 383.14 520.18 260.10 105.91 196.11 169.61 
W13-845-14 PCR1 457.74 930.27 713.91 274.68 144.30 817.23 437.29 384.21 344.12 260.83 0.00 196.92 169.09 
  PCR2 457.48 929.26 713.79 274.70 143.26 816.78 437.12 384.31 344.21 260.81 0.00 196.75 169.81 
W13-845-15 PCR1 457.34 930.90 713.14 274.81 144.89 817.71 437.94 384.82 344.29 260.23 0.00 196.92 169.63 
  PCR2 457.49 929.26 713.79 274.83 144.81 817.06 437.32 384.63 344.64 260.32 0.00 196.60 169.35 
W13-845-16 PCR1 565.77 930.05 713.68 274.43 122.83 817.26 561.55 505.67 468.07 260.42 105.11 196.19 169.25 
  PCR2 565.02 930.34 713.82 274.54 122.02 817.29 561.34 505.82 468.29 260.92 105.92 196.26 169.82 
W13-845-18 PCR1 457.50 930.06 713.44 274.56 144.76 817.30 437.34 384.57 344.59 260.20 0.00 196.20 169.27 
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  PCR2 457.64 929.20 713.79 274.67 144.40 817.71 437.97 384.32 344.78 260.02 0.00 196.64 169.35 
W13-845-19 PCR1 457.29 930.09 713.31 274.69 143.50 816.10 437.18 384.31 344.40 260.04 131.18 195.95 169.13 
  PCR2 457.34 929.35 713.30 274.67 144.67 817.24 437.20 384.90 344.30 260.52 131.83 196.92 169.02 
W13-845-20 PCR1 457.45 930.91 713.69 274.59 144.19 817.71 437.34 384.45 344.20 260.90 0.00 196.34 169.01 
  PCR2 457.96 929.26 713.51 274.51 144.90 817.16 437.97 384.01 344.00 260.91 0.00 196.82 169.97 
W13-845-21 PCR1 457.50 930.98 713.44 274.70 144.76 817.30 437.34 384.57 344.59 260.20 0.00 196.20 169.27 
  PCR2 457.24 929.33 713.34 274.81 144.56 817.20 437.23 384.04 344.82 260.82 0.00 196.82 169.02 
W13-845-22 PCR1 457.50 930.06 713.44 274.93 144.76 817.30 437.34 384.57 344.59 260.20 0.00 196.20 169.27 
  PCR2 457.49 929.26 713.79 274.87 144.81 817.06 437.32 384.63 344.64 260.32 0.00 196.60 169.35 
W13-845-23 PCR1 457.89 930.24 713.87 274.79 144.78 817.28 437.89 384.12 344.09 260.46 0.00 196.64 169.08 
  PCR2 457.46 929.92 713.92 274.71 144.34 817.34 437.84 384.92 344.92 260.00 0.00 196.01 169.89 
W13-845-25 PCR1 457.37 930.06 713.55 274.90 144.64 815.99 437.14 384.23 344.42 260.08 0.00 195.96 169.09 
  PCR2 457.16 929.25 713.26 275.01 144.48 817.12 437.15 383.96 344.74 260.74 0.00 196.74 168.94 
W13-845-26 PCR1 457.75 930.75 713.23 275.13 144.08 817.91 437.08 384.91 344.73 260.23 0.00 196.00 169.97 
  PCR2 457.33 930.13 713.35 274.94 143.54 816.14 437.22 384.35 344.44 260.08 0.00 195.99 169.17 
W13-845-27 PCR1 457.50 930.06 713.44 274.86 144.76 817.30 437.34 384.57 344.59 260.20 0.00 196.20 169.27 
  PCR2 457.43 929.99 713.37 275.05 144.69 817.23 437.27 384.50 344.52 260.13 0.00 196.13 169.20 
W13-845-28 PCR1 457.74 929.43 713.67 275.16 143.28 815.92 437.02 304.23 344.09 260.00 131.21 195.92 169.11 
  PCR2 457.49 929.26 713.79 275.28 144.81 817.06 437.32 384.63 344.64 260.32 131.83 196.60 169.35 
W13-845-31 PCR1 457.34 930.34 713.67 274.00 144.67 817.24 437.94 384.93 344.02 260.62 0.00 196.00 170.00 
  PCR2 457.77 929.46 713.70 274.21 143.31 815.95 437.05 304.26 344.12 260.03 0.00 195.95 169.14 
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3.1 Abstract  
Legionella pneumophila is a water-based bacterium responsible for most cases of 
legionellosis, a atypical pneumonia with an increasing incidence in industrialized countries. The 
study of the genetic diversity and the geographical distribution of L. pneumophila strains are 
essential for the development of public health control strategies, especially in areas where not 
much epidemiological information is available. Genotyping methods, such as Sequence Based 
Typing (SBT) and Multi Locus Variable number of tandem repeats Analysis (MLVA), are 
current approaches used in the identification of L. pneumophila strains. In this study, MLVA 
was selected, due to its high resolution and rapidity, to characterize a total of 431 L. 
pneumophila strains isolated from water and biofilm samples across the West Bank and 
Northern Israel. Most of the environmental isolates in the two areas were identified as serogroup 
1 (83.3% and 62.3% of the isolates in Israel and West Bank, respectively). Remarkably, besides 
the geographical proximity, only two genotypes were common to Israel and West Bank, which 
corresponded to the most prevalent genotypes, Gt4(17) and Gt6(18). Particularly, Gt4(17) and 
Gt6(18) were the most frequently isolated genotypes from the environment (they represented 
together the 49.9% and 57.8% of environmental isolates in Israel and West Bank, 
respectively) as well as from patients affected of pneumonia in Israel (54.5%). These 
genotypes corresponded to Sequence Type 1 (ST1), a common worldwide distributed clonal 
complex. Only three genotypes of L. pneumophila, of which two corresponded to ST1, were 
shared among the Middle East and Europe. This study showed the biogeography of L. 
pneumophila strains in the Middle East and remarkable differences to European strains. 
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3.2 Introduction  
Besides the significance of the L. pneumophila as a water-based pathogen responsible 
of producing a severe, and often fatal, pneumonia in people whose immune defenses are 
weakened, only few studies have been carried out to our knowledge to evaluate the impact of 
this bacterium in the Middle East. Studies carried out in Europe and USA have revealed an 
increase in the incidence of Legionnaires’ disease (LD) in the last years (1–3). Studies 
performed in the Middle East have reported the prevalence of L. pneumophila in freshwater 
systems and assessed their epidemiology by using mostly culture-dependent methods (4, 5). 
More recently, a study reported the presence of L. pneumophila in air conditioned buildings in 
Kuwait by using molecular techniques (6).  
Only a limited amount of data are available about the epidemiology of L. pneumophila 
in the area of Israel (7–9). It was only two years ago when a study described the molecular 
epidemiology of L. pneumophila by Sequence Based Typing (SBT) in Israel (10) and 
Rodríguez-Martínez et al. (2015) (11) described more recently the clonal population of a set of 
environmental isolates of L. pneumophila obtained in a drinking water distribution system at the 
Oranim campus in the city of Kyriat Tivon in Northern Israel. In the area of West Bank, no 
studies regarding the presence and the populations of L. pneumophila have appeared yet. 
The study by Moran-Gilad et al. (2014) (10) showed that the epidemiological 
tendencies of LD in Israel were similar to the tendencies previously shown in the EU. The 
majority of clinical isolates were identified as L. pneumophila serogroup 1 (71.4%). However, 
isolates that belonged to serogroup 3 were as well responsible of causing infections (14.2%) and 
this serogroup was also present among the environmental isolates from drinking water samples 
in Israel (9). According to the molecular assessment of the epidemiology, ST1, the most 
worldwide dispersed sequence type, was the most common among clinical and environmental 
strains in Israel (10). The common presence of serogroup 3 strains among environmental as well 
as clinical isolates in Israel, in contrast to observations in EU (12, 13), the identification of new 
strains and the high dominance of ST1 suggested additional analysis. Especially increasing the 
sample size and the applying high resolution molecular typing methods could help to further 
characterize ST1.  
Multi Locus Variable number of tandem repeats Analysis (MLVA) genotyping has 
exhibited high resolution in comparison to other typing methods for a variety of bacterial 
species (14–16). In the case of L. pneumophila, MLVA genotyping presented higher 
discrimination than SBT (17, 18) and a very high concordance with this current gold standard 
method as described by Pourcel et al. (2007) and Visca et al. (2011) (17, 18) as well as 
presented previously in Chapter II of this thesis. These criteria together with the rapidity, the 
high typeability and reproducibility as well as the existence of a large database made MLVA 
genotyping the method of choice for the study of the populations of L. pneumophila isolates in 
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the Middle East. The study of the genetic diversity and distribution of L. pneumophila strains, 
especially in areas were not much information is available could be essential for later 
epidemiological studies and for public health control strategies.   
The aim of this study was to assess the genetic diversity and the distribution of L. 
pneumophila strains in the Middle East by MLVA high resolution genotyping using a large 
dataset composed of 431 environmental and clinical isolates obtained during the period of 2012-
2014 in Northern Israel and along the West Bank. The genetic diversity of the two areas in the 
Middle East was compared and a further evaluation was carried out by comparing with the 
diversity observed in central Europe using strains from Germany, previously described in 
Chapter II, and the International MLVA Legionella database.  
 
3.3 Material and methods 
3.3.1 Water sampling and Legionella isolation in Israel 
Water sampling was carried out by our collaborating partners from the University of 
Haifa around the campus of Oranim, at Kiryat Tivon, Northern Israel, since summer 2012 until 
autumn 2013 (Table S1, Figure S1). Lake Kinneret water as well as ground water is provided 
as drinking water in Israel. Briefly, seven points were selected covering the water rout at the 
campus. Biofilm and cold water samples were taken seasonally at all sampling points. Hot water 
samples were taken when available. Legionella isolation from biofilm and water samples was 
performed based on ISO 11731:1998 (International Organization for Standardization, 1998) and 
as described by Rodríguez-Martínez et al. (2015) (11). Additionally to the bacterial isolation, 
biotic and abiotic analysis of the water, as heterotrophic plate counts or measurement of 
temperature, pH or chlorine, were carried out for each sample (11). Furthermore, the same 
Legionella isolation procedure was performed for samples taken at eight different locations 
across Northern Israel during spring and summer 2013. They were mostly private homes 
situated in the localities of Kyriat Tivon (Raz and Tamar), Alonei Abba, Yavne´el, Mehanamia, 
Tiberias (Hila and Shosh) and Moshav (Arbel). In addition, one of the sampling sites was 
located at the campus of the Technion University in Haifa (Table S1, Figure S2). Besides the 
environmental isolates obtained during the sampling, 11 L. pneumophila clinical isolates 
obtained from patients affected of pneumonia were kindly provided by the Rambam hospital in 
Haifa. 
 
3.3.2 Water sampling and Legionella isolation along the West Bank 
A sampling campaign was performed by our partners from Al-Quds University in 
Jerusalem along the West Bank during two years (2012-2014). Water and biofilm samples were 
taken from eight hospitals along the West Bank: hospitals A, B and C located in Northern West 
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Bank; hospitals D, E and F in the central area of West Bank and hospitals G and H located in 
Southern West Bank (Table S1, Figure S2). Moreover, samples were as well taken from Al-
Quds University main campus located in Jerusalem, central West Bank. At the hospitals, water 
and biofilm samples were taken from kitchens and toilets but also in showers and faucets 
situated in areas occupied by high risk patients, as the Intensive Care Unit, surgery and 
emergency rooms, as well as areas of oncology. Legionella isolation from water and biofilm 
samples was based on ISO 11731:2004 (19). Biotic and abiotic analyses of the water were 
additionally carried out as described previously (11). 
 
3.3.3 Phenotypic and molecular characterization of L. pneumophila isolates 
Species identification of the L. pneumophila isolates obtained in Israel and West Bank 
was carried out by serotyping and by 16S rRNA Legionella-genus and L. pneumophila-species 
specific PCR. Both PCRs were carried out by using primers and conditions described in 
Material and Methods of Chapter II. Serotyping was performed using a latex agglutination test. 
For isolates from the West Bank, the same procedure was followed as described in Chapter II 
for the isolates obtained in Germany. Strains isolated in Israel were serotyped using a different 
protocol that allowed to distinguish serogroup 3, besides serogroup 1 and serogroups 2-14 as 
described previously (11).  
L. pneumophila isolates were sent to the Helmholtz Centre for Infection Research (HZI) 
in Braunschweig for further molecular characterization. A total of 251 L. pneumophila 
environmental and clinical isolates obtained in Israel were sent on FTA cards (Whatman, 
Germany) or just as pure extracted DNA dissolved in buffer. From the West Bank, a set 
composed of 180 L. pneumophila environmental isolates were sent as fixed on FTA cards and a 
small subset as living biomass streaked out in BCYE (Buffered Charcoal Yeast Extract Agar, 
Oxoid Thermoscientific, Germany) plates (Table S1).  
For DNA extraction out of the FTA cards, the area of the card containing the biomass 
was punched with a puncher into 3 mm circular punches. Punches were transferred to 0.5 ml 
steril water (Roth, Germany). They were incubated for 3 min at room temperature and vortexed 
three times (after water addition, after 1 min and after 3 min incubation). The FTA punch was 
removed and 1x Tris-EDTA buffer (Sigma-Aldrich, Germany) was added to the water to 
preserve the DNA from degradation. DNA was finally quantified by using Picogreen 
(Molecular Probes, Invitrogen) and kept frozen at –20°C for later analyses. 
MLVA-8 and MLVA-12 molecular genotyping assays by capillary electrophoresis were 
carried out for all isolates as detailed in Material and Methods of Chapter II. Representative 
isolates from West Bank and Israel were sent to the National Reference laboratory for 
Legionella infections in Dresden and were additionally analyzed by sequence based typing and 
by monoclonal antibody subgrouping (12, 20). 
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3.3.4 Statistical analysis 
Capillary electrophoresis data analysis and calculation of the number of repeats for each 
VNTR marker were achieved as described in Chapter II. The numerical code used to designate 
MLVA-8 and MLVA-12 genotypes, as well as the joint code for MLVA-8(12) genotypes, was 
continued for the Middle East isolates. Null alleles (“0”) were assigned when no amplicon was 
detected. Clustering analysis was performed in Bionumerics (version 5.0, Applied Maths). 
UPGMA (Unweighted Pair Group Method with Arithmetic Mean) method applying a 
categorical coefficient was used to define the clusters. MLVA-8 profiles obtained in this study 
were compared to those from the international Legionella database ((http://bacterial-
genotyping.igmors.u-psud.fr/ Legionella2006) and clusters were defined applying as criteria a 
cut-off of 60% similarity as previously done (21). Minimum spanning trees were performed 
using the categorical coefficient. Simpson's Index of Diversity coefficient was calculated using 
the online tool provided in http://darwin.phyloviz.net/ComparingPartitions/. To measure the 
variation of the number of repeats at each VNTR locus, the Hunter-Gaston Discrimination 
Index (HGDI), which is a modification of the Simpson's Index of Diversity, was calculated 
using http://www.hpa-bioinfotools.org.uk/cgi-bin/DICI/DICI.pl. The online tool 
http://www.cmbi.ru.nl/cdd/biovenn (22) was used to create Venn diagrams for the comparison 
of strains among the distinct geographical areas under study. Google Earth (version 7.1.5.1557) 
was used to generate a visual representation of the selected sampling locations. 
 
3.4 Results 
3.4.1 Genetic diversity of L. pneumophila strains from the West Bank 
A total of 180 L. pneumophila environmental isolates from seven hospitals and the 
campus of the Al-Quds University from all across West Bank were received at the HZI (Table 
S1). 175 isolates were obtained from biofilm samples, while only five isolates could be isolated 
directly from water. The majority of the isolates were characterized as serogroup 1 (sgp1) 
(n=112, 62.3%) (Table 1). A subset of 10 sgp1 isolates was subgrouped by monoclonal 
antibody and all belonged to the MAb 3/1 negative OLDA subtype. A third part of the isolates 
(n=68, 37.7%) were serotyped as non-sgp1. The specific serogroup of the 54.4% (n=37) of the 
non-sgp1 isolates was additionally analyzed by monoclonal subgrouping and 81% (n=30) of 
them were serotyped as sgp6, followed by sgp8 (n=6) and sgp10 (n=1). The rest of the non-sgp1 
was just characterized as serogroups 2-14 as performed by the agglutination kit.  
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MLVA-8, as well as MLVA-12 and the joint scheme of MLVA-8(12) genotyping, were carried 
out to study of the population of L. pneumophila in the West Bank (Table 2).  The 180 isolates 
were typed in 16 MLVA-8 genotypes (ID=0.771, 95% CI 0.721-0.822), 25 MLVA-12 
genotypes (0.790, 95% CI, 0.739-0.841) and 26 MLVA-8(12) genotypes (ID=0.790, 95% CI 
0.739-0.841). 92.8% (n=167) of the MLVA-8(12) genotypes were found at least twice while, 
only 7.2% (n=13) were found once. About 58% of the strains belonged to only two genotypes. 
In particular, the most frequent isolated genotype was Gt4(17) (n=71, 41.1%), followed by 
Gt6(18) (n=30, 16.7%). Both of them corresponded to ST1. The following most frequent 
genotypes were Gt10(93) (n=16, 8.9%), and Gt9(92) (n=8, 4.4%), corresponding to ST461, and 
Gt13(72) (n=10, 5.6%), which 
corresponded to ST1326. 
When applying MLVA-8(12) 
genotyping 96.6% of isolates 
(n=174) were clustered into four 
MLVA clonal complexes or 
VACCs (VACC1, VACC2, 
VACC5 and VACC11) (Figure 
S3, Figure 1) and the rest 3.6% 
(n=6) were found as individual 
genotypes. VACC1, VACC2 and 
VACC5 were clonal complexes 
previously defined by MLVA in 
the international Legionella 
database whereas VACC11 was described for the first time in this study. The same clusters 
were observed when the reduced MLVA-8 genotyping scheme was applied and only minor 
changes were detected. By using MLVA-8 genotyping the six individual genotypes were 
enclosed into VACC1 (Figure S4). These six isolates, which belonged to two different MLVA-
8(12) genotypes, were all sgp8 strains in contrast with the rest of the strains enclosed in 
VACC1, which were all sgp1. They differed from the rest of isolates contained in VACC1 in 
the number of repeats observed for VNTR markers Lpms31, Lpms33 and Lpms34. Lpms31 
presented 17 repeats in comparison to 4 or 0 in the rest of the profiles of VACC1, and VNTR 
Lpms33 and Lpms34, presented both only one repeat in contrast to 4 and 2 repeats found in 
VACC1, respectively. VACC1 was the largest cluster including 110 isolates (61.2%). VACC11, 
VACC2 and VACC5 were in comparison small clusters counting with 31 (17.2%), 19 (10.5%) 
and 14 (7.7%) isolates respectively. As mentioned above, all sgp1 isolates belonged to VACC1 
when MLVA-8(12) was applied. The other clonal complexes (VACC5 and VACC11) contained 
exclusively non-sgp1 isolates. VACC2 contained mostly non-sgp1 isolates, only two sgp1 
 
Table 1 Serogroup and monoclonal antibody subtyping of 180 
environmental L. pneumophila isolates from West Bank.   
Serogroup 
  MAb 
subgroup 
  Environmental isolates 
  
No. Frequency (%) 
1 
 
OLDA 
 
10 5.6 
1 
 
NA1 
 
102 56.7 
Total sgp1 
   
112 62.3 
6 
 
Dresden 
 
30 16.7 
8 
   
6 3.3 
10 
   
1 0.6 
(2-14) 
   
31 17.2 
Total non sgp1 
 
68 37.7 
Total       180 100 
1NA: Not analyzed 
72 
 
isolates (A100 and A144) isolated from biofilm in different hospitals were included in this 
clonal complex.  
 
The 10% of the total 
number of isolates (n=18) were 
sequence typed (Table 2). 
Among the STs observed, ST461 
and ST1 were the most frequent 
(n=5 and n=4 isolates 
respectively), followed by 
ST1358 (n=3), ST1326 (n=2), 
ST1482 (n=2), ST187 (n=1) and 
ST1438 (n=1). With exception of 
ST1, a highly abundant sequence 
type worldwide distributed, most 
of these sequence types were 
rarely reported in the Legionella 
database. Environmental and 
clinical isolates of ST1326 and 
ST1358 have been found 
extensively across Europe 
besides Canada and Russia, both 
characterized as sgp8 and sgp10. 
ST461 included environmental 
and clinical sgp6 strains isolated 
in Europe, Japan and Australia. 
By contrast, ST1438 was 
reported only once in the 
database, as an environmental 
sgp6 L. pneumophila isolate 
obtained in Israel. ST1482 was 
described for first time during 
this study. 
 
 
 
Table 2. MLVA-8(12) genotypes of 180 environmental L. 
pneumophila isolates from the West Bank and the corresponding ST of 
relevant genotypes. 
ST  
 
MLVA-8(12) 
 
No. of 
MLVA-8(12) 
genotypes 
Frequency (%) 
1 
 
Gt4(17) 
 
74 41.1 
1 
 
Gt6(18) 
 
30 16.7 
461 
 
Gt10(93) 
 
16 8.9 
1326 
 
Gt13(72) 
 
10 5.6 
461 
 
Gt9(92) 
 
8 4.4 
  
Gt10(141) 
 
6 3.3 
1358 
 
Gt12(84) 
 
5 2.8 
1438 
 
Gt16(1) 
 
5 2.8 
  
Gt40(47) 
 
3 1.7 
  
Gt63(83) 
 
3 1.7 
  
Gt64(74) 
 
3 1.7 
  
Gt13(143) 
 
2 1.1 
1482 
 
Gt8(7) 
 
2 1.1 
1358 
 
Gt11(87) 
 
1 0.6 
  
Gt13(106) 
 
1 0.6 
  
Gt16(3) 
 
1 0.6 
  
Gt16(6) 
 
1 0.6 
  
Gt24(68) 
 
1 0.6 
  
Gt38(109) 
 
1 0.6 
  
Gt4(16) 
 
1 0.6 
  
Gt4(20) 
 
1 0.6 
  
Gt55(94) 
 
1 0.6 
  
Gt6(15) 
 
1 0.6 
  
Gt8(142) 
 
1 0.6 
  
Gt8(23) 
 
1 0.6 
187 
 
Gt84(106) 
 
1 0.6 
Total        180 100 
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Figure 1. Minimum-spanning tree based on MLVA-8(12) profiles of 180 L. pneumophila strains isolated in West 
Bank.  Each circle in the tree represents a different MLVA-8(12) genotype. The genotype designation is indicated 
within or near the circle, whose size is proportional to the genotype frequency. Different colours in the pie charts 
refer to the sampling locations (see legend).  Thickness of the branches represents the number of different loci. 
MLVA clonal complexes (VACC) have been shaded. The circles representing the six sgp6 singletons from Al- Quds 
University (Gt11(87) and Gt12(84)) overlap visually with the circle that represent Gt4(17) due to the high abundance 
of this genotype. Singletones have been circled to be better distinguished.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.2 Geographical distribution of MLVA genotypes of L. pneumophila in the West Bank  
At genotype level, only eight out of the 26 MLVA-8(12) genotypes were isolated in 
more than one location. The rest 18 MLVA-8(12) genotypes were isolated exclusively in a 
certain site (Figure 2). Gt4(17), was the only genotype present in all hospitals as well as at the 
University campus. Furthermore, it was not only present but represented a high fraction of the 
isolates in several hospitals: Gt4(17) was the most abundant genotype in B (n=22, 68.7%), A 
(n=20, 71.4%), D (n=15, 83.4%), and C (n=4, 80%) hospitals. At the Al-Quds University it 
accounted for the 40% of the genotypes (n=6). Gt6(18), which only differed in one repeat in the 
VNTR Lpms35 and also corresponded to ST1, was found at the two close F and G hospitals. 
However, while in F hospital it was isolated only once, it was the most abundant genotype at G 
hospital (n=30, 90.9%). The same phenomenon was observed in the case of genotype Gt10(93), 
which corresponded to ST461. It was found in C and F hospitals, yet, it was isolated only once 
in C i and in contrast was the most abundant genotype in F (n=15, 45.5%). Other genotypes that 
were found in more than one location, usually only in one to two locations, can be observed in 
Figure 1 and Figure 2. 
Hospital G, n=34 
Hospital F, n=32 
Hospital B, n=32 
Hospital A, n=28 
Hospital D, n=18 
Al Quds University, n=15 
Hospital E, n=10 
Hospital H, n=6 
Hospital C, n=5 
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Generally, the most frequent genotypes in each hospital were isolated repeatedly during 
samplings performed in recurrent years. Gt4(17) was recurrently isolated in A, B, C, D and F 
hospitals between 2012 and 2014. Gt6(18) was isolated in G hospital in 2013 and 2014. 
Genotypes Gt10(141) and Gt10(93) were isolated in F hospital in 2012, 2013 and 2014 and 
Gt9(92) was isolated in B hospital in 2012, 2013 and 2014.  
 
Figure 2. Geographical distribution of A) MLVA-8(12) genotypes and B) clonal complexes along the West Bank.  
The number of L. pneumophila isolates and letters indicating the designation of the hospitals are representaed above 
the pie chartses. Dark blue in the geographical representation of genotypes and clonal complexes corresponds to 
Gt4(17) (see legend), which is the most abundant genotype of VACC1. 
 
 
 
 
At least two distinct clonal complexes were present at each hospital as well as at the Al-
Quds University. VACC1, the largest clonal complex was present all across the West Bank. 
Genotypes belonging to it were isolated at all seven hospitals and at the Al-Quds University. 
VACC2 isolates were obtained in four hospitals distributed along the West Bank and Al-Quds 
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University. VACC11, although it was present at five hospitals, it was the major clonal complex 
at F hospital (n=22, 66.7%). Isolates grouped into VACC5, the smallest clonal complex, were, 
however, found at four different hospitals located along the Eastern West Bank.  
In summary, the majority of the MLVA-8(12) genotypes were found exclusively in one 
hospital or at the university campus. Only a few MLVA-8(12) genotypes were isolated in more 
than one location, and these common genotypes were usually much more frequent in one of the 
locations, with exception of Gt4(17) that was steadily abundant. In some hospitals certain 
genotypes were especially frequent. When the MLVA-8 profiles were considered, since the 
diversity did not increase significantly from MLVA-8 (0.772, 95% CI 0.721-0.822) to MLVA-
8(12) genotyping (0.790, 95% CI 0.739-0.847), the same general biogeographic patterns were 
found as when studying the population by using MLVA-8(12). 
 
3.4.3 Genetic diversity of L. pneumophila strains from Israel 
Overall, 11 clinical and 240 environmental isolates of L. pneumophila isolated form 10 
different locations and habitats across Northern Israel subjected to MLVA genotyping (Table 
S1). In general, most of the environmental isolates were sgp1 (n=200, 83.3%) in comparison 
with non-sgp1 (n=31, 12.9%) (Table 3). A total of 18 sgp1 isolates were subgrouped by 
monoclonal antibodies and they were confirmed to belong to the virulence-associated ‘MAb3/1-
negative’ subgroup, characterized by the lack of the virulence-associated epitope. Among the 31 
non-sgp1 isolates, the majority were sgp3 (n=26, 84%). All 11 clinical isolates belonged to 
sgp1.  
 
Table 3. Serogroup and monoclonal antibody subgrouping of 251 environmental and clinical L. 
pneumophila isolates from Israel. 
Serogroup 
  MAb 
subgroup 
  Environmental isolates   Clinical isolates  
  
No. Frequency (%) 
 
No. Frequency (%) 
1 
 
OLDA 
 
10 4.2 
 
11 100.0 
  
Oxford 
 
8 3.3 
   
  
NA1 
 
182 75.8 
   
  
Total sgp1 
 
200 83.3 
   
3 
   
26 10.8 
   
2-14 (not 3) 
   
5 2.1 
   
  
Total non-sgp1 
 
31 12.9 
   
NA 
   
9 3.7 
   
NA1: Not analysed 
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The total set of 251 clinical and environmental isolates was typed in 23 MLVA-8 genotypes 
(ID=0.643, 95% CI 0.591-0.695), in 34 MLVA-12 genotypes (ID=0.815, 95% CI 0.777-0.852) 
and 37 MLVA-8(12) genotypes 
(ID=0.818, 95% CI 0.781-0.855). The 
majority of MLVA-8(12)  
genotypes (92%, n=231 isolates) were 
isolated at least twice, while only 8% of 
the genotypes (n=20 isolates) were found 
once (Table 4). More than 70% of the 
isolates (n=184) belonged to only four 
genotypes. The most frequent isolated 
genotype was Gt4(17) (n=92, 36.7%), 
followed by Gt4(16) (n=38, 15.1%), 
Gt6(18) (n=33, 13.2%) and Gt6(15) 
(n=21, 8.4%). Gt4(17) and Gt6(18) 
corresponded, as previously mentioned, 
to ST1. 
At clonal level, 244 of the 251 
isolates (97.2%) clustered together in 
four clonal complexes according to their 
MLVA-8 and MLVA-8(12) profiles 
(VACC1, VACC2, VACC5 and 
VACC6) and only seven isolates 
remained as single isolates (Figure S5). 
No differences were detected in the 
formation of the clusters when the 
different MLVA schemes, MLVA-8 
(Figure S6) or MLVA-8(12) (Figure 3), 
were used. The clonal complex VACC1 
was significantly larger in comparison to 
the other three clusters and comprised 
exclusively sgp1 isolates. It enclosed the 
85% of the isolates (n=213). VACC2, 
VACC5 and VACC6 only comprised 
2.9% (n=7), 6.8% (n=20) and 1.6% (n=4) 
of the rest of the isolates, respectively. 
Table 4. MLVA-8(12) genotypes and the corresponding 
STs of 251 environmental and clinical L. pneumophila 
isolates from the Israel. 
ST  
 
MLVA-8(12) 
 
No. 
Frequency 
(%) 
1 
 
Gt4(17) 
 
92 36.7 
1 
 
Gt4(16) 
 
38 15.1 
1 
 
Gt6(18) 
 
33 13.2 
1 
 
Gt6(15) 
 
21 8.4 
  
Gt6(13) 
 
6 2.4 
  
Gt6(83) 
 
6 2.4 
  
Gt15(95) 
 
5 2.0 
  
Gt27(28) 
 
4 1.6 
  
Gt3(81) 
 
4 1.6 
  
Gt4(110) 
 
4 1.6 
  
Gt57(29) 
 
4 1.6 
  
Gt22(99) 
 
3 1.2 
  
Gt27(2) 
 
3 1.2 
  
Gt23(108) 
 
2 0.8 
  
Gt24(68) 
 
2 0.8 
  
Gt25(7) 
 
2 0.8 
  
Gt45(78) 
 
2 0.8 
  
Gt21(15) 
 
1 0.4 
  
Gt1(88) 
 
1 0.4 
  
Gt15(96) 
 
1 0.4 
  
Gt15(97) 
 
1 0.4 
  
Gt17(111) 
 
1 0.4 
  
Gt18(4) 
 
1 0.4 
  
Gt19(17) 
 
1 0.4 
  
Gt2(89) 
 
1 0.4 
  
Gt2(91) 
 
1 0.4 
  
Gt20(115) 
 
1 0.4 
  
Gt22(98) 
 
1 0.4 
  
Gt26(8) 
 
1 0.4 
  
Gt27(43) 
 
1 0.4 
  
Gt45(107) 
 
1 0.4 
  
Gt5(44) 
 
1 0.4 
  
Gt58(9) 
 
1 0.4 
  
Gt59(112) 
 
1 0.4 
  
Gt6(9) 
 
1 0.4 
  
Gt60(80) 
 
1 0.4 
  
Gt61(82) 
 
1 0.4 
Total       251 100 
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VACC6 was as well composed exclusively of sgp1 isolates, while sgp3 isolates predominated in 
VACC2 and VACC5 clusters. 
 
Figure 3. Minimum-spanning tree based on MLVA-8(12) profiles of 251 clinical and environmental L. pneumophila 
strains isolated in Israel.  Each circle represents a different MLVA-8(12) genotype and is proportional to the genotype 
frequencies. Genotype number is specified within or near the circle. Different colours in the pie charts refer to the 
sampling locations. Thickness of the branches represents the number of different loci. MLVA clonal complexes 
(VACC) have been shaded. Clinical isolates are in yellow as isolates from Rambam Hospital (see legend).  
 
 
3.4.4 Geographical distribution of MLVA genotypes of L. pneumophila in Israel 
The study of the population of L. pneumophila by using the MLVA-8 genotypes 
showed the same biogreographic patterns than when MLVA-8(12) genotypes were analyzed, 
although the resolution of MLVA-8(12) was significantly (ID=0.818, 95% CI 0.781, 0.855) 
increased respect to MLVA-8 (ID=0.643, 95% CI 0.591, 0.695) and 14 additional genotypes 
were observed (Figure 3 and S6). In general, the distribution of genotypes was diverse. With 
exception of the individual genotypes, most of the MLVA-8(12) genotypes where found in 
more than one location and no clear distribution pattern could be observed. Gt4(17), the most 
abundant environmental genotype isolated in Northern Israel, was found in five of the ten 
sampled locations (Figure 4). This genotype was most frequent genotype isolated at the Oranim 
campus in Kyriat Tivon. It was also found in one othe houses sampled as well in Kyriat Tivon 
and in the near locality of Alonei Abba (Figure 3 and 4). In the Eastern part of North Israel, 
Gt4(17) was isolated from the drinking water system of one of the houses sampled in Tiberias. 
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The next more frequent genotypes isolated from the environment, Gt6(18), Gt6(15) and Gt4(16) 
were differenciated of Gt4(17) in only one VNTR locus (Gt6(18) and Gt4(16)) and two VNTR 
loci (Gt6(15)) (Figure 3) and all corresponded to ST1. All these highly genetic related 
genotypes were, as well as Gt4(17), all frequently isolated at the Oranim campus.  
 
 
 
Figure 4. Geographical distribution of clonal complexes (A) and MLVA-8(12) (B) genotypes in North Israel. 
Numbers inside the pie charts indicate the number of L. pneumophila isolates.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interesting, Gt6(18) was only found in the Western part of Northern Israel (Oranim and Raz in 
Kyriat Tivon, Alonei Abba and at the Technion Univeristy located in Haifa) (Figure S2). By 
contrast, Gt6(15) was found, besides at the Oranim campus, in the sampled locations situated in 
A 
B 
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Figure 5. MLVA-8(12) genotypes abundances of the 11 clinical isolates of L. pneumophila from 
Israel and its corresponding isolates from the environment.  
the Eastern part of the area (Tiberias, Yavne´el and Mehanamia). Gt4(16) was isolated was 
abundant in both, western and eastern parts of North Israel.  
Among these abundant genotypes, Gt4(17) as well as Gt6(18) were also found as 
clinical isolates. Other two clinical isolates presented genotypes (Gt19(17) and Gt20(115)) with 
only a single locus different to Gt4(17). Interesting, 9 of the 11 clinical isolates provided by the 
Rambam Hospital matched their genotype with environmental isolates obtained in North Israel 
(Figure 5). Gt22(99) and Gt24(68) were found in the locations of Alonei Abba and Yavniel 
respectively, indicating the potential of infection of these environmental strains. Only two 
genotypes, Gt19(17) and Gt20(115), did not have an environmental match.  
 
 
VACC1, the largest clonal complex, was found in every location sampled in Northern 
Israel and was the most abundant clonal complex of every location (Figure 5). The great 
majority of isolates in Israel were obtained during a thorough water sampling carried out across 
the Oranim campus for more than a year (summer 2012 until autumn 2013). A total of 165 L. 
pneumophila isolates were obtained from the seven selected points (points A to G) along the 
drinking water supply system on the campus (Figure S1) More than 92% of the Oranim isolates 
(n=152) belonged to VACC1 and were characterized as sgp1 (with exception of nine isolates for 
which no serogroup information was available). VACC1 isolates were found in five out of the 
seven sampling points (C, D, E, F, G, no Legionella was isolated from point B) as exclusive 
clonal complex in those points. However, most of the isolates obtained in point A (83.4%, 
n=10) belonged to VACC5 and were subgrouped as sgp3. This chraracteristic spatial 
distribution of the L. pneumophila genotypes along the different sampling points was previously 
shown by Rodríguez-Martínez et al. (2015) (11) and was confirmed in this study with an 
increased number of isolates.  
Besides the sgp3 isolates obtained in Oranim, VACC5 was as well composed of seven 
sgp3 isolates obtained in the small locality of Moshav (Arbel sampling point), in the eastern 
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edge close to Lake Tiberias. Isolates belonging to VACC2 had a diverse geographical origin, 
although it was a small clonal complex. These isolates were found in Haifa (at the Technion 
University), Alonei Abba and Yavne´el. Furthermore, it contained the genotypes [Gt22(99) and 
Gt24(68)] of the two clinical isolates from Alonei Abba and Yavne´el. VACC6, formed only by 
four isolates, was exclusively composed by two clinical isolates and two isolates obtained in the 
locality of Alonei Abba, situated in the eastern part of North Israel.  
 
3.4.5 Analysis of the MLVA genotypes in different habitats in Israel 
The systematic sampling of different habitats (hot water, cold water and biofilm) that 
was carried out during two years across the Oranim campus (Figure S2) and in the rest of 
selected sampling points in Northern Israel allowed the comparison of diversity of genotypes 
among the different habitats. 
The study by Rodríguez-Martínez et al. 2015 using the MLVA-8 profiles of a set of 68 
isolates obtained at the Oranim campus during the first year of sampling showed that the most 
predominant MLVA-8 genotype in the water system, Gt4, was highly frequent in water as well 
as in biofilm (58% and 70% abundances, respectively). These results were confirmed for the 
enlarged dataset of 165 isolates obtained during two years and by the use of the higher 
resolution MLVA-8(12) genotyping (Figure 6). MLVA-8(12) genotypes Gt4(16) and Gt4(17), 
both corresponding to Gt4 of the MLVA-8 genoytping, were the most abundant genotypes in 
water (n=55, 51.9%; ID= 0.797, 95% CI 0.729-0.864) as well as in biofilm (n=33, 66%; 
ID=0.739, 95% CI 0.651-0.827). Likewise, Gt6(15) and Gt6(18), the second more frequent 
genotypes (corresponding to Gt6 of MLVA-8 genotyping), were abundant in both habitats as 
well.  
 
Figure 6. MLVA-8(12) ge-notypes abundances of 165 environmental L. pneumo-phila strains isolated from water 
and biofilm across the Oranim campus.  
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3.4.6 Overview of the clonal structure of L. pneumophila isolates in the Middle East and 
central Europe 
In general, the study of the population of L. pneumophila isolates in the areas of 
Northern Israel and along the West Bank showed similar patterns. Sgp1 isolates were more 
frequent than non-sgp1 isolates in both areas, i.e. 83.3% and 62.3% were characterized as sgp1 
in Israel and West Bank, respectively. However, higher diversity was observed among the non-
serogroup1 isolates in the West Bank in comparison to Israel. In the sampled locations in Israel, 
sgp3 prevailed over other non-sgp1 isolates (84% of non-sgp1 isolates were sgp3), which could 
not be further identified and remained as sgp 2-14. In West Bank, sgp3 was not observed among 
the group of 54.4% of non-sgp1 isolates that were additionally sub-grouped. In this group the 
majority of isolates were sgp6, and sgp8 and sgp10 were detected as well. 
According to the MLVA genotyping, both areas were characterized by the presence of a 
few single genotypes, most of their genotypes were isolated more than once. The diversity was 
slightly higher in Israel (ID=0.818, 95% CI 0.781-0.855) than along the West Bank (ID=0.790, 
95% CI 0.739- 0.841), although in West Bank the sampled area was more extent. Nevertheless, 
the most abundant and more widely distributed genotypes were common to the two areas. In 
particular, Gt4(17) and Gt6(18), both corresponding to ST1, constituted 51.7% and 58.8% of the 
total genotypes in Israel and West Bank, respectively (Figure 7). At clonal level, five clonal 
complexes were detected in the two areas (VACC1, VACC2, VACC5, VACC6 and VACC11). 
VACC1, VACC2 and VACC5 were shared by Israel and the West Bank (Figure 7).  
 
Figure 7. Minimum spanning tree of MLVA-8(12) profiles of 451 clinical and environmental L. pneumophila strains 
isolated in Israel and West Bank.  Each circle represents a different MLVA-8(12) genotype and is proportional to the 
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genotype frequencies. Different colours in the pie charts represent the different geographical areas where the isolates 
were obtained (see legend). Thickness of the branches represents the number of different loci. MLVA clonal 
complexes (VACC) are represented by shading. 
 
By contrast, most of the genotypes were found in Germany as single genotypes (71% of 
the 179 L. pneumophila isolates were singletons) and therefore the diversity was higher 
(ID=0.973, 95% CI 0.962-0.984) than in Israel or the West Bank. However, Gt4(17) was the 
most common genotype in Germany as well, accounting with 14% of the environmental isolates 
and 6.6% of clinical isolates. In addition to Gt4(17), only two more MLVA-8(12) genotypes 
were common between Middle East and Germany, i.e. Gt4(16) and Gt24(68), which 
corresponded to ST1 and ST93, respectively (Figure 8).  
 
Figure 8. Venn diagram of the number of individual MLVA-8(12) genotypes shared among distinct geographic 
areas. The size of the circle is proportional to the number of genotypes of each area. 
 
Gt24(68) matched to a sgp3 clinical isolate in Germany and to a sgp1 clinical isolate in Israel. 
In the West Bank this genotype was isolated from biofilm in Al-Makassed Hospital, indicating 
the presence of pathogenic strains in this location. Germany shared only one MLVA-8(12) 
genotype with Israel, i.e. Gt18(4), which corresponded as well to ST1, and two genotypes with 
West Bank, i.e. Gt64(74) and Gt40(47), corresponding to ST440 and ST292, respectively. In 
spite of the proximity of the two sampling areas in Middle East, only two MLVA-8(12) 
genotypes were found in common between the West Bank and Northern Israel, i.e. Gt6(15) and 
Gt6(18), which matched to ST1, in addition to the three genotypes common to Germany. 
Besides the worldwide distributed ST1, sequence types ST93, ST292 and ST440 had in 
common their extensive distribution. ST292 corresponds mostly to environmental and clinical, 
sgp6 isolates observed across Europe and Russia. ST93, has been as well found across Europe 
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and China and is represented mainly by environmental, sgp3 isolates. Finally, only seven 
isolates with ST440 are found at the Legionella Sequence Based Typing (SBT) database and 
they were environmental and clinical, sgp6 and sgp10 isolates, obtained from France and 
Germany. Overall, the majority of MLVA-8(12) genotypes in this study were unique of Europe 
or Middle East and those common to the two areas were known to be worldwide distributed.  
The high exclusivity observed at genotype level between Middle East and Europe 
contrasted with the high similarity observed at clonal level. Comparing the L. pneumophila 
isolates from the Middle East with the 179 isolates from Germany used in this study and with 
the international Legionella database, it was observed that all five clonal complexes found in the 
Middle East were found in Europe as well (Figure 9).  
 
Figure 9. Minimum-spanning tree of MLVA-8(12) profiles of 610 clinical and environmental L. pneumophila strains 
isolated in Israel, West Bank and Germany.  Each circle represents a different MLVA-8(12) genotype and is 
proportional to the genotype frequencies (designation of genotypes not included). Different colours in the pie charts 
represent the different geographical areas where the isolates were obtained (see legend).  Thickness of the branches 
represents the number of different loci. MLVA clonal complexes (VACC) are represented by shading.   
 
VACC1, the largest clonal complex in the Middle East, was broadly distributed across 
Europe, as already described in Chapter II. Genotypes that belonged to VACC1 were isolated in 
distant countries as Greece, Scotland, Sweden and Spain. VACC2 was a large clonal complex in 
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Germany, observed in all regions. It was observed frequently in France, formed by 
environmental and clinical isolates of different serogroups. Additionally, several reference 
strains known to have been originally isolated in United States, among them L. pneumophila 
strain Bloomington-2 and L. pneumophila strain Chicago-2, have been included in VACC2. 
VACC5 was a smaller clonal complex in Germany, although it was widespread. In the database, 
VACC5 was formed by clinical and environmental isolates of distinct serogroups isolated in 
different European countries, such as Denmark, Switzerland, Belgium Greece and UK. VACC6 
was extensively distributed in Germany and it was composed of clinical and environmental 
isolates of different serogroups. VACC6 appeared at the Legionella database as a large clonal 
complex formed by numerous environmental sgp1 isolates from France and few clinical isolates 
isolated from Sweden. VACC11 was not described in the database, so it could be considered as 
a novel clonal complex found during this study.  
 
A more detailed analysis of the population structure at the level of the VNTR markers 
that define the genotypes showed that, overall, a higher variability in the number of repeats for 
most VNTR markers was observed among the isolates obtained in Germany as shown by their 
HGDI discriminatory index (Hunter Gaston Discriminatory Index). (Table 5). This could be 
due to the general greater diversity of habitats and locations where the isolates have been 
obtained from. Some VNTR markers appeared to be less variable and showed a reduced number 
of repeats. This reduction was consistent among the isolates of Middle East and Central Europe, 
as shown for markers Lpms3, Lpms17 and Lpms40. However, other markers showed a greater 
variability, and this variability was especially noticeable in the European isolates in contrast to 
the isolates from the Middle East. Examples of VNTR markers with higher number of repeats in 
isolates from Europe in comparison to isolates from the Middle East are Lpms13, Lpms31, 
Lpms35 or Lpms39. In general, the same repeats prevailed independently of the area where the 
isolate was obtained from. Null alleles were present at different frequencies in distinct VNTR 
markers of the three areas. Especially high were the frequencies of null alleles in Lpms40 and 
Lpms44 for isolates from Germany. Remarkably, a new allele of Lpms34 was described during 
this study. The new allele had a size of 634 base pairs and was formed of four repeats. A total of 
31 (17.2%) isolates from West Bank contained this allele. However, it was very infrequently 
found out of the West Bank area. It was not present in any of the 250 L. pneumophila isolates 
from Northern Israel and it was observed exclusively in one clinical isolate from Germany 
(L01-138). This allele was not described in previous MLVA studies for L. pneumophila and 
therefore, should be incorporated in the allele assignment reference table provided at L. 
pneumophila MLVA database for future studies.  
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3.5 Discussion  
3.5.1 Diversity of L. pneumophila populations 
Not so many studies have reported the status of the epidemiology of L. pneumophila in 
the area that comprises Israel and West Bank (8, 10) and the  studies realized in the area of 
Table 5. VNTR characteristics of the L. pneumophila strains isolated in Israel, West Bank and Germany (average 
values based on 611 strains). 
 
Israel 
 
West Bank 
 
Germany 
VNTR  
No. of 
repeats 
HGDI1 
(CI 
95%)  
Null 
alleles 
(%) 
 
No. of 
repeats 
HGDI 
(CI 
95%)  
Null 
alleles 
(%) 
 
No. of 
repeats 
HGDI 
(CI 
95%)  
Null 
alleles 
(%) 
Lpms1 5 
0.241 
(0.171-
0.312) 
0.8 
 
4 
0.528 
(0.459-
0.596) 
  
5 
0.528 
(0.476-
0.580) 
 
Lpms3 3 
0.266 
(0.201-
0.330) 
0.8 
 
2 
0.461 
(0.420-
0.502) 
  
3 
0.486 
(0.453-
0.519) 
0.56 
Lpms13 6 
0.225 
(0.157-
0.292) 
0.8 
 
5 
0.579 
(0.506-
0.652) 
  
10 
0.737 
(0.684-
0.791) 
 
Lpms17 2 
0.016 
(1.000-
0.038) 
  
2 
0.115 
(0.053-
0.178) 
  
2 
0.033 
(1.000-
0.070) 
 
Lpms19 4 
0.223 
(0.157-
0.289) 
2.39 
 
2 
0.022 
(1.000-
0.053) 
1.11 
 
8 
0.405 
(0.322-
0.488) 
6.15 
Lpms31 6 
0.246 
(0.176-
0.317) 
  
6 
0.576 
(0.513-
0.639) 
1.67 
 
15 
0.869 
(0.853-
0.886) 
1.68 
Lpms33 3 
0.237 
(0.169-
0.304) 
  
4 
0.575 
(0.506-
0.643) 
  
5 
0.683 
(0.642-
0.724) 
 
Lpms34 4 
0.128 
(0.072-
0.184) 
0.8 
 
4 
0.503 
(0.429-
0.577) 
2.22 
 
5 
0.565 
(0.515-
0.615) 
1.12 
Lpms35 8 
0.597 
(0.550-
0.644) 
2.79 
 
6 
0.687 
(0.641-
0.733) 
1.67 
 
20 
0.858 
(0.827-
0.889) 
 
Lpms38 3 
0.512 
(0.466-
0.559) 
6.77 
 
3 
0.249 
(0.168-
0.330) 
4.44 
 
8 
0.3 
(0.213-
0.387) 
8.38 
Lpms39 7 
0.304 
(0.231-
0.378) 
  
3 
0.509 
(0.445-
0.574) 
  
12 
0.813 
(0.785-
0.841) 
6.7 
Lpms40 3 
0.225 
(0.161-
0.289) 
  
3 
0.493 
(0.444-
0.541) 
3.33 
 
3 
0.6 
(0.552-
0.648) 
20.11 
Lpms44 5 
0.318 
(0.247-
0.389) 
1.99 
 
3 
0.498 
(0.463-
0.533) 
  
3 
0.514 
(0.446-
0.582) 
14.53 
1 HGDI: Hunter Gaston Discriminatory Index  
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Israel remarked interesting facts that could deserve more attention and further analysis, as the 
high frequency of serogroups that have been found just rarely in other areas worldwide or the 
presence of new sequence types, suggesting the existence of a rich genetic diversity still to be 
assessed. In the present study, the systematic sampling carried out during two years along a vast 
area combining the sampling of different types of habitats (bulk water and biofilm), lead to a 
large collection of 420 environmental L. pneumophila isolates that could complement previous 
studies and bring new insights into the molecular epidemiology and genetic diversity of L. 
pneumophila in this particular area of the Middle East. In general, studies focused on the genetic 
diversity of L. pneumophila in the environment are not so common (23, 24) as those based 
primarily in clinical isolates (25–27). Studies including environmental samples have been 
usually realized with the aim of establishing epidemiological links between clinical isolates and 
their presumed environmental sources during legionellosis outbreaks (21, 28). However, since 
the Legionella infections are originated directly from the environment and do not occur by 
human-to-human transmission, the study of the genetic diversity and the distributions of L. 
pneumophila strains using this large set of environmental isolates could be relevant in public 
health control strategies in the Middle East and in later epidemiological studies.  
Moran-Gilad et al. (2014) (10) indicated in their study that the tendency of higher 
number of nosocomial cases of LD in Israel could be due to the under-diagnosis and under-
reporting of community-acquired cases. The methodical sampling of water and biofilm from the 
water systems in different private houses and public buildings in Northern Israel as well as the 
selection of hospitals distributed along the West Bank allowed the evaluation of the strains that 
could represent risk of infection, resulting in community-acquired and nosocomial cases of LD. 
Although most of the L. pneumophila isolates from the West Bank (n=177, 98.3%) were 
obtained from biofilm samples, the strains isolated could be considered representative of the 
water system since it has been showed that more than 95% of the microbial biomass in a 
drinking water supply system is found in the biofilms attached to the pipe walls (29) due to the 
multiple advantages that biofilm represents for microorganisms, as protection of external factors 
and beneficial interactions with other microorganisms. Additionally, from the point of view of 
public health biofilm sampling has a great importance since it has been observed that L 
pneumophila strains derived from biofilm replicate significantly more in murine macrophages 
than planktonic bacteria (30).  
Overall, the great majority of strains isolated from the area under study in the Middle 
East were characterized as sgp1 (83.3% and 62.3% of the isolates in Israel and West Bank, 
respectively). This serogroup was the most abundant in the area of West Bank as well as in 
Northern Israel (Table 1 and 3). This fact followed the tendency already reported by other 
studies that have described sgp1 as the most frequently detected environmental serogroup in 
different geographic regions (5, 31, 32). Besides the high prevalence of sgp1, other serogroups 
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were isolated, especially along the West Bank, where the fraction of non-sgp1 isolates went up 
to 37.7%. Sgp6 was particularly abundant (16.7%). Sgp8 and sgp10 were as well isolated in the 
West Bank, although in smaller proportions (3.3% and 0.7%, respectively). In Israel, the 
number of non-sgp1 isolates was lower than in the West Bank (16.6%) and sgp3 was the most 
frequently serogroup observed (10.8%) within this group. This serogroup has been found to be 
very frequent in drinking water systems in Israel (9, 10). It cannot be excluded that sgp3 was not 
present among the isolates from West Bank, since only 54.4% of the non-sgp1 isolates could be 
additionally subgrouped. The results obtained here were highly concordant to those from two 
studies about the distribution of L. pneumophila serogroups in man-made water systems not 
related to human disease (25, 31). L. pneumophila sgp1 was the most frequently isolated 
serogroup followed by sgp6 and sgp3 in France and the UK, where they were as frequently 
observed as sgp10. Both sgp3 and sgp6 were the serogroups responsible for more cases of LD 
after sgp1, according to the European surveillance data (2). 
Multi Locus Variable number of tandem Repeats Analysis (MLVA) was the method of 
choice in this study to evaluate the diversity and population structure of the large set of 431 L. 
pneumophila isolates from the Middle East. Representative isolates were as well typed by 
Sequence Based Typing (SBT). The combined MLVA-8(12) genotyping scheme showed higher 
discriminatory power than MLVA-8 in the isolates from Northern Israel and the West Bank. In 
the West Bank, the number of genotypes increased from 16 to 26 when applying MLVA-8(12) 
(0.790, 95% CI, 0.739-0.841) in comparison to MLVA-8 (ID=0.771, 95% CI 0.721-0.822). In 
Israel, the number of genotypes increased from 23 with MLVA-8 genotyping (ID=0.643, 95% 
CI 0.591-0.695) to 37 with the MLVA-8(12) scheme (ID=0.818, 95% CI 0.781-0.855). Despite 
the proximity of the two areas, only five MLVA-8(12) genotypes were common between the 
West Bank and North Israel (Figure 8). This could be due to the different origin of the water 
supplied in both areas, groundwater in West Bank and surface water in Northern Israel. Of the 
five common genotypes, two of them, Gt4(17) and Gt6(18), were the most frequent and more 
broadly distributed genotypes in each area (Figure 1 and 3). Furthermore, they were equally 
abundant in water and biofilm in the drinking water supply systems in Israel and corresponded 
to ST1. These results confirmed those by Moran-Gilad et al. (2014) (10) where ST1 was 
described as the most prevalent sequence type in Israel. Interesting, in Israel most of the 
MLVA-8(12) genotypes were found in more than one sampling location, yet in the West Bank 
each hospital presented particular genotypes. As demonstrated by Rodriguez-Martínez et al. 
(2015) (11) water physicochemical parameters, such as temperature and pH, can affect the 
presence and abundance of particular genotypes in Northern Israel. Therefore, additional 
analysis should be carried out to validate the presence of potential ecotypes in the hospitals of 
West Bank. 
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The populations of L. pneumophila in Germany differed nearly completely to the 
populations of L. pneumophila in the Middle East. It was observed that only three MLVA-8(12) 
genotypes were shared by the two distinct geographic areas. Gt4(17) was one of the common 
genotypes and, as in the Middle East, it was very abundant among both environmental and 
clinical isolates in Germany. Specifically, this genotype was the most abundant among the 
clinical isolates obtained in Israel and the second most abundant in Germany. ST1, the sequence 
type matching genotype Gt4(17), is one of the most the most abundant sequence type 
worldwide, as already discussed in Chapter II (27, 31, 33, 34). The high abundance of ST1 in 
the environment has been reported in several studies. In Japan, the majority of environmental 
isolates (29%) were ST1 (36) as well as in South Korea, where ST1 was distributed across all 
sampled facilities and regions and accounted for 48.1% of the isolates (32). ST1 was the most 
abundant sequence type among environmental isolates in Canada and it was found ubiquitously 
across the country (34). In a study conducted across the United States, ST1 was the most 
frequent sequence type among both clinical sporadic and environmental isolates, accounting for 
the 25% and 49% of the total number of isolates respectively  (27). In Europe, ST1 has been 
also reported the most predominant sequence type among environmental isolates in Germany 
(37), England and Wales (31), Portugal (38) and Spain (39). ST1, has been found often in 
Europe very frequently not only in the environment but also responsible of cases of pneumonia 
(40, 41). Moran-Gilad et al. (2014) (10) showed as well that the 42.8% of the clinical strains 
from Israel analysed in his study belonged to ST1. 
Despite the low number of isolates from this study selected for Sequence Based Typing 
(10% of isolates from West Bank and 2.4% of isolates from Israel), a novel sequence, ST1482, 
was identified. Among other unique sequence types that have been observed, ST1438 had been 
previously identified exclusively in Israel (10) and the rest appeared to be, as ST1, broadly 
distributed  according to the SBT database. For instance, ST1358 was among the most 
frequently isolated sequence types across a Spanish region (39) and ST461 was a sgp6 strain 
isolated from different hospitals in Poland (42). 
The clonal population structure of L. pneumophila in the Middle East was characterized 
by the presence of five clonal complexes or VACCs (VACC1, VACC2, VACC5, VACC6 and 
VACC11).  VACC11 was first defined during this study and it was formed exclusively by a 
group of 31 strains isolated from several hospitals in West Bank. VACC1, which main genotype 
was Gt4(17) and also included the pathogenic L. pn. Paris reference strain, was the largest 
cluster (Figure 7) in the Middle East. This cluster enclosed closely related sgp1 strains isolated 
in most of the sampling locations in Northern Israel and the West Bank. The rest of the clonal 
complexes were significantly reduced in comparison to VACC1. Especially small was VACC6, 
which included two clinical isolates and two environmental isolates obtained in the locality of 
Alonei Abba in Northern Israel. When comparing the population of L. pneumophila in Middle 
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with the population in Germany, it was revealed that VACC1 was the dominant cluster followed 
by VACC2, which included the L. pn. Philadelphia reference strain. This pattern was consistent 
with previous studies (18). In the study by Visca et al. (2011), the population structure of a set 
of L. pneumophila strains with different origins from the European Union Legionella (EUL) 
collection was investigated by MLVA-8 genotyping. The 86% of the strains were grouped into 
clonal complexes, of which VACC1 was the largest cluster followed by VACC2.  
This general clonal structure observed in Europe and Middle East with prevalence of 
VACC1 contrasted with the study at local scale carried out in the French city of Rennes  (21). In 
this study was observed that the whole water supply system of the city was colonized by few 
closely related strains belonging to VACC6. Two of the other clonal complexes found in the 
water system of the city, i.e. VACC1 and VACC2, were significantly smaller clusters. It should 
be pointed out that all VACC6 strains had been isolated from hot water supplies, while VACC1 
and VACC2 strains were isolated from cooling towers distributed around the city. Considering 
the global distribution of single strains and its genetically similar variants, i.e. Gt4(17) and 
VACC1, it can be suggested that geographical barriers are not the main force influencing the 
differentiation of L. pneumophila strains. However, it cannot be excluded the significance of the 
geography. As shown in this study, each area (Northern Israel, the West Bank and Germany) 
was supplied by different water sources and presented mostly unique genotypes.  In the other 
hand, both the existence of global and local strains, suggested that the environmental conditions 
of the habitats, especially temperature, could play a very important role thriving the evolution of 
L. pneumophila. Ecological barriers could be then responsible for the separation of the distinct 
clones. Clonal complexes widely distributed could have a wider adaptation range than smaller 
ones. Alternatively, widely distributed clones could be adapted to ecological conditions more 
common in water systems. The possible adaptation of the clonal complexes to different 
ecological niches leads to the concept of ecotype (43). Edward et al. (2008) (44) investigated the 
clonal population of L. pneumophila by analysing the sequences of six loci of the SBT scheme 
in 335 globally distributed clinical and environmental isolates. The presence of large clonal 
complexes composed of isolates from very distant localizations also suggested the absent of 
geographic separation and therefore, it was proposed that the clusters would be adapted to 
specific ecologies, establishing stable ecotypes. Recently, Rodríguez et al. (2015) (11), also 
suggested the presence of specific ecotypes in the same drinking water system of the Oranim 
campus as used in this study. Their study revealed the occurrence of different genotypes adapted 
to different temperature ranges. Particularly, the most abundant genotype, i.e. Gt4, which 
corresponded to Gt4(17) and dominated the clonal complex VACC1, was better adapted to 
colder temperatures (20.6°C). Another genotype found in their study, i.e. Gt15, which belonged 
to a distinct clonal complex (VACC5), was adapted to significantly higher temperatures 
(45.1°C). This agrees with the observations from the water system in France (21). Further 
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research would be needed for a better understanding of the ecological features that might drive 
the differentiation of the L. pneumophila populations into genetic clusters.  
  
3.5.2 Effectiveness of the selection of MLVA as principal genotyping method  
Bacterial genotyping is an essential tool in molecular epidemiology. Determining the 
relatedness between bacterial strains and combining with epidemiological information is crucial 
in order to understand the transmission and evolution of pathogens. In addition, the use of 
molecular markers has become popular in ecological studies. Typically, genotyping methods are 
applied to study organisms in their natural habitats and to evaluate the effect of diverse 
environmental or anthropogenic disturbance and variations. 
Whole genome sequencing (WGS) is an increasingly popular technique with great 
potential in microbial identification and genotyping (45). WGS has also been shown to be 
suitable for population and epidemiological studies of different bacteria (46–48). Although 
further improvements in data analysis and standardization are needed, this method it is 
considered as a possible routine procedure for surveillance and outbreak investigations (45). In 
the case of L. pneumohila, WGS has been applied in several studies (28, 49, 50), demonstrating 
its potential in providing high quality typing and epidemiological data. Despite of the 
advantages associated to WGS, there are situations in which the application of alternative, faster 
and lower cost genotyping tools are desirable. In this study, the high number of isolates (more 
than 700 isolates) of L. pneumophila collected during extensive sampling campaigns in the 
Middle East and Germany required a genotyping method able to characterize such large number 
of isolates in a time and cost efficient manner. Multi Locus variable number of tandem repeats 
(VNTR) Analysis (MLVA) had been previously described as a high throughput tool for 
subtyping of different bacterial pathogens (16, 51). MLVA relies on the use of genetic markers 
as VNTR loci, which are genomic regions with high mutational rate and thus, high number of 
possible allelic states  (17). The capability of multiplexing the amplification of VNTR loci made 
the approach very rapid. Additionally, the application of capillary electrophoresis increased the 
throughput, accuracy and the reproducibility of the method.  Due to the use of highly variable 
genetic regions, MLVA has been shown to have high discriminatory power (52, 53). Here, all 
MLVA schemes combining different number of VNTR loci tested (MLVA-8, MLVA-12 and 
the joint MLVA-8(12) scheme) revealed higher resolution than Sequence Based Typing (SBT), 
the standard typing method for L. pneumophila. However, concordance with SBT was excellent, 
making MLVA genotyping method appropriate for the characterization of numerous L. 
pneumophila isolates. Finally, the study of the high amount of isolates from different habitats 
and geographies by MLVA genotyping presented in this study has provided an effective basis 
for further research. For instance, further genome analyses of representative MLVA genotypes 
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can be applied to gain additional insights in the evolutionary forces that shape and form the 
distinct clonal complexes or lineages. Moreover, physiological and ecological studies of 
different MLVA genotypes are foreseen to investigate the role of the ecotypes in water supply 
systems (11). 
 
 
3.6 References 
1.  European Centre for Disease Prevention and Control. 2015. Legionnaires ’ disease in 
Europe, 2013. ECDC Surveillance report. 
2.  CDC. 2011. Legionellosis — United States, 2000–2009. MMWR Morb Mortal Wkly 
Rep 60:2000–2009.  
3.  Cunha BA, Burillo A, Bouza E. 2015. Legionnaires’ disease. Lancet 387:376–385. 
4.  Hames N. 2005. Prevalence of Legionella pneumophila serogroup 1 in water distribution 
systems in Izmir province of Turkey. APMIS 1:664–669. 
5.  Erdogan H, Arslan H. 2007. Colonization of Legionella species in hotel water systems 
in Turkey. J Travel Med 14:369–373. 
6.  Al-Matawah Q, Al-Zenki S, Al-Azmi A, Al-Waalan T, Al-Salameen F, Hejji A Ben. 
2015. Legionella detection and subgrouping in water air-conditioning cooling tower 
systems in Kuwait. Environ Sci Pollut Res 22:10235–10241. 
7.  Lieberman D, Schlaeffer F, Boldur I, Horowitz S, Friedman MG, Leiononen M, 
Horovitz O, Manor E, Porath A. 1996. Multiple pathogens in adult patients admitted 
with community-acquired pneumonia: a one year prospective study of 346 consecutive 
patients. Thorax 51:179–84. 
8.  Moran-Gilad J, Lazarovitch T, Mentasti M, Harrison T, Weinberger M, Mordish 
Y, Mor Z, Stocki T, Anis E, Sadik C, Amitai Z, Grotto I. 2012. Humidifier-associated 
paediatric Legionnaires’ disease, Israel, February 2012. Euro Surveill 17:20293. 
9.  Yarom R, Sheinman R, Armon R. 2010. Legionella pneumophila serogroup 3 
prevalence in drinking water survey in Israel (2003-2007). Water Sci Technol Water 
Supply 10:746–752. 
10.  Moran-Gilad J, Mentasti M, Lazarovitch T, Huberman Z, Stocki T, Sadik C, 
Shahar T, Anis E, Valinsky L, Harrison TG, Grotto I. 2014. Molecular epidemiology 
of Legionnaires’ disease in Israel. Clin Microbiol Infect 20:690–696. 
11.  Rodríguez-Martínez S, Sharaby Y, Pecellín M, Brettar I, Höfle M, Halpern M. 
2015. Spatial distribution of Legionella pneumophila MLVA-genotypes in a drinking 
water system. Water Res 77:119–132. 
12.  Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, 
92 
 
Lindsay D, Lück PC, Marques T, Mentula S, Peeters MF, Pelaz C, Struelens M, 
Uldum S a., Wewalka G, Harrison TG. 2002. Pan-European study on culture-proven 
Legionnaires’ disease: Distribution of Legionella pneumophila serogroups and 
monoclonal subgroups. Eur J Clin Microbiol Infect Dis 21:710–716. 
13.  Beauté J, Zucs P, de Jong B. 2013. Legionnaires disease in Europe, 2009-2010. Euro 
Surveill 18:20417. 
14.  Bowden KE, Williams MM, Cassiday PK, Milton A, Pawloski L, Harrison M, 
Martin SW, Meyer S, Qin X, DeBolt C, Tasslimi A, Syed N, Sorrell R, Tran M, 
Hiatt B, Tondella ML. 2014. Molecular epidemiology of the pertussis epidemic in 
Washington State in 2012. J Clin Microbiol 52:3549–57. 
15.  Kjeldsen MK, Torpdahl M, Campos J, Pedersen K, Nielsen EM. 2014. Multiple-
locus variable-number tandem repeat analysis of Salmonella enterica subsp. enterica 
serovar Dublin. J Appl Microbiol 116:1044–54. 
16.  Roussel S, Felix B, Vingadassalon N, Grout J, Hennekinne JA, Guillier L, Brisabois 
A, Auvray F. 2015. Staphylococcus aureus strains associated with food poisoning 
outbreaks in France: Comparison of different molecular typing methods, including 
MLVA. Front Microbiol 6:1–12. 
17.  Pourcel C, Visca P, Afshar B, D’Arezzo S, Vergnaud G, Fry NK. 2007. Identification 
of variable-number tandem-repeat (VNTR) sequences in Legionella pneumophila and 
development of an optimized multiple-locus VNTR analysis typing scheme. J Clin 
Microbiol 45:1190–9. 
18.  Visca P, D’Arezzo S, Ramisse F, Gelfand Y, Benson G, Vergnaud G, Fry NK, 
Pourcel C. 2011. Investigation of the population structure of Legionella pneumophila by 
analysis of tandem repeat copy number and internal sequence variation. Microbiology 
157:2582–94. 
19.  International Organization for Standardization. 2004. ISO 11731-2. Water quality – 
detection and enumeration of Legionella. 
20.  Gaia V, Fry NK, Afshar B, Luck CP, Meugnier H, Etienne J, Peduzzi R, Harrison 
TG. 2005. Consensus Sequence-Based scheme for epidemiological typing of clinical and 
environmental isolates of Legionella pneumophila. J Clin Microbiol 43:2047–2052. 
21.  Sobral D, Le Cann P, Gerard  a, Jarraud S, Lebeau B, Loisy-Hamon F, Vergnaud 
G, Pourcel C. 2011. High-throughput typing method to identify a non-outbreak-
involved Legionella pneumophila strain colonizing the entire water supply system in the 
town of Rennes, France. Appl Environ Microbiol 77:6899–907. 
22.  Hulsen T, de Vlieg J, Alkema W. 2008. BioVenn - a web application for the 
comparison and visualization of biological lists using area-proportional Venn diagrams. 
BMC Genomics 9:488. 
93 
 
23.  Coscollá M, González-Candelas F. 2007. Population structure and recombination in 
environmental isolates of Legionella pneumophila. Environ Microbiol 9:643–656. 
24.  Coscollá M, Fenollar J, Escribano I, González-Candelas F. 2010. Legionellosis 
outbreak associated with asphalt paving machine, Spain, 2009. Emerg Infect Dis 
16:1381–7. 
25.  Sánchez-Busó L, Coscollá M, Pinto-Carbó M, Catalán V, González-Candelas F. 
2013. Genetic characterization of Legionella pneumophila isolated from a common 
watershed in Comunidad Valenciana, Spain. PLoS One 8:e61564. 
26.  Coscollá M, González-Candelas F. 2009. Direct sequencing of Legionella pneumophila 
from respiratory samples for sequence-based typing analysis. J Clin Microbiol 47:2901–
5. 
27.  Doleans A, Aurell H, Reyrolle M, Lina G, Freney J, Vandenesch F, Etienne J, 
Jarraud S, Ce L. 2004. Clinical and environmental distributions of Legionella strains in 
France are different. J Clin Microbiol 42:458–460. 
28.  Kanatani J-I, Isobe J, Kimata K, Shima T, Shimizu M, Kura F, Sata T, Watahiki 
M. 2013. Molecular epidemiology of Legionella pneumophila serogroup 1 isolates 
identify a prevalent sequence type, ST505, and a distinct clonal group of clinical isolates 
in Toyama Prefecture, Japan. J Infect Chemother 19:644–52. 
29.  Kozak-Muiznieks N a, Lucas CE, Brown E, Pondo T, Taylor TH, Frace M, 
Miskowski D, Winchell JM. 2014. Prevalence of sequence types among clinical and 
environmental isolates of Legionella pneumophila serogroup 1 in the United States from 
1982 to 2012. J Clin Microbiol 52:201–11. 
30.  Reuter S, Harrison TG, Köser CU, Ellington MJ, Smith GP, Parkhill J, Peacock SJ, 
Bentley SD, Török ME. 2013. A pilot study of rapid whole-genome sequencing for the 
investigation of a Legionella outbreak. BMJ Open 3:e002175. 
31.  Douterelo I, Boxall JB, Deines P, Sekar R, Fish KE, Biggs C a. 2014. Methodological 
approaches for studying the microbial ecology of drinking water distribution systems. 
Water Res 65:134–156. 
32.  Abu Khweek A, Fernández Dávila NS, Caution K, Akhter A, Abdulrahman B a, 
Tazi M, Hassan H, Novotny L a, Bakaletz LO, Amer AO. 2013. Biofilm-derived 
Legionella pneumophila evades the innate immune response in macrophages. Front Cell 
Infect Microbiol 3:18. 
33.  Harrison TG, Afshar B, Doshi N, Fry NK, Lee J V. 2009. Distribution of Legionella 
pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in 
recent clinical and environmental isolates from England and Wales (2000-2008). Eur J 
Clin Microbiol Infect Dis 28:781–91. 
34.  Lee HK, Shim JI, Kim HE, Yu JY, Kang YH. 2010. Distribution of Legionella species 
94 
 
from environmental water sources of public facilities and genetic diversity of L. 
pneumophila serogroup 1 in South Korea. Appl Environ Microbiol 76:6547–6554. 
35.  Cazalet C, Jarraud S, Ghavi-helm Y, Kunst F, Glaser P, Etienne J, Buchrieser C. 
2008. Multigenome analysis identifies a worldwide distributed epidemic Legionella 
pneumophila clone that emerged within a highly diverse species. Genome Res 18:431–
441. 
36.  Reimer AR, Au S, Schindle S, Bernard KA. 2010. Legionella pneumophila 
monoclonal antibody subgroups and DNA sequence types isolated in Canada between 
1981 and 2009: Laboratory component of national surveillance. Eur J Clin Microbiol 
Infect Dis 29:191–205. 
37.  Kozak-Muiznieks N a., Lucas CE, Brown E, Pondo T, Taylor TH, Frace M, 
Miskowski D, Winchell JM. 2014. Prevalence of sequence types among clinical and 
environmental isolates of Legionella pneumophila serogroup 1 in the United States from 
1982 to 2012. J Clin Microbiol 52:201–211. 
38.  Amemura-Maekawa J, Kikukawa K, Helbig JH, Kaneko S, Suzuki-Hashimoto  a., 
Furuhata K, Chang B, Murai M, Ichinose M, Ohnishi M, Kura F. 2012. Distribution 
of monoclonal antibody subgroups and sequence-based types among Legionella 
pneumophila Serogroup 1 isolates derived from cooling tower water, bathwater, and soil 
in Japan. Appl Environ Microbiol 78:4263–4270. 
39.  Borchardt J, Helbig JH, Lück PC. 2008. Occurrence and distribution of sequence 
types among Legionella pneumophila strains isolated from patients in Germany: 
common features and differences to other regions of the world. Eur J Clin Microbiol 
Infect Dis 27:29–36. 
40.  Chasqueira MJ, Rodrigues L, Nascimento M, Ramos M, Marques T. 2014. Genetic 
diversity and evolutionary relationships among Legionella pneumophila clinical isolates, 
Portugal , 1987 to 2012. Euro Surveill 19:1–7. 
41.  Sánchez-Busó L, Coscollà M, Palero F, Camaró ML, Gimeno A, Moreno P, 
Escribano I, López Perezagua MM, Colomina J, Vanaclocha H, González-Candelas 
F. 2015. Geographical and Temporal Structure of Legionella pneumophila Sequence 
Types in Comunitat Valenciana (Spain), 1998-2013. Appl Environ Microbiol 81:7106-
7113. 
42.  Vekens E, Soetens O, Mendonça R De, Echahidi F, Roisin S, Deplano A, Eeckhout 
L. 2012. serogroup 1 clinical isolates from Belgium between 2000 and 2010. Euro 
Surveill 19:1–6. 
43.  Fontana S, Scaturro M, Rota MC, Caporali MG, Ricci ML. 2014. Molecular typing 
of Legionella pneumophila serogroup 1 clinical strains isolated in Italy. Int J Med 
Microbiol 304:597–602. 
95 
 
44.  Pancer K. 2013. Sequence-based typing of Legionella pneumophila strains isolated 
from hospital water distribution systems as a complementary element of risk assessment 
of legionellosis in Poland. Ann Agric Environ Med 20:436–440. 
45.  Fraser C, Alm EJ, Polz MF, Spratt BG, Hanage WP. 2009. The bacterial species 
challenge: making sense of genetic and ecological diversity. Science 323:741–746. 
46.  Edwards MT, Fry NK, Harrison TG. 2008. Clonal population structure of Legionella 
pneumophila inferred from allelic profiling. Microbiology 154:852–64. 
47.  Sabat AJ, Budimir A, Nashev D, Dijl JM Van, Laurent F, Grundmann H, Friedrich 
AW. 2013. Overview of molecular typing methods for outbreak detection and 
epidemiological surveillance. Euro Surveill 8:1–15. 
48.  Leopold SR, Goering R V., Witten A, Harmsen D, Mellmann A. 2014. Bacterial 
Whole-Genome Sequencing revisited: portable, scalable, and standardized analysis for 
typing and detection of virulence and antibiotic resistance genes. J Clin Microbiol 
52:2365–2370. 
49.  Schmid D, Allerberger F, Huhulescu S, Pietzka  a., Amar C, Kleta S, Prager R, 
Preußel K, Aichinger E, Mellmann  A. 2014. Whole genome sequencing as a tool to 
investigate a cluster of seven cases of listeriosis in Austria and Germany, 2011-2013. 
Clin Microbiol Infect 20:431–436. 
50.  Holmes A, Allison L, Ward M, Dallman TJ, Clark R, Fawkes A, Murphy L, 
Hanson M. 2015. The utility of Whole Genome Sequencing of Escherichia coli O157 
for outbreak detection and epidemiological surveillance. J Clin Microbiol 53:3565-3573. 
51.  Underwood AP, Jones G, Mentasti M, Fry NK, Harrison TG. 2013. Comparison of 
the Legionella pneumophila population structure as determined by sequence-based 
typing and whole genome sequencing. BMC Microbiol 13:302. 
52.  Lévesque S, Plante P-L, Mendis N, Cantin P, Marchand G, Charest H, Raymond F, 
Huot C, Goupil-Sormany I, Desbiens F, Faucher SP, Corbeil J, Tremblay C. 2014. 
Genomic characterization of a large outbreak of Legionella pneumophila serogroup 1 
strains in Quebec City, 2012. PLoS One 9:e103852. 
53.  Sobral D, Mariani-Kurkdjian P, Bingen E, Vu-Thien H, Hormigos K, Lebeau B, 
Loisy-Hamon F, Munck  a, Vergnaud G, Pourcel C. 2012. A new highly 
discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological 
survey of Pseudomonas aeruginosa in cystic fibrosis patients. Eur J Clin Microbiol 
Infect Dis 31:2247–56. 
54.  Elberse KEM, Nunes S, Sá-Leão R, van der Heide HGJ, Schouls LM. 2011. 
Multiple-locus variable number tandem repeat analysis for Streptococcus pneumoniae: 
comparison with PFGE and MLST. PLoS One 6:e19668. 
55.  Lienemann T, Kyyhkynen A, Halkilahti J, Haukka K, Siitonen A. 2015. 
96 
 
Characterization of Salmonella typhimurium isolates from domestically acquired 
infections in Finland by phage typing, antimicrobial susceptibility testing, PFGE and 
MLVA. BMC Microbiol 15:131. 
 
3.7 Supplementary material 
 
Table S1. Sampling locations and number of isolates obtained in each location in West Bank and Northern Israel.  
 
Area Sampling location Coordenates  
No. of 
isolates 
Frequency 
(%) 
West Bank 
A hospital 32°27'42"N, 35°17'33"E 28 15.6 
B hospital 32°13'31"N, 35°14'28"E 31 17.2 
C hospital 32°13'22"N, 35°15'43"E 5 2.8 
D hospital 31°53'45"N, 35°12'23"E 19 10.6 
E hospital 31°46'50"N, 35°14'46"E 10 5.6 
F hospital 31°42'39"N, 35°11'52"E 33 18.3 
G hospital 31°33'23"N, 35° 4'59"E 33 18.4 
H hospital 31°31'49"N, 35° 5'59"E 6 2.3 
Al-Quds University 31°45'18"N, 35°15'37"E 15 8.3 
Total      180 100 
North Israel  
Alonei Abba  32°43'51"N, 35°10'19"E 16 6.4 
Arbel 32°48'73"N, 35°29'80"E 9 3.6 
Mehanamia 32°39'90"N, 35°33'30"E 5 2.0 
Kyriat Tivon (Oranim 
campus)  
32°71'29''N, 35°10'97''E 165 65.7 
Rambam Hospital 32°49'58"N, 34°59'8"E 11 4.4 
Kyriat Tivon (Raz) 32°42'58"N,35°7'39"E 18 7.2 
Kyriat Tivon (Tamar) 32°42'58"N,35°7'39"E 3 1.2 
Technion University  32°46'36"N, 35° 1'23"E 5 2.0 
Tiberias (Hila) 32°47'34"N, 35°30'92"E 11 4.4 
Tiberias (Shosh) 32°47'66"N, 35°31'90"E 5 2.0 
Yavne'el 32°42'31"N, 35°30'13"E 3 1.2 
Total      251 100 
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Figure S1: Drinking water system sampling map at Oranim campus, Kiryat Tivon, Israel. Seven sampling points 
were selected in order to cover the drinking water system route. Sampling points are marked with capital letters. 
Points where cold and warm water was sampled are underlined. A- Shower. B- Garden irrigation faucet. C- Sink 
faucet. D- Toilet sink faucet. E- Shower. F- Sink faucet. G- Toilet sink faucet.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Map of the area under study in Middle East showing the sampling locations in North Israel (blue place 
marks) and the West Bank (green place marks). Image source: Google earth V 7. 1.5.1557. (December 14, 2015). 
Middle East. 31°11’42.57’’N, 36°49’33.41’’E, Eye alt 217.22 mi. US Dept of State Geographer. Image Landsat 
ORION-ME 2016. 
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Figure S3. UPGMA inferred from the clustering analysis of the MLVA-8(12) profiles of 180 L. pneumophila strains 
isolated from water and biofilm samples taken from the Al-Quds University campus and from seven hospitals along 
the West Bank. MLVA clusters (VACC) of three or more genotypes were defined using a cutoff of 60% of similarity 
and are shown with colours. 
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Figure S4. Minimum-spanning tree based on MLVA-8 profiles of 180 L. pneumophila strains isolated in West Bank.  
Each circle in the tree represents a different MLVA-8 genotype. The genotype designation is indicated within or near 
the circle, whose size is proportional to the genotype frequency. Different colours in the pie charts refer to the eight 
sampling locations (see legend).  Thickness of the branches represents the number of different loci. MLVA clonal 
complexes (VACC) have been shaded.  
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Figure S5. UPGMA obtained from the clustering analysis of the MLVA-8(12) profiles of 251 L. pneumophila 
environmental and clinical strains isolated from nine different locations in North Israel. MLVA clusters (VACC) of 
three or more genotypes are shown with colors, following the same definition criteria and colour code as the L. 
pneumophila isolates from West Bank (Figure S3). 
 
 
102 
 
 
 
 
 
103 
 
 
 
Figure S6. Minimum-spanning tree based on MLVA-8 profiles of 251 clinical and environmental L. pneumophila 
strains isolated in Israel.  Each circle represents a different MLVA-8(12) genotype and is proportional to the genotype 
frequencies. Genotype number is specified within or near the circle. Different colours in the pie charts refer to the 
sampling locations.  Thickness of the branches represents the number of different loci. MLVA clonal complexes 
(VACC) have been circled. Clinical isolates are indicated as isolates from Rambam Hospital (see legend). 
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4.1 Abstract 
Legionella pneumophila is an intracellular pathogen of environmental protozoa that 
inhabits natural freshwater environments as well as drinking water distribution systems 
(DWSS). L. pneumophila is able to cause Legionnaires´ disease due to its capacity to replicate 
within human macrophages after inhalation of contaminated aerosols. Temperature is one of the 
key factors affecting the growth of L. pneumophila in freshwater systems. L. pneumophila 
virulence is also known to be dependent on growth temperature. In this study, the effect of 
distinct temperatures (15ºC, 22ºC, 30ºC, 37ºC, 40ºC, 43ºC and 45°C) on growth in liquid 
medium of 26 clinical and 37 environmental isolates characterized by MLVA genotyping was 
examined. In addition, the virulence of a total of 85 isolates was tested by in-vitro assays using 
THP-1 human cell-like macrophages. Results showed that the growth abilities of clinical and 
environmental isolates differ with temperature. Environmental isolates presented higher ability 
to grow at low temperatures (15°C, 22°C) while clinical isolates appeared to be more adapted to 
grow at high temperatures (30°C, 43°C). Clinical and environmental isolates presented their 
optimum growth temperature at 37ºC and both groups of isolates could not be differentiated at 
this temperature. Growth temperature also appeared to influence specific genotypes. In 
particular, the growth of genotype Gt4(17), which corresponded to the globally distributed 
sequence type ST1, was significantly enhanced at low temperatures. The assessment of 
infectivity revealed the potential high pathogenicity of certain genotypes and clonal complexes. 
These findings may assist the understanding of the epidemiology of individual L. pneumophila 
strains and provide insights into the ecology of this opportunistic pathogen.  
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4.2 Introduction 
Legionnaires´disease (LD) is an often fatal pneumonia caused by the ability of L. 
pneumophila strains to replicate within alveolar macrophages. It has been demonstrated that L. 
peumophila has gained this ability by exploiting in the human cells the same conserved 
signaling pathways as it uses to replicate inside protozoa, its natural hosts (1). Both in protozoa 
and in human cells, an important virulence factor is the Dot/Icm type IVB translocation system. 
Currently, it has been established the Dot/Icm type IVB system is responsible in the strain L. 
pneumophila Philadelphia-1 for the translocation of over 330 proteins into the host cell, which 
represents over 10% of the proteome of this strain (2). Most of these effectors have been shown 
to have function redundancy; therefore, the lack of some of them does not usually decrease or 
eliminate the virulence of the strain. Besides the Dot/Icm type IVB translocation system  L. 
pneumophila strains possess additional virulence factors common to other bacteria such as 
lipopolysaccharides (LPS) (3).   
The virulence varies thoroughly within different strains of the species L. pneumophila. 
Some strains and serogroups are more virulent than others. Epidemiological studies have shown 
that of all Legionella species, L. pneumophila serogroup1 (sgp1) is the most virulent and the 
most common cause of Legionnaires´ disease (LD) (4). In the same European-wide study, 
Helbig et al. (2002) (4) indicated that the majority of sgp1 strains presented the virulence 
epitope and were classified as MAb 3/1 positive (67%) while only the 12% were subtyped as 
MAb 3/1 negative. Furthermore, different studies in the US and Europe have revealed that most 
of the cases of LD are due to only few strains. They presented similar results, indicating that 
some of the sequence types (ST) of clinical and environmental isolates of L. pneumophila sgp1 
were responsible for outbreaks and sporadic cases in the US and Europe, among which ST1 or 
ST47 were very frequent (5–7).  In addition, it has been demonstrated that the most common 
clinical STs are rarely found in the environment and vice versa (5, 8).  The rapid advances in 
genome sequencing have revealed new features of the L. pneumophila pathogenesis (9). Yet, it 
is not completely understood what makes certain strains more pathogenic than others.  
The ecology of L. pneumophila could play an important role since other factors besides 
virulence, as the bacterial concentration at the source and the success to disseminate through 
aerosol droplets, can lead to cause infection. The presence of biofilm in freshwater systems and 
the interaction with their natural host are essential factors that influence the survival and growth 
of L. pneumophila in aquatic environments. In addition, water temperature is crucial in the 
colonization of drinking water distribution systems (DWSS). Rodríguez-Martínez et al. (2015) 
(10) have demonstrated the correlation between the temperature in a local drinking water system 
and the prevalence of different MLVA genotypes. Different genotype distribution patterns were 
observed at low temperatures (about 20°C) and high temperatures (above 40°C), suggesting the 
existence of ecotypes adapted to cold or warm freshwater.  
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In order to get insights into the physiology related with temperature and virulence of L. 
pneumophila strains at both genotype and clonal level, the growth and the infectivity potential 
were studied. On the one hand, the virulence potential of a large set of strains composed of 85 
environmental and clinical isolates characterized by MLVA high resolution genotyping were 
studied by macrophage infectivity assays. As pointed out by Mercante and Winchel (2015) (11), 
the relevance of the genotypes for health can only be finally assessed by isolate-based studies in 
macrophage assays. In this study, the THP-1 human macrophage-like cell line was selected for 
the infectivity assays due to the extensive use as model for Legionella virulence, in 
transcriptome analysis as well as in the assessment of the virulence of environmental strains (12, 
13). The uptake, intracellular replication or the cytotoxicity to host cells were examined. On the 
other hand, the physiology of 63 strains was evaluated by studying growth at seven different 
temperatures (15°C, 22°C, 30°C, 37°C, 40°C, 43°C and 45°C) in liquid medium. The evaluation 
of the growth allowed inferring differences between clinical and environmental strains as well 
as differences between genotypes.  
This study aimed to help understanding the pathogenicity and the role of the 
temperature in the growth of L. pneumophila, since both traits are essential for the ecology of 
this pathogen. In particular, the examination of these traits at the genotype and clonal level 
could assist epidemiological studies and the prevention of legionellosis.  
 
4.3 Material and methods 
4.3.1 Bacterial strains 
A set of 26 clinical and 37 environmental strains of L. pneumophila were used in this 
study to investigate growth in liquid culture at different temperatures. To study the infectivity to 
human macrophages, the number of strains was increased to 85 (34 clinical and 51 
environmental strains) (Table S1). Strains were selected according to their MLVA-8(12) 
genotype and their isolation abundance. The overall strategy of strain selection aimed to have a 
highly diverse set of strains, with a representation of as many different MLVA genotypes as 
possible. Therefore, those genotypes isolated at a minimum of three times were considered for 
analysis.  In addition, the selection of the strains also focused on the study of the most abundant 
genotypes, such as Gt4(17), which has been isolated in different habitats and geographic regions 
(Europe and the Middle East). Gt4(17) strains from Israel, the West Bank and Germany isolated 
from water and biofilm were included in this study. 
  
4.3.2 Determination of growth parameters of L. pneumophila strains in liquid culture 
Growth of 63 L. pneumophila strains (26 clinical and 37 environmental strains) (Table S1) 
was determined in BYE liquid medium at six different temperatures: 22°C, 30°C, 37°C, 40°C, 
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43°C and 45°C. In addition, 34 out of the 63 strains were also studied at 15°C. All L. 
pneumophila strains were plated in BCYE agar plates and incubated at 37°C for three days. To 
limit the variability in the physiological state of bacteria that will serve as inoculum, all strains 
were additionally precultured in broth until the bacteria had reached the stationary phase (the 
time needed for the strains to achieve the stationary phase was previously determined). For that, 
50 ml of 1:2 diluted BYE liquid medium [10 g N-(2-Acetamido)-2-aminoethanesulfonic acid 
(ACES), 10 g yeast extract, 0.4g L-cysteine and 0.25 g ferric nitrate and 1 g α-ketoglutaric acid 
per litre of sterile water] were inoculate with fresh biomass and incubated at 37°C with agitation 
(100 rpm) for 48 h. After incubation, precultures were diluted with fresh medium and the optical 
density at 600 nm (OD600nm) of all the strains were set to of 0.01 (equivalent to cell density of 
107 cells/ml) to standardize the initial inoculum. Microtiter flat-bottom plates containing 200 µl 
of culture per well at OD600nm 0.01 were incubated at the specific temperature in a Bioscreen C 
growth curve analyzer set at continuous shaking. The OD600nm was measured every 15 min for 
48 h when studying growth at 30°C, 37°C, 40°C, 43°C and 45°C, for 140 h to study growth at 
22ºC and for 400 h at 15ºC. Each strain was studied using five replicates at each temperature. 
Five replicates of only BYE medium without bacteria were included in each plate to serve as 
negative control and blank values for OD600nm. 
 
4.3.3 Growth of L. pneumophila strains in human macrophage-like cell line 
A total of 85 L. pneumophila strains (34 clinical and 51 environmental strains) (Table S1) 
were selected to study their pathogenicity. Before the infection experiments, L. pneumophila 
strains were grown in 50 ml of BYE liquid medium 1:2 diluted with sterile water for 48 h at 
37°C to assure that all strains had reached their stationary phase. The time needed for the strains 
to reach the stationary phase was previously determined. Bacterial density was assessed by the 
absorbance at 600 nm with a spectrophotometer Nanocolor Vis (Macherey-Nagel, Düren, 
Germany). Absorbances were previously calibrated with a standard curve of colony forming 
units (CFU). Briefly, 10 ml of bacterial culture was centrifuged at 3500 rpm during 15 min, the 
pellet was suspended in 5 ml of phosphate buffer saline and the optical density at 600nm was 
adjusted to 0.7, which was equivalent to 109 bacteria/ml. The number of cells was checked by 
plating in BCYE agar plates and counting the CFU. Bacteria was diluted with RPMI-1640 
modified medium (Gibco, Germany) to the specific multiplicity of infection (MOI).  
THP-1 cells (ATCC TIB-202TM) were maintained in RPMI-1640 modified medium 
(Gibco, Germany) containing 10% fetal bovine serum (FBS) (Gibco, Germany) and 2mM L-
Glutamine (Gibco, Germany) in a humid atmosphere containing 5% CO2 at 37°C. Before each 
infection experiment, exponentially growing THP-1 monocytes were washed with complete 
medium, counted and incubated with phorbol-12-myristate-13-acetate (PMA) (Sigma Aldrich, 
Germany) at a concentration of 100ng/ml for 48h in 5% CO2 at 37°C to induce maturation of 
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the monocytes into macrophage-like adherent cells. Adherent cells were washed three times 
with PBS prior to infection. 
Intracellular multiplication assays of L. pneumophila strains were carried out as previously 
described (14). Briefly, differentiated THP-1 macrophages (2·105 cells per well) in 24-well 
plates were infected in triplicate with 1 ml of bacterial suspension at a multiplicity of infection 
(MOI) of 1. After 1 h incubation, cells were washed twice with PBS and incubated with 1 ml of 
RPMI medium containing 100 μg/ml gentamycin (Sigma-Aldrich, Germany) for 1 h at 5 % 
CO2 and 37°C to kill extracellular bacteria. Infected macrophages were lysed after 1 h, 24 h and 
48 h using 1 ml of 0.25% Triton 100X (Sigma-Aldrich, Germany) during 20 sec. Dilutions of 
the lysate were plated in triplicates in BCYE agar plates and incubated at 37°C to determine the 
CFU. 
Uptake of the different L. pneumophila strains into the macrophages was assessed 
following the procedure of the intracellular multiplication assays described above. However, 
THP-1 macrophages were infected using a higher MOI for shorter time (MOI 50 for 30 min).   
Cytotoxicity assays were carried out by infecting THP-1 macrophages seeded in 96-
well plates at a density of 105 cells per well with L. pneumophila strains at different MOIs (MOI 
10, MOI 25, MOI 50 and MOI 75) during 1 h at 37% and 5% CO2. To measure the percentage 
of viable macrophages after the infection a colorimetric assay based in the oxidation-reduction 
of resazurin acid (Alamar blue) (Sigma Aldrich, Germany) was used. After infection and 
washing with PBS, macrophages were incubated with 200 µl of RPMI medium supplemented 
with 10% of Alamar blue (Sigma-Aldrich, Germany). Absorbance was measured at wavelengths 
of 570nm and 600nm after 5 h and 24 h using a Synergy 2 microplate reader (Biotek, Germany).  
 
4.3.4 Data processing and statistical analysis 
The growth of the L. pneumophila strains in batch cultures was analysed in two 
different steps. First, raw optical density measurements directly obtained from Bioscreen C 
were examined as previously described (15). Briefly, blank OD values (only BYE medium) 
were substracted to all measurements. To normalize the data, each OD measurement was 
divided by the initial OD of the inoculum (Nt/N0) and then the natural logarithm of the ratio 
Nt/N0 was calculated for each well. In graphs and growth curves representations, the natural 
logarithm of the ratio Nt/N0 was shortened as “LnOD600nm”. Averages of the five replicates 
were calculated per strain. Second, after pre-treating the OD measurements as explained, data 
were analysed using the statistical package “opm” for R (16), using a spline-fit algorithm for 
curve fitting. Growth kinetics were summarized in three parameters: lag time (λ), growth rate 
(µ) and maximum cell density (A).  These parameters were calculated for each strain at each 
temperature.  Statistical analyses were performed using GraphPad Prism version 5.00 
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(GraphPad Software, San Diego California USA). Data were checked for normality using 
D’Agostino and Pearson omnibus normality test. To determine if temperature had significant 
effects on lag time, growth rate and maximal density non-parametric Kruskal-Walis test and 
Dunn´s Multiple Comparison test were applied. Student´s t-tests or non-parametric Mann-
Whitney tests were applied to compare each growth parameter between environmental and 
clinical isolates, and between genotypes at each studied temperature. Growth curves were built 
using GraphPad Prism version 5.00. Multivariate analyses were carried out using Primer version 
7.0.9. Growth rates and maximum density values of each strain at each temperature were first 
normalized by subtracting the median and dividing by the interquartile range of the values of 
each temperature. Principal coordinate analysis (PCO) was performed from a resemblance 
matrix that was created by Euclidean distance. One-way Analysis of Similarities (ANOSIM) 
test was used to infer differences between the groups represented in the PCOs using Primer 
version 7.0.9. 
Intracellular multiplication of L. pneumophila strains in THP-1 human macrophages was 
presented as relative growth. Data were normalized by dividing the CFU/ml obtained at 24 h 
and 48 h by the number of CFU/ml at 2 h. Uptake levels were calculated as previously defined 
(17) using the formula  [% uptake = (CFU of gentamicin-resistant bacteria/CFU of inoculum) x 
100]. To correct for variation between experiments, the uptake was reported as relative to the 
reference strain L. pn. Philadelphia-1, i.e., [relative entry = (% uptake of test strain/ % uptake of 
L. pn. Philadelphia-1) x 100)]. Cytotoxicity of L. pneumophila strains to the monolayers of 
macrophages was calculated as the ratio of the absorbance of the reduced Alamar blue of 
infected monolayers to that of uninfected ones (18). Specifically, the percentage of cytotoxicity 
was calculated by the formula [((O2xA1) – (O1xA2) / (O2xP1) – (O1xP2)) x100], where O1 
and O2 were the molar extinction coefficients of oxidised Alamar blue at 570 and 600nm, 
respectively; A1 and A2 were the absorbances of infected cells at 570 and 600nm, respectively; 
and P1 and P2 were the absorbances of non-infected cells at 570 and 600nm, respectively. 
Cytotoxicity of each L. pneumophila strain was measured in triplicate for each MOI. A dotA 
negative mutant of the strain L. pneumophila Philadelphia-1 was used as negative control in the 
three different infection assays. Kruskal-Wallis non-parametric test was used to test differences 
between genotypes or clonal complexes during the uptake and at each time point (2h, 24h or 
48h) of their intracelular growth. Non-parametric Mann-Whitney and Kruskal-Wallis tests were 
used to compare the percentage of cytotoxicity between environmental and clinical isolates as 
well as to compare the cytotoxicity of different serogroups, genotypes or clonal complexes. To 
assess the differences in cytotoxicity between serogroup 1 and non-serogroup isolates and, in 
addition, between Gt4(17) clinical and environmental isolates, two tailed unpaired T test was 
used. Calculations and graphs were generated using GraphPad Prism version 5.00. 
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 4.4 Results 
4.4.1 Growth of L. pneumophila strains at various temperatures 
A set of 63 L. pneuomphila isolates, which were previously characterized by their 
serogroup, MLVA genotype and their virulence potential to human macrophages (Table S1), 
were selected to study their growth in BYE liquid medium at a range of temperatures that varied 
from 15°C to 45°C. Specifically, 37 isolates were obtained from freshwater systems and 26 had 
clinical origin. Quantitative growth of environmental and clinical isolates was studied by the 
analysis of three important parameters that describe bacterial growth in batch culture: growth 
lag (λ), growth rate (µ) and maximum biomass or maximum cell density (A). L. pneumophila 
presented the characteristic growth response to temperature of mesophilic microorganisms 
(Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effect of temperature on the growth rates (μ) of L. pneumophila  
(averages of the growth rates of all 63 isolates at each temperature are presented). 
 
The 31 isolates studied at 15°C were all able to multiply at this temperature. Likewise, all 63 
isolates studied at the rest of temperatures multiplied between 22°C and 40°C. The upper limit 
of growth temperature could be stablished in this study at 43°C since at this point only 41 out of 
63 isolates multiplied. At 45°C none of the L. pneumophila isolates multiplied. At this 
temperature, the optical density, as measure of the cell density or biomass, did not increase in 
comparison to the initial inoculum. Instead, it decreased rapidly, signal of denaturation and 
breakdown of cell components. The study of lag times revealed significant differences of this 
parameter according to the growth temperature (P<0.001) (Figure 2A). At low temperatures L. 
pneumophila isolates needed longer times to start growing exponentially. Specifically, the 
longest lag times were reached at 15°C and 22°C, with averages of 81.9 h and 21.2 h, 
respectively. On the contrary, the shortest lag time were reached by the 41 isolates that were 
able to multiply at 43°C, with an average of 2.9 h. As can be seen on Figure 1, the optimum 
growth temperature, at which growth was significantly most rapid, was 37°C. The growth rates 
varied significantly along the range of temperatures (P<0.001) (Figure 2B).  Below and above 
37°C growth rates decreased gradually. As well as the other two parameters, cell densities 
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reached in the batch cultures varied significantly with the temperature (Figure 2C). Cell 
densities were very similar at 15°C and 43°C, presenting the lowest values. On the contrary, 
higher cell densities were observed at 22°C, 30°C, 37° and 40°C.  
 
Figure 2. A) Lag time (λ), B) growth rate (µ) and C) maximal cell density (A) of L. pneumophila isolates at different 
temperatures. The growth of 31 isolates was examined at 15°C. 63 isolates were studied at the rest of temperatures. 
Different letters over the box plots indicate significant differences between temperatures calculated by Kruskal-
Wallis non-parametric test and Dunn´s Multiple Comparison test with a confidence level of 95% (Same letters over 
the box plots of specific temperatures indicate no significant differences between those temperatures for the specific 
parameter).  
 
 
 
4.4.2 Effect of temperature on the growth of environmental and clinical isolates of L. 
pneumophila 
Differences could be observed between environmental and clinical isolates by 
inspecting the growth curves (graphical data) obtained from the batch cultures at the different 
temperatures (Figure 3). In general, environmental strains multiplied more rapidly and 
efficiently at low temperatures (15°C and 22°C) than clinical isolates. However, at higher 
temperatures (30°C, 40°C and 43°C) this pattern was reverted and clinical isolates showed 
higher growth capacities than environmental isolates. At 37°C, the optimum growth 
temperature, the growth of both groups of isolates became identical. At lower temperatures 
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clinical isolates exhibited significant longer lag times than environmental isolates (Figure 4A). 
As the temperature increased, lag periods became even, showing no differences between the 
groups. On the contrary, clinical isolates presented significantly higher growth rates than 
environmental isolates at higher temperatures (30°C and 43°C) and significantly lower at 22°C 
(Figure 4B). At 37°C and 40°C, the growth rates of both types of isolates were almost identical, 
slightly higher in the clinical strains. As it occurred with these two parameters, clear differences 
were observed between the cell densities of the groups in relation to the temperature (Figure 
4C).  
 
Figure 3. Growth 
curves representing 
the average and 
standard deviations 
(grey lines) of 37 
environmental and 26 
clinical L. 
pneumophila isolates 
at six different 
temperatures (only 12 
environmental and 22 
clinical isolates were 
tested at 15°C). The 
parameters lag phase 
(h), growth phase µ 
(h-1) and maximum 
density were 
calculated from the 
curves and used to 
infer differences 
between clinical and 
environmental isola-
tes. 
 
At 15°C and 22°C, environmental isolates increased significantly in cell densities in comparison 
to the clinical isolates. However, a shift occurred when the temperature was increased to 30°C. 
Although at this temperature the differences between the two groups were not as pronounced as 
at colder conditions, cell densities of clinical isolates became significantly higher than those of 
the environmental isolates. As temperature increased to 37°C and 40°C both groups reached 
very similar cell densities. At 43°C a general decrease of the growth of both types of isolates 
was noticed.  Only 54% of environmental isolates were able to growth at this temperature in 
comparison to the 80.7% of the clinical isolates. Additionally, clinical isolates reached cell 
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densities significantly higher than those of the environmental isolates. Figure 5 represents the 
lag time, growth rate and maximal cell density of environmental and clinical isolates as 
functions of the temperature. The shift caused by the temperature in the cell densities of both 
groups can be clearly identified. 
 
Figure 4 A) Lag time (λ), B. growth rates (µ) and C. maximal cell density (A) of L. pneumophila clinical and 
environmental isolates at different temperatures. The growth of n=31 isolates was examined at 15 °C. n=63 isolates 
were studied at the rest of temperatures. Asterisks denote significant differences calculated by Kruskal-Wallis non-
parametric test and Dunn´s Multiple Comparison test with a confidence level of 95%. 
 
In order to visualize the correlations between the different growth parameters of environmental 
and clinical isolates and the temperature, multivariate analyses were carried out. No correlation 
was observed in the principal coordinate analysis (PCO) when the analysis was performed using 
the three parameters (lag time, growth rate and maximal cell density) (Figure S1). However, 
multivariate analysis using ANOSIM revealed significant differences in the growth rates and 
maximal densities between clinical and environmental isolates of L. pneumophila (R=0.206, 
P<0.001) (Figure 6). Environmental isolates divided significantly more rapid and reached 
higher densities than clinical isolates at low temperatures, especially at 15°C. The opposite 
occurred at high temperatures that favored the multiplication of clinical isolates. At their 
optimum growth temperature, particularly at 37°C, the maximum densities of clinical and 
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environmental isolate were highly comparable and both groups could not be distinguished. 
Interesting, the evenness of the maximal density at 37ºC contrasted with the variation of the 
growth rates at this temperature, which varied up to two fold (Figure 7). A good correlation was 
observed between growth rate and maximal density for the rest of temperatures (Figure 7). 
Multivariate analysis applying only the growth rates at all different temperatures showed the 
same distinction between clinical and environmental isolates (Figure S1). However, 
multivariate analyses did not show clear differences between the two types of isolates along the 
range of temperatures when comparing exclusively their maximal densities (Figure S2). 
 
 
Figure 5. Overview of temperature and growth response of environmental and clinical isolates of L. pneumophila. 
Averages of A) lag time, B) growth rates and C) maximal cell densities of environmental and clinical isolates as 
functions of the temperature. 
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Figure 6. Principal coordinate analysis (PCO) of the growth rate (µ) and maximal density (A) of 37 environmental 
and 26 clinical L. pneumophila isolates growing at six different temperatures. Significant differences between 
environmental and clinical isolates were detected (ANOSIM R=0.206, P<0.001) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Correlation between cell density and growth rate at different temperatures. 
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4.4.3 Effect of temperature on the growth of different L. pneumophila genotypes 
The 25.4% (n=16) of the L. pneumophila isolates used in this study belonged to 
MLVA-8(12) genotype Gt4(17), which has been shown to correspond to the world wide 
distributed ST1. The two main growth parameters that define growth, growth rate and cell 
density, were used to compare the growth kinetics of Gt4(17) to the rest of genotypes (here 
named as non-Gt4(17) (Figure 8). Comparisons to other specific genotypes were statistically 
not possible due to the high diversity of the non-Gt4(17) group, which accounted with a low 
number of isolates of each genotype. No significant differences were observed between the lag 
times of Gt4(17) and other genotypes at low or high temperatures when compared by t-test or its 
non-parametric variant (Figure 9A) The same phenomenon was observed in terms of growth 
rate and cell density (Figure 9B and 9C). However, the analysis of similarity revealed 
significant differences between the growth rates and maximum density of Gt4(17) and non-
Gt4(17) (ANOSIM R=0.373, P<0.001) when these parameters were used to compare both 
groups at all temperatures tested (15°C, 22°C, 30°C, 37°C, 40°C and 43°C). 43.6% of the total 
variance between the isolates was explained by the first component (PCO1) represented in the x 
axis of the PCO plot (Figure 10A). According to this component, low temperatures (15°C and 
22°C) would favor the growth of Gt4(17) isolates.  
 
Figure 8. Growth curves 
representing the average and 
standard deviations of 16 
Gt4(17) isolates and 47 non-
Gt4(17) L. pneumophila isolates 
at 22°C, 30°C and 43°C. The 
average and standard deviations 
of 10 Gt4(17) and 24 non-
Gt4(17) were compared at 
15°C. Parameters growth rate 
and maximum density were 
calculated from the curves and 
used to infer differences 
between clinical and environ-
mental isolates 
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Figure 9. A) Lag time, B) growth rate and C) maximum cell density of Gt4(17) compared to other MLVA genotypes 
(non-Gt4(17) at 15°C, 22°C, 30°C and 43°C. The group of non-Gt4(17) genotypes was composed of 47 isolates that 
belonged to 14 MLVA-8 genotypes. At 15°C only 10 Gt4(17) and 24 non-Gt4(17) isolates were studied. To compare 
Gt4(17) and non-Gt4(17) isolates at each temperature, t-test or Mann-Whitney test were used according to normality 
of the data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. A) Principal coordinate analysis (PCO) of the growth rate and maximum density of 63 L. pneumophila 
isolates classified according to their MLVA genotype. Gt4(17) isolates were compared to the rest of the genotypes, 
which were grouped as non-Gt4(17). The analysis of similarity revealed significant differences between Gt4(17) and 
all the other genotypes (ANOSIM R=0.373, P<0.001).  
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B) Principal coordinate analysis (PCO) considering exclusively the growth rate of 63 L. pneumophila isolates 
classified according to their MLVA genotype. Analysis of the variance showed greater differences between Gt4(17) 
(blue filled and unfilled dots) and the rest of genotypes (grey filled and unfilled dots) when only this parameter is 
analyzed (R=0.503, p<0.001). Significant differences were also observed between environmental (filled blue dots) 
and clinical (unfilled blue dots) Gt4(17) isolates (R=0.297, p<0.05). The rest of non-Gt4(17) isolates were as well 
differentiated in environmental and clinical isolates (grey filled and unfilled dots, respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strains of genotype Gt4(17) have been found frequently in the environment but has also been 
responsible of multiple cases of legionellosis (5). To determine possible growth differences 
between clinical and environmental isolates of this genotype, growth rates and maximum cell 
densities were compared at six different temperatures. Figure 11 shows the growth curves of 
the two types of strains of Gt4(17). The lag time of clinical and environmental isolates differed 
significantly at 22ºC and 30ºC (Figure 12A). Clinical Gt4(17) isolates needed longer periods of 
time than Gt4(17) environmental isolates to start growing exponentially at 22ºC (P<0.001). The 
opposite occurred with the increase of temperature to 30ºC, lag times of clinical isolates were 
significantly shorter in comparison to those of environmental isolates (P<0.05). Significant 
differences were observed in the growth rates of environmental and clinical Gt4(17) isolates 
exclusively at 30°C (Figure 12B). Gt4(17) clinical isolates could multiply more rapidly than 
environmental isolates at this temperature. Analysis of similarity also showed significant 
differences between the growth rates of clinical and environmental Gt4(17) isolates when only 
this parameter was represented by PCO (ANOSIM R=0.297, p<0.05) (Figure 10B). When the 
growth densities were considered, it was observed that environmental Gt4(17) isolates reached 
significantly higher cell density at low temperature (15°C) than clinical isolates (Figure 12C). 
In contrast, Gt4(17) clinical isolates reached significantly higher (P<0.05) cell density than 
environmental isolates at 30ºC (Figure 12C). At 43°C only 20% (two out of ten) of the 
environmental Gt4(17) isolates were able to grow in contrast to the 66.6% (four out of six) 
clinical isolates. In Figure 11 it can be seen how environmental isolates were able to form 
B 
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higher amounts of biomass at low temperatures while clinical isolates grew more efficiently at 
higher temperature.  
 
 Figure 11. Growth curves representing the average and standard deviations of 6 environmental and 10 clinical 
Gt4(17) isolates at 15°C, 
22°C, 30°C and 43°C. 
The average and 
standard deviations of 4 
environmental and 6 
clinical Gt4(17) were 
compared at 15°C. The 
parameters growth phase 
µ (h-1) and maximum 
density were calculated 
from the curves and used 
to infer differences 
among clinical and 
environmental isolates.  
 
 
 
 
 
 
 
 
 
 
 
Besides comparing the growth of environmental and clinical L. pneumophila isolates 
and the growth of specific genotypes, the differences in the growth between serogroups was 
compared. In particular, multivariate analyses were carried out in order to infer differences 
between serogroup 1 isolates and the rest of serogroups contained in the dataset (Figure S3). No 
differences were observed in the growth of isolates of distinct serogroup. In addition, it was also 
confirmed that environmental strains isolated in Europe had a similar growth behavior to the 
environmental strains isolated in the Middle East (Figure S4). The group composed of 
environmental strains was homogeneous, independently of the geographical origin of the 
strains. 
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Figure 12. Comparison of growth rates (A) and maximum cell density (B) of environmental (n=6) and clinical 
(n=10) Gt4(17) isolates at 15°C, 22°C, 30°C and 43°C. At 15°C only 4 environmental and 6 clinical Gt4(17) isolates 
were studied. Asterisks indicate significant differences according to Mann-Whitney test (P<0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.4 Intracellular growth and uptake of L. pneumophila strains by THP-1 macrophage-
like cells 
An infection model that allowed the study of the uptake, intracellular growth and 
cytotoxicity in the human macrophage cell line THP-1 was stablished to investigate the 
intracellular behavior of genetically and phenotypically distinct L. pneumophila strains. Uptake, 
intracellular growth and cytotoxic assays were initially assessed in a group of 21 environmental 
L. pneumophila strains with different phenotypic and genetic characteristics (serogroups and 
MLVA genotypes). The reference strain L. pneumophila Philadelphia-1 ATCC33152 and its 
Icm/Dot deficient dotA mutant were used as positive and negative controls, respectively. 
Specifically, the 21 environmental strains were grouped according to their serogroup, MLVA 
genotype and to their MLVA Clonal Complex (VACC) in order to assess the inference of these 
genetic features in the intracellular growth of the strains. To compare the cytotoxicity, uptake 
and intracellular growth of the strains grouped in different clonal complexes, only those VACCs 
composed of at least three different genotypes and two different serogroups were selected. As 
shown in Figure 13A, no significant differences were observed in the cytotoxicity between 
strains of different serogroups and genotypes after 5 h of infection. Cytotoxicity levels were 
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highly consistent at the four different MOI applied. Uptake levels were highly variable between 
the genotypes, however, only those of Gt12(84), which belonged to serogroup 8 (sgp8), were 
significant in comparison to the dotA mutant (P<0.05) (Figure 13B). These results suggested 
that there could be potential differences in the efficiency of different genotypes to enter the 
macrophages. 
 
 
Figure 13.  Cytotoxicity and relative uptake of 21 environmental L. pneumophila isolates grouped by their MLVA-
8(12) genotype and and serogroup. A) Cytotoxicity to THP-1 macrophages of three genotypes with their 
corresponding serogroups, the reference strain L. pn. Philadelphia-1 and its dotA mutant as negative control at four 
distinct MOI (10, 25, 50 and 75) after 5 h post-infection. B) Relative uptake by THP-1 macrophages by three distinct 
genotypes in comparison to the reference strain L.pn. Philadelphia-1. The uptake of L.pn. Philadelphia-1 was 
arbitrarily set to 100. Data points and error bars represent the mean and standard deviations, respectively, of 
triplicates of three isolates of each genotype.  
 
As shown in Figure 14, no differences were observed in the intracellular replication between 
strains of different serogroups and genotypes (A) or among strains that belonged distinct clonal 
complexes (B) after 1 h, 24 h or 48 h post infection. Only significant differences were observed 
among the strains and the dotA mutant at 24 h and 48 h. The clinical reference strain showed a 
highly similar pattern of intracellular multiplication to the environmental strains. Despite the 
great potential of the intracellular growth and uptake assays, cytotoxicity assay was preferred 
for the analysis of the large dataset of environmental and clinical L. pneumophila isolates 
utilized in this study as it enabled a rapid overview about their infectivity. 
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Figure 14. THP-1 macrophage 
infection at MOI 1 by L. pneumophila 
strains grouped according to their 
MLVA genotype (A) and their clonal 
complex (B). In A, at least three 
distinct L. pneumophila strains of the 
same serogroup and genotype were 
compared.  In B, VACC8 was 
composed of eight L. pneumohila 
strains of three different serogroups 
and four genotypes. VACC1 was 
formed by seven strains of two 
serogroups and three genotypes. Each 
data point represents the mean and 
standard deviation (error bars). 
Infections were performed in triplicates 
for each strain.  
 
 
 
4.4.5 Cytotoxicity of L. pneumophila strains to THP-1 macrophage-like cells. 
Cytotoxicity of a dataset composed of 85 L. pneumophila environmental and clinical 
isolates was examined by the infection of THP-1 macrophages during 1 h at four different MOI 
(10, 25, 50 and 75) and taking absorbance measurements at 5 h and 24 h of incubation with 
Alamar blue after infection. In general, cytotoxicity decreased after 24 h in comparison with the 
cytotoxicity observed after only 5 h post infection. (Figure S5). The different MOIs presented 
proportional results. The percentage of cytotoxicity increased proportionally in all isolates with 
the use of higher MOI. However, significant differences among strains were only able to be 
detected when low MOI, as 10 and 25, were applied. Thus, to perform comparisons among 
strains and avoid data redundancy only data from measurements at 5h using MOI 10 were 
considered for further analysis.  
The group of 85 L. pneumophila strains contained 51 environmental and 33 clinical 
isolates of different serogroups and genotypes (in addition to the L. pneumohila Philadelphia-1 
dotA mutant strain) (Table S1). Environmental isolates produced significantly higher 
cytotoxicity to THP-1 macrophages than clinical isolates. Nevertheless, the range of 
cytotoxicity differed considerably among isolates within each group, oscillating between 20% 
and more than 60% (Figure 15). 
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Figure 15. Cytotoxicity of 51 environmental and 
33 clinical L. pneumophila isolates at 5 h 
postinfection and incubation with Alamar blue 
(MOI 10). Cytotoxicity of each isolate was 
examined in triplicate. Asterisks denote statistically 
significant differences (P<0.05) by Mann-Whitney 
U test.  
 
 
 
 
 
According to epidemiological studies (19) serogroup 1 is the most virulent of the more 
than 15 serogroups that have been described for the species L. pneumophila since it is the most 
frequent cause of legionellosis. Infections performed comparing different serogroups in human 
macrophages as well as in the natural hosts also suggested the higher virulence potential of 
serogroup 1 over other serogroups (20). Consequently, the differences in cytotoxicity among 
environmental and clinical isolates could be due to the presence of certain serogroups. However, 
93% (n=31) of the clinical isolates used in this study, represented in Figure 15, were 
characterized as sgp1 in contrast with the 47% (n=24) of the environmental isolates. The 
cytotoxicity to THP-1 macrophages was highly similar between sgp1 and non-sgp1 isolates 
(Figure 16A) and no significant differences were found between both groups. Population 
studies have also revealed that not only the sgp1 strains possessed higher virulence that non-
sgp1strains (5) but the virulence of the sgp1 strains can be as well influenced by modifications 
in the lipopolysaccharide (LPS) epitope (21). The LPS patterns are detected by monoclonal 
antibodies leading to the classification of sgp1 strains into distinct monoclonal subgroups. 
Monoclonal subgroups are classified into MAb 3/1 negative and MAb 3/1 positive according to 
their virulence, being MAb 3/1 positive strains commonly isolated from patients but rarely 
found in freshwater systems (5). The 29 L. pneumohila sgp1 isolates from this study which were 
subtyped by monoclonal subgrouping were clustered by their MAb 3/1 classification to analyze 
their cytotoxicity to THP-1 human macrophages. Results showed that MAb 3/1 positive and 
negative strains have highly comparable levels of cytotoxicity (Figure 16B). No significant 
differences were observed between both groups.  
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Figure 16. Analysis of the effect of the serogroup and the monoclonal subgroup to the cytotoxicity caused to THP-1 
macrophages. A) Comparison of 55 sgp1 and 29 non-sgp1 L. pneumophila isolates. Two tailed unpaired T test 
showed no significant differences among the groups (P>0.05). B) Comparison of sgp1 isolates with different 
monoclonal antibody (MAb) subtypes. Two tailed unpaired T test revealed again no significant differences among the 
two groups (P>0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
A more detailed comparison was carried out in order to search for general features, as 
specific serogroups or genotypes that could influence the virulence of the strains during the 
infection to human macrophages. The cytotoxicity level of different serogroups was compared 
(Figure 17). At least 4 isolates were included in each group. Isolates belonged to different 
MLVA genotypes, in the cases of sgp1, sgp3 and sgp4. Non-sgp1 isolates whose serogroup was 
not further identified were grouped together and compared to the rest as sgp 2-14. Overall, 
significant cytotoxicity differences were found between the serogroups (P<0.05). Specific 
pairwise comparisons noted significant dissimilarities between sgp3 and sgp4 and between sgp4 
and the reference strains. Sgp1 and sgp 2-14, the richest groups in terms of number of strains 
and genotypes, showed a higher variability in cytotoxicity.   
 
Figure 17. Cytotoxicity to THP-1 human 
macrophages of different serogroups and three sgp1 
reference strains at 5h post infection (MOI 10). 
Significant differences were found between the 
serogroups (P<0.05) by the non-parametric Kruskal-
Wallis test. Mutant strain dotA functions as negative 
control. 
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Figure 18. A) Evaluation of cytotoxicity to THP-1 macrophages of Sgp1 strains classified in different MLVA 
genotypes. Kruskal Wallis significance test showed substantial differences between the diverse genotypes and 
reference strains (P<0.05). B) The different clonal complexes or clusters of genotypes (VACC) showed as well 
noticeable differences between them regarding the virulence to THP-1 human macrophages (Kruskal Wallis 
significance test, P<0.05). 
 
Since sgp1 is the most isolated serogroup among clinical strains but it is also very 
persistent in the freshwater systems, multiple sgp1 strains of different MLVA genotypes were 
compared in order to discern differences in the virulence potential of distinct genotypes, 
independently of the serogroup (Figure 18A). A minimum of four different isolates of Gt75(49) 
and seven of Gt4(17) and Gt6(18) were analyzed. Gt75(49), which was represented by four 
clinical isolates, exhibited higher cytotoxicity than the reference strains and the environmental 
genotypes Gt4(17) and Gt6(18). These results showed the high variability in infectivity potential 
of the strains with the same serogroup. To estimate specifically the virulence of the isolates that 
belong to the different clonal complexes, only those clonal complexes including different 
serogroups and genotypes were selected. Significant variances were observed among the clonal 
complexes (P<0.05), especially among VACC2 and VACC8, which were composed of five and 
three distinct MLVA-8(12) genotypes respectively (Figure 18B). 
The cytototoxicity to THP-1 human macrophages of the same genotype isolated from 
patients or from the environment was evaluated. In particular, the cytotoxicity of environmental 
and clinical isolates of Gt4(17) genotype, which corresponded to the highly abundant ST1, was 
compared (Figure 19).  The virulence did not differ significantly between environmental and 
clinical Gt4(17) isolates within all MOI tested. 
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Figure 19. Cytotoxicity to THP-1 human 
macrophages of 17 environmental and 9 clinical 
isolates of Gt4(17) after 5 h of incubation with 
Alamar blue (MOI 10).  Each isolate was 
analyzed in triplicates. Two tail unpaired T-test 
revealed no significant differences among the 
groups (P>0.05). 
 
 
 
 
4.5 Discussion  
4.5.1 Effect of temperature on growth of environmental and clinical strains of L. 
pneumophila 
Temperature is one of the most important environmental factors affecting the 
metabolism of microorganisms since bacteria cannot regulate their temperature. Temperature 
mediates changes in growth, development and pathogenesis of the bacteria (22, 23). Water 
temperature has been considered one of the major impact factors of contamination by 
Legionella (24). Microbial batch cultures constitute a basic microbiological method that allows 
addressing important physiological questions, such the growth response to controlled 
environmental factors, e.g. temperature. By cultivating bacteria, essential parameters in their 
growth cycle, such as lag time, growth rate and maximum density or yield, can be determined. 
For every microorganism, there is a minimum and maximum temperature below and above 
which growth is not possible and an optimum temperature at which growth is fastest. In this 
study it was shown that L. pneumophila responded to temperature like a typical mesophilic 
bacterium. The upper temperature limit was stablished at 43°C. Only 65% (n=41) of the isolates 
could grow at this temperature and none of them did grow when temperature was increased to 
45°C. The lower limit was not finally determined. Although growth was significantly 
decelerated at 15°C, all isolates tested were able to grow at this temperature. The optimum 
growth temperature was 37°C. At 37°C the growth was most rapid and the highest cell density 
was reached. Below and above this temperature, cell density and growth rate decreased. Konishi 
et al. 2006 (25) already reported that cell growth in liquid culture decreased markedly at 
temperatures above 44°C.  
Examination of the growth kinetics of environmental and clinical L. pneumophila 
isolates revealed that temperature affected the growth behaviour of both groups of strains 
(Figure 4) differently. Generally, environmental strains presented higher growth rates and cell 
densities, as well as shorter lag times, than clinical strains at low temperatures (15°C and 22°C). 
With the increase of the temperature to 30°C this pattern shifted and the growth rates and cell 
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densities reached by clinical strains exceeded those of the environmental ones. Specially, 
significant differences were observed in cell density between both groups at this temperature. At 
43°C, growth capacities of clinical strains were superior in comparison to environmental strains. 
Moreover, at this limit temperature only 54% of the environmental strains exhibited growth in 
comparison to the 80.7% of the clinical strains. Interestingly, both groups showed very similar 
growth kinetics around the optimum growth temperature (37°C and 40°C). The effect of the 
temperature on growth can be explained in terms of temperature dependence of the structure of 
cell components, especially proteins and lipids, and temperature dependence of metabolic 
reaction rates. In this way, growth rate can be affected by changes in the reaction rates, which in 
turn depend on the activation energies of the reactions. These changes can produce many other 
additional effects on metabolic regulatory mechanisms, specificity of enzyme reactions, cell 
permeability and cell composition. For example, it has been demonstrated that the metabolic 
activity associated with cell division is likely to be affected by temperature (26). Konishi et al. 
(2006) (25) compared the growth in liquid medium as well as in BCYE plates of three 
serogroup 1 L. pneumophila strains, two of them of clinical origin and the type strain ATCC 
33152, at temperatures between 30°C to 47°C. They noted that the clinical strains formed 
shorter filaments between 39°C and 40°C. Bacterial elongation and filaments formation has 
been shown to be related to the function of constitutional enzymes for bacterial binary fission 
(26). These results would indicate that enzymes of the two clinical strains probably kept their 
functional integrity at higher culture temperature (39°C) than the type strain (37°C).  
Selective pressures provided by diverse habitats during their recent evolution may 
explain this physiological diversity of L. pneumophila strains in relation to temperature. Roller 
& Schmidt (2015) (27) have described how efficient growth can have very important ecological 
implications. Growth rate, defined as the number of cells produced per time unit, is considered 
one of the most important components of the fitness in most environments, and therefore an 
essential trait in the life of microorganisms. Additionally, the efficiency of growth is equally 
important to the growth rate in the adaptation of strains to the environment and plays a very 
important role in the survival and persistence of the microorganisms when environmental 
conditions change and resources become limited. Efficiency of growth has been usually 
described in terms of yield, that is to say, the number of cells or biomass produced per unit of 
resource consumed. In this study, the amount of resources provided to the strains, in form of 
BYE medium, was constant. Therefore, the biomass produced (or cell density, as it has been 
termed during this chapter) could be directly related to the growth efficiency of the strains. 
Here, high growth rates were followed of high growth efficiency at all tested temperatures. At 
15°C and 22°C the growth rates and growth efficiency of environmental strains were 
significantly higher than those of the clinical strains. At high temperatures (30°C and 43°C) the 
opposite occurred and both growth rate and efficiency of clinical strains were higher in 
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comparison to those of environmental strains. Moreover, independently of the type of strains, 
good correlations were observed between the growth rate and the growth efficiency (Figure 7) 
at low and high temperatures (not at 37°C where the growth efficiency is maximum).  
Independently of having higher growth rates or being metabolically more efficient, 
environmental strains would be favoured at low temperatures over clinical strains and clinical 
strains would be favoured at high temperatures. The results in this study have also revealed the 
effect of temperature on the growth at genotype level. Gt4(17), genotype corresponding to ST1, 
presented significant higher growth rates at low temperatures (15°C and 22°C). The study by 
Rodríguez-Martínez et al. (2015) (10) supported the findings presenting here. They studied 
seasonally the presence of L. pneumophila MLVA-8 genotypes and the environmental factors 
affecting a local drinking water distribution system. Gt4 [here Gt4(17)] due to the use of 
MLVA-8(12) combined genotyping) was dominant in the system, both in water and in biofilm, 
and prevailed during the seasons. This genotype was predominant at low temperatures, about 
20°C, and it did not show any correlation to any of the other environmental parameter analysed, 
such as pH or chlorine levels. Its presence was primarily triggered by the temperature of the 
system. Interesting, it was always detected in those water samples with high Legionella counts, 
and most likely those Legionella counts were, in fact, Gt4. Schwake et al. (2015) (28) have 
recently shown that Legionella populations in tap water were more stable at 25°C than at 4°C 
and 32°C. Previously, Ohno & Kato (2003) (29) demonstrated that L. pneumophila exhibited 
longer potential survival without loss of cultivability in microcosms with lower temperatures 
(25°C). This could suggest that Gt4(17) strains are abundant in the environment due to their 
general adaption to low temperatures, which can be found, for instance, in the cold water of that 
supply drinking water distribution system, as remarked by Rodríguez-Martínez et al. (2015) 
(10). Comparisons of the growth kinetics of environmental and clinical isolates of genotype 
Gt4(17) confirmed that Gt4(17) clinical isolates were better adapted to high temperatures, and, 
thus, followed the general trend. This adaptability to higher temperatures might explain the fact 
that Gt4(17) or ST1, being one of the most abundant sequence types isolates from the 
environment worldwide, has the capability of producing sporadic cases of legionellosis, 
especially in elderly immunocompromised patients (30, 31).  At clonal level, the high spread 
around Europe and Middle East of VACC1, whose representative strain is L. pneumophila 
Paris, might be due to the adaptation of its strains to low temperatures. Rodríguez-Martínez et 
al. (2015) (10) also showed that the other genotype that was found in their water system, Gt15, 
was always related to the highest temperatures of the system (45.1°C) and low Legionella 
counts were observed where Gt15 was detected. Gt15 belonged to clonal complex VACC5, 
which has been found to contain clinical isolates from Germany and other European countries. 
As explained in Roller & Schmidt (2015) (27), in natural environments other aspects as 
spatial heterogeneity, availability of resources and temporal resource dynamics could also 
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influence the selection based on growth. They proposed that these factors influence the 
competition between individuals and favour those microorganisms that could grow using the 
resources more efficiently. Yet, in the case of L. pneumophila, temperature may influence in 
turn both resources and its temporal dynamics. Due to the harsh conditions of most natural 
freshwater environments, most of the time these bacteria live associated with biofilms (32). In 
the case of L. pneumophila, its establishment and persistence in natural and man-made 
environments is facilitated by biofilm formation and colonization within multispecies microbial 
communities (33, 34). Previous studies have revealed that L. pneumophila was able to replicate 
extracellularly in the biofilm matrix by using extracellular products released by other bacteria 
and algae (35). In addition, L. pneumophila has the ability to obtain carbon and energy sources 
from dead organic material, such as other microorganism, possibly produced after disinfection 
measures (36). Nevertheless, the main route for L. pneumophila replication, and thus, for 
obtaining nutrients and resources, occurs within protozoa. The high concentration of 
microorganisms within biofilms makes it possible that free-living protozoa can pray and feed on 
bacteria and Legionella can parasitize and multiply within protozoans, contributing to the 
prokaryotic-eukaryotic co-evolution (37). The efficiency with which these pathogens exploit the 
available host nutrients for their proliferation is of high relevance and has been called 
“nutritional virulence”. Since the host can complicate the access to the nutrients, pathogens have 
adapted diverse metabolic routes to successfully use what is available and multiply (38, 39).  
Co-culture and in-vitro infection studies have demonstrated the active predation of 
Legionella spp. by protozoa (40). On the other hand, the capability of L. pneumophila to 
parasitize and grow within a wide range of protozoa species has been demonstrated and the 
dependence of those interactions on physical conditions of the system, such as temperature (41). 
Buse & Ashbolt (2011) (42) examined the potential effect of in-premise plumbing temperatures 
(24°C, 32°C, 37°C and 41°C) on the growth potential of different L. pneumophila strains within 
common free-living amoebae. They also examined the effect of the temperature on the growth 
of amoebas in the presence of prey bacteria. Acanthamoeba polyphaga showed growth between 
24°C and 32°C, Hartmannella vermiformis between 32°C and 37°C and Naegleria fowleri from 
32°c to 41°C. Below the minimum growth temperature amoebal trophozoites encysted within 
few days. Above their upper growth limit (32°C, 37°C and 41°C, respectively) encystment was 
followed rapidly by lysis of the cells. On the other hand, growth of L. pneumophila strains was 
dependent on the host (i.e L. pneumophila strain Bloomington-2 replicated successfully in the 
presence of A. polyphaga and N. fowleri but not within H. vermiformis), but as well on the 
temperature. No strain could grow at 24°C and the maximum growth was observed in all cases 
between 30°C and 37°C. This study demonstrated the growth dependence to both temperature 
and host and supported the results obtained by studying the growth kinetics of 63 different L. 
pneumophila strains at different temperatures.  
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The impact of temperature on the virulence of bacterial pathogens is well stablished. In 
the case of bacterial pathogens of mammals, especially those that circulate often between 
environmental reservoirs and their warm-blooded hosts such as Yersinia species, elevated 
temperature (37°C) can indicate a successful infection of the host (43, 44). When bacteria sense 
the increase of temperature, virulence genes encoding type III secretion system, adhesins and 
other virulence factors are expressed (43, 45). The infectivity of the L. pneumophila strains has 
been shown previously (46, 47) to change according to the temperature.  Edelstein et al. (1987) 
(46) demonstrated that this bacterium was about fivefold more virulent to guinea pigs when 
grown at 41°C than when it was grown at 25°C. Tachibana et al. (2013) (48) also showed that 
environmental strains isolated from a spa at 45°C were significantly more virulent than the 
clinical strain that they used as control.  
 
4.5.2 Assessment of the virulence potential of environmental and clinical strains of L. 
pneumophila in a human macrophage-like cell line 
L. pneumophila is an opportunistic pathogen that, besides parasitizing their natural host, 
is also capable to infect human cells by using a large set of effector proteins that have been 
acquired along the evolution with their natural amoeba hosts. A recent study has compared the 
genomes of 38 Legionella species and has identified in total nearly 6000 potential effector 
proteins (9). L. pneumophila is one of the species with a high number of species-specific 
effectors. Elucidating the role that each effector plays in the infection is usually complicated due 
to the high redundancy of effector functions. Next to highly sophisticated proteomic analysis, 
the in-vitro infection of host cells is a very usefull experimental approach to assess the virulence 
phenotype of L. pneumophila strains. 
The understanding of L. pneumophila pathogenicity has been achieved mostly by the 
study of clinical isolates. Nevertheless, the analysis of the pathogenicity of environmental 
isolates is essential since environmental strains are considered the primary source of outbreaks 
as well as nosocomial and community acquired Legionnaires’ disease (LD). In this study, an 
extensive dataset composed of 34 clinical and 51 environmental isolates was used to determine 
potential differences between environmental and clinical isolates in the interaction with one of 
their model host systems. Generally, the degree of virulence of the of L. pneumophila strains is 
determined by studying various traits such as cytotoxicity and intracellular multiplication within 
macrophages. Other approaches, as induction of apoptosis/DNA fragmentation, pore-formation-
mediated cytolysis of the host, presence of the dot/icm loci and manifestation of specific 
serogroup or the virulence epitope MAb 3/1 are also used commonly (4, 49). Yet, none of these 
traits is conclusive. Moreover, specific strains are thought to be particularly pathogenic since 
they are frequently found among clinical isolates, although it is still not clear which specific 
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factors promote their pathogenicity. The assessment of the virulence of L. pneumophila strains 
is, nonetheless, very helpful in order to understand the epidemiology of these bacteria.  The high 
resolution MLVA genotyping applied in this study to clinical and environmental L. 
pneumophila isolates allowed to improve the insights of the population structure of this 
pathogen in Europe (50) and offered an exhaustive view of the populations in the Middle East, 
especially of areas where no previous studies had been carried out. Therefore, to complement 
the genotyping results and better understand its epidemiological significance, the virulence of 
representative MLVA genotypes and the virulence at clonal level were assessed based in the 
cytotoxicity produced to human macrophages. In general, the virulence to human macrophages 
according different traits was assessed by using a diverse group of well geno- and physio-typed 
isolates to understand the importance of such traits.  
Uptake, intracellular multiplication and cytotoxicity assays using THP-1 macrophages-
like cells were used to examine the potential virulence of the L. pneumophila isolates. However, 
due to the high number of isolates to be tested and the greater effort and longer time required to 
test the growth kinetics for all isolates, a cytotoxicity assay based on absorbance measurements 
to indicate apoptosis was the approach selected for the final virulence assessment. Cytotoxicity 
was measured using four different multiplicity of infection (MOI) values (MOI 10, 25, 50 and 
75) at 5 h and 24 h after infection. All 86 isolates tested showed significant levels of 
cytotoxicity in comparison to the dotA mutant of L. pneumophila Philadelphia-1, suggesting that 
all strains could cause infection to human cells in greater or lesser extent, probably due to the 
redundancy of effectors injected into the host cell. Cytotoxicity levels of all isolates increased 
proportionally with the increase of the MOI after 5 hours of incubation with Alamar blue, 
demonstrating the importance of the infection dose in the development of infection. At high 
MOI, i.e. MOI 75, the levels of cytotoxicity were generally very high for all strains tested and 
no significant differences could be detected, suggesting that inhalation of high doses of L. 
pneumophila could very likely cause infection independently of the inhaled strain.  
Overall, the group of environmental isolates showed greater average cytotoxicity levels 
than the group composed of clinical isolates. In both groups, the range of relative cytotoxicity 
was very broad, ranging from 20% to 70%. Greater or equal pathogenicity to macrophages of 
environmental isolates in comparison to clinical isolates have been previously demonstrated 
(48, 51).  Tachibana et al. (2013) (48) described the intracellular growth in THP-1 macrophages 
of several L. pneumophila isolates obtained from a spa in Japan. All of them presented 
significantly higher pathogenicity than the clinical reference strain.   
The serogroup of the L. pneumophila isolates is one of the traits that was first 
determined after isolation in order to classified the isolates and determine their virulence 
potential. The serogroups of L. pneumophila are highly variable and their specificity is 
determined by its lipopolysaccharide (LPS) characteristics. L. pneumophila strains can be 
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classified into 15 different serogroups and monoclonal subgroups can be differentiated within 
serogroups 1, 4, 5 and 6 (52, 53). Genetic differences among the serogroups have been observed 
in the gene cluster regulating the biosynthesis of the O-antigen (54). The relation of the LPS and 
the pathogenicity of L. pneumophila strains is assumed since epidemiological data has shown 
that L. pneumophila serogroup 1 (sgp1), and particularly those strains carrying the virulence-
associated LPS epitope recognized by monoclonal antibody (MAb) 3/1 positive, are the most 
common cause of LD in United States and Europe (55, 56).  
In this study, the cytotoxicity to THP-1 human macrophages caused by sgp1 isolates did 
not differ to that caused by the rest of serogroups (non-sgp1). Moreover, the levels of 
cytotoxicity did not vary between the sgp1 isolates that presented the virulence epitope (MAb 
1/3 positive) to those that did not present it (MAb 1/3 negtive). This high similarity between 
MAb 1/3 positive and MAb 1/3 negative strains was consistent with a previous study by Helbig 
et al. (2001) (57), where it was demonstrated that modifications in the LPS, although helpful as 
a typing tool, did not influence the virulence of the strains. The lack of differences in the levels 
of cytotoxicity between sgp1 and non-sgp1, which was contrary to what it could be expected, 
could be due to the high pathogenicity of the other serogroups used in the study (sgp3, sgp4, 
sgp8 and sgp2-14). Specifically, sgp3 has been reported to cause community-acquired 
pneumonia (58) and it is the second serogroup (3%) responsible for cases of legionellosis after 
sgp1 in Europe (19). Sgp4 and sgp8, although in much smaller proportions, have been also 
found to be responsible of community-acquired pneumonia cases and even a small outbreak 
(59). The fact that nine isolates in this study could not be sub-grouped to determine their 
specific serogroup and were enclosed in the group 2-14, makes a more accurate comparison 
between serogroups difficult. However, the four isolates from West Bank included in this group 
are likely to be sgp6, since all close genetically related isolates of their clonal complex 
(VACC11) were serotyped as sgp6. The rest five strains were isolated from the cooling tower at 
the HZI campus where only sgp4 and sgp6, besides sgp1, were obtained. Sgp6 is, after sgp1 and 
sgp3, the third serogroup (2%) found to cause legionellosis in Europe (19). Since sgp1 and non-
sgp1 strain presented similar cytotoxicity to their host, the high clinical prevalence as well as 
the high rate of isolation of sgp1 from water could lead to hypothesize that sgp1 strains would 
have environmental advantages, as, for instance, increased virulence to their natural amoeba 
hosts. Messi et al. (2013) (20) demonstrated that out of a group of L. pneumophila strains of 
different serogroups isolated from tap water, the sgp1 strain multiplied more efficiently within 
Acantamoeba polyphaga than sgp6 and sgp9 strains. Nevertheless, the study carried out by 
Kahn et al. (2013) (54) revealed that sgp1 and sgp6 strains induced different immune responses, 
the sgp1 strains having a higher potential to disseminate through the blood stream and to lead to 
bacteremia.  
Epidemiological studies have pointed out that, besides the high clinical prevalence of 
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sgp1 strains, few strains are responsible for most of the cases of legionellosis, suggesting 
differences in pathogenicity within sgp1 (5, 60). In this study, cytotoxicity levels to THP-1 
macrophages varied significantly among different MLVA genotypes characterized as sgp1. The 
cytotoxicity of Gt75(49), genotype represented by clinical isolates, was significantly higher that 
the cytotoxicity exhibited by the clinical reference strains and the genotypes Gt4(17) and 
Gt6(18), both represented by environmental isolates and ST1. In order to rule out that clinical 
and environmental isolates of the same genotype presented distinct pathogenicity, the 
cytotoxicity of environmental and clinical isolates of Gt4(17) was compared and no significant 
differences were detected.  Gt75(49) isolates were MAb 1/3 positive and corresponded to ST62. 
ST62 is the second most frequently found sequence type among clinical L. pneumophila 
serogroup 1 isolates in the Netherlands (61) and has been recurrently reported related to cases of 
legionellosis  in other European and non-European countries  (6, 60, 62). These results showed 
the high variability of the infectivity potential of genotypes with the same serogroup. 
As presented in Chapter II and Chapter III the populations of L. pneumophila appeared 
to be naturally clonal and virulence traits could be linked to clonal complexes as it occurs in 
other microorganisms (63). Differences in the infectivity potential at clonal level were observed. 
VACC8 was the clonal complex that presented the highest average cytotoxicity in contrast to 
VACC2, which showed the lowest cytotoxicity level. VACC1, the largest and most diverse 
clonal complex analyzed in this study, showed a broad range of cytotoxicity suggesting high 
diversity in virulence potential of genotypes within the same clonal complex. The 85.7% of the 
isolates grouped in VACC1 and used in the analysis were sgp1 and the variability within this 
serogroup was also demonstrated. VACC8 was composed exclusively of 12 environmental 
isolates that belonged to serogroups 1(MAb negative), 4 and 8. They were isolated from biofilm 
in the West Bank and from the cooling tower at the HZI campus. VACC8 isolates belong to the 
so called “Lorraine lineage” because of the type strain of the cluster L. pneumophila Lorraine. 
The Lorraine strain, also known as ST47, is a highly virulent strain common in Europe. It is a 
significant cause of Legionnaires’ disease in France, causing about 10% of the cases of culture-
confirmed Legionnaires’ disease (64). It has also been shown to have caused the 25% culture-
confirmed community acquired cases of Legionnaires´ disease in England and Wales during 
2000–2008 (5). Although most of the cases have been caused by Lorraine strains sgp1, this 
study revealed the high virulence potential of Lorraine strains with other serogroups. VACC2 is 
known as the “Philadelphia lineage”. Although in this study VACC2 isolates (sgp1 and sgp6) 
showed reduced cytotoxicity, cooling tower isolates belonging to this clonal complex and 
characterized as sgp1 were responsible for two outbreaks occurring in 2000 and 2006 in Rennes, 
France. The last clonal complex whose pathogenicity was studied was VACC5, which consisted 
of sgp1 clinical isolates and sgp3 environmental isolates. Clinical sgp3 isolates from VACC5 
have been reported in France (50), suggesting the capacity of causing disease of the members of 
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this VACC.  
Nevertheless, despite the research efforts it is still not well understood what makes a 
strain more virulent than another. For instance, there are many uncertainties about the bacterial 
concentration required to result in a case of legionnaire’s disease (LD) (65). In addition, in-vitro 
models of macrophage infections, as it was shown in the first part of this chapter, have 
confirmed that the infectivity potential of L. pneumophila strains can vary extensively. 
Especially, the infectivity potential varied between strains of serogroup 1. L. pneumophila  
serogroup 1 is the most commonly identified pathogen and  is as well the most common 
serogroup isolated from the environment, as it was shown in Chapter II and Chapter III (5, 19). 
Its high occurrence in the environment may be related to the ability to replicate in a broader host 
range or to multiply more efficiently than other serogroups when the environmental conditions 
are suitable. Further research would be needed to better understand the ecological interactions 
between L. pneumophila and its in-situ hosts. Additionally, further research should take into 
consideration physiological studies to better understand the metabolism of different L. 
pneumophila strains. The relation between physiological traits and clonality would also deserve 
more attention, since a relation was found in this work between virulence potential and clonal 
complexes. Likewise, the relation between clonality and adaptation to different temperature 
ranges should be investigated. 
As lLD is not transmitted from person to person, insights into the ecology of L. 
pneumophila may yield information that can be used to prevent the colonization of man-made 
freshwater systems by L. pneumophila strains. Understanding the ecology of this pathogen 
could help to determine methods for preventing its environmental dissemination and the 
transmission of legionellosis. 
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4.7 Supplementary material  
Table S1. List of L. pneumophila strains used in the infectivity and growth assays. Results of cytotoxicity at MOI 10 used in this study for comparisons between strains. Growth rates (μ) and 
maximum density (A) at each temperature tested.  
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A108                            Gt10(93) 6 Dresden             VACC11  Env. WB 54.8 (6.6) N.A. N.A. 0.07 3.06 0.20 3.05 0.32 3.64 0.33 3.79 0.17 2.76 40 40 
A112                            Gt10(93) 6 Dresden             VACC11  Env. WB 51.1 (6.0 )* N.A. N.A. 0.08 4.77 0.19 3.02 0.33 3.73 0.38 3.65 0.09 1.38 40 22 
A114                            Gt10(93) 6 Dresden             VACC11  Env. WB 67.2 (1.9) * N.A. N.A. 0.11 4.45 0.16 2.46 0.31 3.83 0.34 3.83 0.11 2.32 40 22 
A127                            Gt10(93) 6 Dresden             VACC11  Env. WB 62.6 (2.4) * N.A. N.A. 0.11 4.61 0.18 3.00 0.31 4.02 0.35 3.98 0.11 2.11 40 22 
A14                             Gt12(84) 8 Singleton Env. WB 50.6 (9.8) N.A. N.A. 0.07 3.09 0.18 3.04 0.30 3.61 0.34 3.89 N.G. N.G. 40 40 
A15                             Gt12(84) 8 Singleton Env. WB 52.6 (4.5) N.A. N.A. 0.08 2.90 0.20 3.17 0.32 3.68 0.34 3.80 0.18 2.70 40 40 
A17                             Gt12(84) 8 Singleton Env. WB 36.3 (2.5) * 0.04 3.67 0.09 3.94 0.22 4.18 0.31 3.69 0.35 3.60 NG NG 40 30 
A16                             Gt12(84) 8 Singleton Env. WB 41.8 (2.3) * 0.03 4.05 0.09 3.83 0.23 3.68 0.30 3.67 0.35 3.60 0.17 2.74 40 22 
A18                             Gt12(84) 8 Singleton Env. WB 39.5 (1.0) * N.A. N.A. 0.12 4.55 0.19 4.31 0.35 4.18 0.35 4.04 0.04 0.37 40 22 
H23                             Gt14(30) 6 Chicago             Singleton Env. G N.A. N.A. N.A. 0.11 4.50 0.17 2.52 0.33 3.80 0.31 3.44 0.05 0.67 37 37 
H1                              Gt14(31) 6 Chicago             Singleton Env. G 41.8 (2.2) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
H20                             Gt14(31) 6 Chicago             Singleton Env. G 41.2 (2.4) N.A. N.A. 0.07 2.95 0.17 3.00 0.28 3.77 0.37 3.75 0.22 2.37 40 37 
H22                             Gt14(31) 6 Chicago             Singleton Env. G 41.8 (3.4) N.A. N.A. 0.07 3.04 0.18 2.95 0.28 3.73 0.37 3.70 0.33 2.70 40 37 
H2                              Gt14(31) 6 Chicago             Singleton Env. G 40.4 (1.6) 0.03 3.76 0.10 4.05 0.21 3.87 0.30 3.66 0.33 3.59 0.04 0.64 40 22 
H3                              Gt14(31) 6 Chicago             Singleton Env. G 43.9 (1.4) 0.04 3.81 0.09 4.15 0.19 3.98 0.31 3.81 0.31 3.71 N.G. N.G. 40 22 
H4                              Gt14(31) 6 Chicago             Singleton Env. G 55.8 (2.9) * N.A. N.A. 0.10 4.68 0.22 4.19 0.32 4.21 0.29 4.01 0.07 0.85 37 22 
O100                            Gt15(95) 1 VACC5   Env. Is 31 (0.8) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O58                             Gt15(95) 3 VACC5   Env. Is 42.2 (1.2) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O59                             Gt15(95) 3 VACC5   Env. Is 33.1 (1.4) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O60                             Gt15(95) 3 VACC5   Env. Is 31.6 (1.2) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O61                             Gt15(95) 3 VACC5   Env. Is 35.6 (2.3) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
142 
 
H35                             Gt22(102) 1 VACC6   Env. G 44.3 (5.6) * 0.03 3.72 0.09 4.24 0.21 4.26 0.30 3.90 0.36 3.97 0.11 1.70 40 30 
O-H6                            Gt22(99) 1 VACC6   Clin. Is 34.4 (1.3) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O-H8                            Gt22(99) 1 VACC6   Clin. Is 31.7 (2.0) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
L11-082                         Gt23(71) 1 Knoxville           VACC2   Clin. G 28.4 (1.2) 0.03 2.61 0.07 2.35 0.22 4.31 0.35 3.99 0.30 3.97 0.24 2.76 37 30 
L11-219                         Gt23(71) 1 Knoxville           VACC2   Clin. G 31.6 (1.8) N.A. N.A. 0.06 2.79 0.22 4.36 0.34 3.84 0.33 4.06 0.26 2.57 37 30 
L03-315                         Gt23(73) 1 Knoxville           VACC2   Clin. G 28 (9.5) 0.03 2.41 0.07 2.97 0.22 4.07 0.33 4.03 0.32 3.99 0.23 2.48 37 30 
L09-183-1                       Gt23(73) 1 Knoxville           VACC2   Clin. G 31.5 (4.5) 0.03 2.52 0.07 2.59 0.21 4.06 0.31 3.60 0.25 3.65 0.30 3.17 37 30 
H42                             Gt4(14) 1 Singleton Env. G 50.3 (1.8) * 0.03 3.58 0.09 4.66 0.20 4.41 0.27 3.92 0.24 3.58 N.G. N.G. 37 22 
O123                            Gt4(17) 1 VACC1   Env. Is 64.5 (7.2) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O128                            Gt4(17) 1 VACC1   Env. Is 56.3 (4.4) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O55                             Gt4(17) 1 VACC1   Env. Is 61.3 (4.5) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O72                             Gt4(17) 1 VACC1   Env. Is 60.4 (3.4) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O75                             Gt4(17) 1 VACC1   Env. Is 40.2 (2.7) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O-H10                           Gt4(17) 1 VACC1   Clin. Is 30.3 (0.9) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O-H4                            Gt4(17) 1 VACC1   Clin. Is 43.9 (1.9) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O-H9                            Gt4(17) 1 VACC1   Clin. Is 27.5 (1.9) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
H50                             Gt4(17) 4 Portland            VACC1   Env. G 58.3 (0.4) N.A. N.A. 0.05 2.27 0.15 2.96 0.28 3.61 0.23 3.69 0.12 1.25 37 40 
H39                             Gt4(17) 4 Portland            Singleton Env. G 56.1 (4.4) * N.A. N.A. 0.09 3.49 0.19 3.16 0.25 3.74 0.24 3.59 N.G. N.G. 37 37 
H51                             Gt4(17) 4 Portland            Singleton Env. G 51 (4.5) N.A. N.A. 0.05 2.82 0.15 2.88 0.24 3.59 0.24 3.51 0.08 1.42 37 37 
H16                             Gt4(17) (2-14)                Singleton Env. G 34.3 (2.2) * 0.03 3.93 0.09 3.89 0.20 3.97 0.28 3.82 0.23 3.64 N.G. N.G. 37 30 
H38                             Gt4(17) 1 Singleton Env. G 37.1 (0.9) * 0.03 3.72 0.10 4.07 0.20 4.12 0.25 3.84 0.12 2.14 N.G. N.G. 37 30 
L03-610  Gt4(17) 1 OLDA                VACC1   Clin. G 43.1 (2.5) 0.03 2.42 0.08 3.01 0.29 3.97 0.31 3.70 0.33 3.58 0.21 2.78 40 30 
L08-417                         Gt4(17) 1 OLDA                VACC1   Clin. G 47.2 (0.9) 0.03 2.37 0.07 2.36 0.21 4.01 0.27 3.52 0.17 3.38 N.G. N.G. 37 30 
L08-498                         Gt4(17) 1 OLDA                VACC1   Clin. G 24.2 (1.3) 0.03 2.46 0.07 2.52 0.22 4.08 0.30 3.54 0.21 3.59 0.25 3.57 37 30 
L09-346                         Gt4(17) 1 Allentown/ France VACC1   Clin. G 53.9 (3.3) 0.03 2.54 0.06 2.50 0.24 4.61 0.33 3.66 0.34 3.84 0.13 1.06 40 30 
L10-226                         Gt4(17) 1 OLDA                VACC1   Clin. G 35.5 (1.2) 0.03 2.55 0.07 2.72 0.22 4.55 0.27 3.78 0.20 3.85 0.02 0.37 37 30 
A1                              Gt4(17) 1 OLDA                VACC1   Env. WB 30.8 (1.7) 0.03 4.18 0.10 4.26 0.20 4.04 0.26 3.67 0.12 1.80 N.G. N.G. 37 22 
A139                            Gt4(17) 1 VACC1   Env. WB 17.3 (6.7) N.A. N.A. 0.10 3.97 0.20 3.37 0.21 3.87 0.23 2.42 N.G. N.G. 40 22 
A5                              Gt4(17) 1 OLDA                VACC1   Env. WB 25.5 (3.9) 0.03 3.76 0.10 4.35 0.20 3.97 0.27 3.53 0.12 1.95 N.G. N.G. 37 22 
H40                             Gt4(17) 4 Portland            Singleton Env. G 49.2 (4.1) * N.A. N.A. 0.10 3.96 0.14 2.45 0.29 3.68 0.23 3.40 N.G. N.G. 37 22 
H72                             Gt4(17) 1 Singleton Env. G 31.8 (4.2) * N.A. N.A. 0.10 4.38 0.18 3.39 0.36 3.78 0.16 3.20 N.G. N.G. 37 22 
L. pn. Paris  Gt4(17) 1 VACC1   Clin. 27.9 (1.9) 0.03 3.67 0.11 4.36 0.20 4.14 0.32 3.82 0.19 3.53 N.G. N.G. 37 22 
A3                              Gt4(20) 1 OLDA                VACC1   Env. WB 47.5 (3.3) * 0.03 4.43 0.08 4.49 0.20 3.91 0.25 3.66 0.12 1.70 N.G. N.G. 37 22 
H6                              Gt5(11) 4 Portland            VACC1   Env. G 58.3 (4.0) * N.A. N.A. 0.10 4.78 0.26 4.52 0.37 4.37 0.35 4.37 N.G. N.G. 37 22 
H7                              Gt5(12) 4 Portland            VACC1   Env. G 55.9 (1.7) * N.A. N.A. 0.09 4.56 0.21 4.25 0.32 4.30 0.20 4.03 N.G. N.G. 37 22 
L. pn Chicago-2          Gt52(105) 6 VACC2   Clin. 18.7 (0.9) N.A. N.A. 0.06 2.82 0.19 3.15 0.31 3.62 0.38 4.52 0.04 0.96 40 40 
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A121                            Gt55(94) 6 Dresden             VACC11  Env. WB N.A. N.A. N.A. 0.09 4.61 0.17 2.90 0.30 3.93 0.34 3.73 0.12 2.54 40 22 
O28                             Gt6(18) 1 OLDA                VACC1   Env. Is 51.7 (3.4) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O29                             Gt6(18) 1 VACC1   Env. Is 25.7 (2.6) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O35                             Gt6(18) 1 VACC1   Env. Is 38.8 (3.7) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O93                             Gt6(18) 1 VACC1   Env. Is 43.4 (2.0) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O94                             Gt6(18) 1 VACC1   Env. Is 40.1 (3.0) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O-H5                            Gt6(18) 1 VACC1   Clin. Is 41.9 (0.5) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
O-H7                            Gt6(18) 1 VACC1   Clin. Is 51.3 (2.8) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
L09-178                         Gt64(114) 1 Knoxville           VACC2   Clin. G 23.5 (3.1) 0.03 2.46 0.07 2.77 0.21 4.25 0.31 3.59 0.29 3.67 N.G. N.G. 37 30 
L08-449 Gt64(115) 1 OLDA/Oxford               VACC2   Clin. G 20.2 (1.3) 0.02 2.35 0.06 2.65 0.24 3.78 0.32 3.35 0.36 3.50 N.G. N.G. 40 30 
L09-226                         Gt64(115) 1 Knoxville           VACC2   Clin. G 30.6 (2.9) 0.03 2.59 0.06 2.72 0.23 4.48 0.31 3.62 0.29 3.67 0.07 1.29 37 30 
L12-284                         Gt64(115) 1 Knoxville           VACC2   Clin. G 21.1 (1.6) 0.03 2.63 0.12 4.57 0.23 4.26 0.29 3.67 0.34 4.03 0.24 2.94 40 30 
A144                            Gt64(72) 1 VACC2   Env. WB 55 (6.4) * N.A. N.A. 0.11 4.26 0.16 2.87 0.35 3.90 0.18 3.48 N.G. N.G. 37 22 
L. pn. Philadelphia-1 Gt64(74) 1 VACC2   Clin. 32.4 (3.7) * 0.03 3.60 0.11 4.30 0.22 4.22 0.25 3.84 0.12 2.08 0.11 1.86 37 22 
H5                              Gt7(26) 1 Bellingham          VACC1   Env. G 44.3 (3.0) N.A. N.A. 0.07 2.93 0.20 3.11 0.30 3.67 0.34 3.85 0.23 3.21 40 40 
H13                             Gt7(26) 1 Bellingham          Singleton Env. G 47.4 (3.7) N.A. N.A. 0.06 2.89 0.19 3.26 0.31 3.68 0.27 3.64 0.19 2.95 37 37 
H10                             Gt7(26) 1 Bellingham          Singleton Env. G 58.8 (7.3) * 0.04 3.53 0.08 4.20 0.22 4.04 0.32 3.49 0.34 3.63 N.G. N.G. 40 22 
H11                             Gt7(26) 1 Bellingham          Singleton Env. G 36.5 (1.8) * N.A. N.A. 0.12 4.53 0.25 4.15 0.37 4.11 0.36 4.19 0.06 0.77 37 22 
H12                             Gt7(26) 1 Bellingham          Singleton Env. G 53.8 (2.6) * N.A. N.A. 0.11 4.56 0.23 4.20 0.34 4.23 0.37 4.23 0.04 0.43 40 22 
L06-129                         Gt71(135) 1 OLDA                VACC5   Clin. G 37.8 (1.8) 0.03 2.44 0.07 2.88 0.23 4.23 0.31 3.92 0.32 4.25 0.26 3.77 40 40 
L03-095                         Gt71(135) 1 Philadelphia        VACC5   Clin. G 42.1 (4.7) 0.02 2.59 0.07 2.79 0.24 4.18 0.33 3.80 0.35 3.77 0.29 3.38 40 30 
L06-153                         Gt71(135) 1 OLDA                VACC5   Clin. G 38.4 (3.6) 0.03 2.70 0.06 2.95 0.23 4.37 0.32 3.61 0.31 3.67 N.G. N.G. 37 30 
L09-329                         Gt75(49) 1 Philadelphia        VACC1   Clin. G 52.6 (1.3) 0.03 2.61 0.06 2.25 0.23 4.50 0.32 3.58 0.31 3.78 0.08 0.71 37 30 
L10-023                         Gt75(49) 1 Knoxville           VACC1   Clin. G 72.7 (0.4) 0.02 2.18 0.05 1.98 0.25 4.53 0.32 3.59 0.33 3.86 0.28 3.09 40 30 
L10-033                         Gt75(49) 1 Knoxville           VACC1   Clin. G 67.9 (5.3) 0.02 2.33 0.06 2.26 0.24 4.38 0.30 3.69 0.33 3.92 0.15 3.27 40 30 
L10-069                         Gt75(49) 1 Knoxville           VACC1   Clin. G 54.8 (1.2) 0.02 2.23 0.07 2.36 0.25 4.08 0.33 3.62 0.30 3.97 0.24 2.89 37 30 
L. pn. Corby                    Gt86(97) 1 Singleton Clin. 26.9 (8.2) 0.03 3.63 0.10 4.55 0.21 4.23 0.38 4.05 0.41 3.95 0.15 3.55 40 22 
L. pn. Bloomington-2  Gt89(96) 3 VACC6   Clin. 34.1 (0.8) N.A. N.A. 0.12 4.28 0.23 3.20 0.33 3.94 0.37 3.90 0.16 2.59 40 22 
L. pn. Los Angeles-1 N.T. 4 Singleton Clin. 17.4 (2.8) N.A. N.A. 0.10 4.15 0.22 3.29 0.33 3.97 0.40 4.48 0.17 2.69 40 40 
ΔdotA L. pneumohila Philadelphia-1 (negative control) 3.1 (2.1)* N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
1 Sgp-Mab: serogroup and monoclonal antibody subgroup 
                 2 MLVA CC: MLVA Clonal complex 
                  3 Percentage of cytotoxicity at MOI 10 used in this study. SD: Standard deviation of replicates. MOIs 25, 50 and 75 were also analyzed for the same set of strains but data are not shown here. Asterisks indicate strains whose 
intracellular multiplication and uptake by THP-1 was studied.  
4 μ: Growth rate and 5A: Maximum density.  
                 N.T: not typeable; N.A: not assessed; N.G: no growth Env.: environmental, Clin.: clinical; WB: West Bank, G: Germany, Is: Israel 
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Figure S1. Principal coordinate analysis (PCO) of the growth rate (µ) of 37 environmental and 26 clinical L. 
pneumophila isolates growing at six different temperatures. Significant differences between environmental and 
clinical isolates were detected (ANOSIM R=0.206, P<0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Principal coordinate analysis (PCO) of the maximal density (A) of 37 environmental and 26 clinical L. 
pneumophila isolates growing at six different temperatures. No differences were detected between environmental and 
clinical isolates by analyzing this growth parameter.  
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Figure S3. Principal coordinate analysis (PCO) of the growth rate (µ) of 37 environmental and 26 clinical L. 
pneumophila isolates growing at six different temperatures grouped according to their serogroup (sgp1 and non-
sgp1). No significant differences were observed between the two groups. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. Principal coordinate analysis (PCO) of the growth rate (µ) and maximum density of 26 clinical and 37 
environmental L. pneumophila strains isolated in Europe and the Middle East growing at six different temperatures. 
No differences were observed in the growth of environmental strains from the two distant geographic areas. 
(ANOSIM R=0.045, P>0.05). 
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Figure S5. Cytotoxicity of a reduced group of 12 clinical L. pneumophila isolates after 5 h (black bars) and 24 h 
(grey bars) post infection of THP-1 human macrophages. Infections were carried out in triplicates. L. pn. 
Philadelphia-1 and dotA were used as positive and negative controls. A) MOI 10. B) MOI 25. C) MOI 50 and D) 
MOI 75.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 Appendix 
 
1. Table A1. List of L. pneumophila strains (n=611) isolated in Germany, Israel and West 
Bank analyzed in this study. 
2. Post-print of the article published in:  
Rodríguez-Martínez S, Sharaby Y, Pecellín M, Brettar I, Höfle M, Halpern M. 
2015. Spatial distribution of Legionella pneumophila MLVA-genotypes in a drinking 
water system. Water Res 77:119–132. doi:10.1016/j.watres.2015.03.010 
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Table A1. List of L. pneumophila strains ( n=610 ) isolated in Germany, Israel and West Bank analyzed in this study. 
     
Strain Sgp, mAb1 ST ST profile2 
MLVA-
8(12) 
MLVA-8(12) profile3 MLVA_CC Country Location Sample type Year 
Berlin 10 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1994 
Berlin 13 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1995 
Berlin 15 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1995 
Berlin 16 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1995 
Berlin 2 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1994 
Berlin 3 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1994 
Berlin 6 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1994 
Berlin 7248/99 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1999 
Berlin 8 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1994 
Berlin 9 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 1994 
Charite18398 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 2001 
ChariteWV4205 1 Knoxville 182 3,4,1,3,35,9 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 2001 
Freiburg 1 1 Bellingham 59 7,6,17,3,13,11 Gt22(64) 8,8,10,2,5,14,4,1,13,3,10,0,8 VACC6 Germany Freiburg Clinical 1999 
H15 1 
  
Gt4(14) 7,7,10,2,4,9,4,2,17,0,14,5,5 VACC1 Germany Braunschweig Environ. 2012 
H18 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Germany Braunschweig Environmental 2013 
H21 1 Oxford 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Braunschweig Environmental 2013 
H23 6 Chicago 
  
Gt14(30) 7,8,8,2,4,14,2,1,18,3,0,4,8 
 
Germany Braunschweig Environmental 2013 
H26 10 
  
Gt62(10) 7,0,10,2,4,9,4,2,17,0,14,5,5 VACC1 Germany Braunschweig Environmental 2013 
H28 4 Portland 
  
Gt4(14) 7,7,10,2,4,9,4,2,17,0,14,5,5 VACC1 Germany Braunschweig Environmental 2013 
H29 4 Portland 
  
Gt22(100) 8,8,10,2,5,14,4,1,13,2,10,0,8 VACC6 Germany Braunschweig Environmental 2013 
H3 Chicago 1431 7,8,8,2,4,2,1 Gt14(31) 7,8,8,2,4,14,2,1,18,3,14,4,8 
 
Germany Braunschweig Environmental 2009 
H30 10 
  
Gt49(101) 8,8,10,2,5,14,4,1,14,2,10,0,8 VACC6 Germany Braunschweig Environmental 2013 
H31 (2-14) 
  
Gt51(103) 8,8,11,2,5,14,4,1,13,3,10,0,8 VACC6 Germany Braunschweig Environmental 2013 
H32 10 
  
Gt22(102) 8,8,10,2,5,14,4,1,13,0,10,0,8 VACC6 Germany Braunschweig Environmental 2013 
H35 1 
  
Gt22(102) 8,8,10,2,5,14,4,1,13,0,10,0,8 VACC6 Germany Braunschweig Environmental 2013 
H46 4 Portland 
  
Gt43(104) 8,8,9,2,5,14,4,1,13,0,10,0,8 VACC6 Germany Braunschweig Environmental 2014 
H47 10 
  
Gt43(104) 8,8,9,2,5,14,4,1,13,0,10,0,8 VACC6 Germany Braunschweig Environmental 2014 
H5 1 Bellingham 48 5,2,22,27,6,10,12 Gt7(26) 7,7,12,2,4,18,3,1,17,3,14,5,8 VACC1 Germany Braunschweig Environmental 2009 
H50 4 Portland 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Braunschweig Environmental 2014 
H6 4 Portland 
  
Gt5(11) 7,7,10,2,4,9,3,1,17,0,14,5,5 VACC1 Germany Braunschweig Environmental 2009 
H61 (2-14) 
  
Gt22(113) 8,8,10,2,5,14,4,1,13,0,10,5,8 VACC6 Germany Braunschweig Environmental 2014 
H7 4 Portland 
  
Gt5(12) 7,7,10,2,4,9,3,1,17,3,14,5,5 VACC1 Germany Braunschweig Environmental 2009 
Hamburg P1-B 1 Philadelphia 332 7,10,17,6,14,11,3 Gt44(54) 8,8,10,2,0,14,4,1,13,3,6,0,8 VACC6 Germany Hamburg Clinical 1996 
Hamburg P1-A 1 Philadelphia 332 7,10,17,6,14,11,3 Gt44(54) 8,8,10,2,0,14,4,1,13,3,6,0,8 VACC6 Germany Hamburg Clinical 1996 
Heidelberg P5 1 Bellingham 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC6 Germany Heidelberg Clinical 1996 
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Strain Sgp, mAb ST ST profile 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
L01-138 6 Chicago 437 
 
Gt9(129) 9,8,11,2,4,13,3,4,17,3,6,4,8 VACC11 Germany Schwedt Clinical 2001 
L01-284 1 Benidorm 387 2,6,17,14,13,11 Gt48(60) 8,8,10,2,4,15,3,1,5,3,9,0,8 VACC10 Germany Görlitz Clinical 2001 
L01-354 1 Benidorm 34 3,13,1,25,14,9 Gt52(75) 8,8,11,2,5,16,1,1,3,3,6,4,8 VACC2 Germany Hannover Clinical 2001 
L01-389 1 Knoxville 23 2,3,9,10,2,1,6 Gt36(45) 8,7,11,2,4,13,4,3,26,3,20,5,0 VACC3 Germany Magdeburg Clinical 2001 
L01-403 1 Philadelphia 23 2,3,9,10,2,1,6 Gt36(45) 8,7,11,2,4,13,4,3,26,3,20,5,0 VACC3 Germany Heidelberg Clinical 2001 
L01-409 1 Knoxville 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 2001 
L01-443 1 Knoxville 9 3,10,1,3,14,9,11 Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2 Germany Herford Clinical 2001 
L02-034 10 440 3,10,1,28,14,9,1 Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2 Germany Görlitz Clinical 2002 
L02-456 1 Knoxville 182 3,4,1,3,35,9,11 Gt64(119) 8,8,11,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 2002 
L02-465 1 Benidorm 425 2,10,3,15,9,4,11 Gt27(133) 10,8,8,2,5,13,2,2,18,3,10,4,8 VACC5 Germany Berlin Clinical 2002 
L02-521 1 Philadelphia 62 8,10,3,15,18,1,6 Gt29(27) 7,7,12,2,4,15,2,2,22,3,20,5,0 VACC1-B Germany Bad Langensalza Clinical 2002 
L02-705 1 Benidorm 387 2,6,17,14,13,11,11 Gt48(60) 8,8,10,2,4,15,3,1,5,3,9,0,8 VACC10 Germany Görlitz Clinical 2002 
L03-023 1 Knoxville 20 2,3,18,15,2,1,6 Gt33(40) 8,7,7,2,4,13,5,3,31,3,25,5,0 VACC3 Germany Erlangen Clinical 2003 
L03-095 1 Philadelphia 62 8,10,3,15,18,1,6 Gt71(135) 10,8,8,2,4,13,2,2,17,3,10,4,8 VACC5 Germany Saarbrücken Clinical 2003 
L03-315 1 Knoxville 182 3,4,1,3,35,9,11 Gt23(73) 8,8,10,2,4,17,1,1,3,3,6,5,8 VACC2 Germany Frankfurt/Oder Clinical 2003 
L03-407 1 Benidorm 15 12,9,26,5,26,17,15 Gt66(131) 6,7,4,2,4,13,2,3,23,11,11,4,8 
 
Germany Frankfurt/Oder Clinical 2003 
L03-610 grün 1 OLDA 7 1,4,3,1,1,1,6 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Magdeburg Clinical 2003 
L03-610 rot 1 OLDA 7 1,4,3,1,1,1,6 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Magdeburg Clinical 2003 
L03-638 1 Bellingham 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC6 Germany München Clinical 2003 
L04-041 3 87 2,10,3,28,9,4,13 Gt30(137) 10,8,0,2,5,13,5,2,18,0,10,4,8 
 
Germany Kassel Clinical 2004 
L04-146 1 Knoxville 387 2,6,17,14,13,11,11 Gt48(60) 8,8,10,2,4,15,3,1,5,3,9,0,8 VACC10 Germany Görlitz Clinical 2004 
L04-485 1 Knoxville 182 3,4,1,3,35,9,11 Gt82(124) 8,8,10,2,5,16,1,1,3,3,6,0,8 VACC2 Germany Frankfurt/Oder Clinical 2004 
L04-497 1 Benidorm 407 6,10,15,3,21,14,9 Gt79(125) 8,8,8,2,5,12,4,1,24,3,6,0,8 VACC6 Germany Frankfurt/Main Clinical 2004 
L04-545 6 Dresden 292 6,10,19,28,19,4,3 Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 
 
Germany Heide-West Clinical 2004 
L04-598 6 Chicago 424 7,10,17,3,13,14,9 Gt82(127) 8,8,10,2,4,14,4,1,13,3,10,0,8 VACC6 Germany Frankfurt/Oder Clinical 2004 
L05-228 1 Benidorm 46 5,1,22,5,6,10,12 Gt37(55) 8,7,12,2,4,19,4,1,16,17,12,5,8 VACC5 Germany Cottbus Clinical 2005 
L05-341 6 Chicago 81 2,10,3,28,9,4,9 Gt8(132) 10,8,8,2,4,13,2,2,18,3,10,0,8 VACC1 Germany Darmstadt Clinical 2005 
L05-362-1 1 Benidorm 6 1,4,3,1,1,1,15 Gt4(14) 7,7,10,2,4,9,4,2,17,0,14,5,5 VACC5 Germany Kiel KH Clinical 2006 
L06-129 1 OLDA 169 6,10,3,10,9,4,6 Gt71(135) 10,8,8,2,4,13,2,2,17,3,10,4,8 VACC5 Germany Brandenburg Clinical 2006 
L06-153 1 OLDA 169 6,10,3,10,9,4,6 Gt71(135) 10,8,8,2,4,13,2,2,17,3,10,4,8 VACC2 Germany Brandenburg Clinical 2006 
L06-604 1 Knoxville 347 3,4,1,3,14,9,11 Gt54(123) 8,8,12,2,5,17,1,1,3,3,6,4,8 VACC6 Germany Braunschweig Clinical 2007 
L07-002 1 Philadelphia 332 7,10,17,6,14,11,3 Gt82(126) 8,8,10,2,4,14,4,1,13,3,6,0,8 
 
Germany Gotha Clinical 2007 
L07-363 1 Knoxville 92 2,3,18,5,5,1,2 Gt80(65) 8,8,9,2,4,13,2,3,15,3,0,5,0 VACC1 Germany Stuttgart Clinical 2007 
L07-551-1 1 Oxford/Phil. 1 1,4,3,1,1,1,1 Gt18(4) 7,7,7,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Hannover Clinical 2007 
L07-552-1 1 Philadelphia 1 1,4,3,1,1,1,1 Gt18(4) 7,7,7,2,4,9,4,2,17,3,14,5,5 
 
Germany Hannover Clinical 2007 
L07-590 1 Allentown/France 18 2,10,9,13,2,5,6 Gt73(51) 7,7,12,2,4,17,4,3,24,19,20,5,0 VACC8 Germany Dresden Clinical 2007 
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Strain Sgp, mAb ST ST profile 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
L07-667 1 Philadelphia 82 5,1,22,10,6,10,6 Gt37(46) 8,7,12,2,4,19,4,1,16,3,12,5,8 VACC2 Germany Homburg Clinical 2008 
L08-147-1 1 Knoxville 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 2008 
L08-147-2 1 Knoxville 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 2008 
L08-148-1 1 Denver 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Clinical 2008 
L08-148-2 1 Denver 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC3 Germany Berlin Clinical 2008 
L08-217 1 Philadelphia 23 2,3,9,10,2,1,6 Gt36(45) 8,7,11,2,4,13,4,3,26,3,20,5,0 VACC1-A Germany Freiburg Clinical 2008 
L08-378 1 Philadelphia 1292 
 
Gt69(67) 7,7,10,2,4,13,4,3,18,3,28,5,8 VACC1 Germany Berlin Clinical 2008 
L08-417 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC2 Germany Saarbrücken Clinical 2008 
L08-422-2 3 93 3,10,1,28,14,9,13 Gt86(118) 8,8,12,1,0,17,1,1,3,0,6,4,8 
 
Germany München Clinical 2008 
L08-444 1 OLDA 562 
 
Gt34(136) 10,8,9,2,4,13,2,2,12,3,10,5,8 VACC2 Germany Hannover Clinical 2008 
L08-449 1 OLDA/Oxford 561 
 
Gt64(115) 8,8,11,2,4,17,1,1,3,3,6,4,8 VACC1 Germany Stuttgart Clinical 2008 
L08-498 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC2 Germany Greifswald Clinical 2008 
L08-532 1 Philadelphia 736 
 
Gt53(85) 8,8,12,2,4,17,1,1,3,3,6,4,8 VACC2 Germany Berlin Clinical 2009 
L09-178 1 Knoxville 1352 
 
Gt64(114) 8,8,11,2,4,17,1,1,3,3,6,5,8 VACC2 Germany München Clinical 2009 
L09-183-1 1 Knoxville 179 3,4,1,1,1,9,11 Gt23(73) 8,8,10,2,4,17,1,1,3,3,6,5,8 VACC6 Germany Birkenfeld Clinical 2009 
L09-183-2 1 Benidorm 334 2,6,17,6,13,11,11 Gt81(128) 8,8,10,2,0,14,4,1,6,3,10,0,8 VACC2 Germany Birkenfeld Clinical 2009 
L09-210 1 Knoxville 9 3,10,1,3,14,9,11 Gt52(122) 8,8,11,2,5,17,1,1,3,3,6,4,8 VACC2 Germany Bad Nauheim Clinical 2009 
L09-226 1 Knoxville 737 
 
Gt64(115) 8,8,11,2,4,17,1,1,3,3,6,4,8 VACC2 Germany Hannover Clinical 2009 
L09-313 3 93 3,10,1,28,14,9,13 Gt84(116) 8,8,11,1,0,17,1,1,3,3,6,4,8 VACC1-B Germany Freiburg Clinical 2009 
L09-329 1 Philadelphia 62 8,10,3,15,18,1,6 Gt75(49) 7,7,13,2,4,15,2,2,22,3,20,5,0 VACC1 Germany Trier Clinical 2009 
L09-346 1 Allentown/France 23 2,3,9,10,2,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC3 Germany Freiburg Clinical 2009 
L09-415 1 OLDA 177 1,4,3,1,1,12,6 Gt36(45) 8,7,11,2,4,13,4,3,26,3,20,5,0 VACC3 Germany Jena Clinical 2009 
L09-561 1 Oxford 23 2,3,9,10,2,1,6 Gt36(45) 8,7,11,2,4,13,4,3,26,3,20,5,0 VACC3 Germany Freiburg Clinical 2009 
L09-624 1 Oxford 23 2,3,9,10,2,1,6 Gt36(45) 8,7,11,2,4,13,4,3,26,3,20,5,0 VACC2 Germany Freiburg Clinical 2010 
L10-005 3 93 3,10,1,28,14,9,6 Gt24(117) 8,8,11,2,0,17,1,1,3,0,6,4,8 VACC1-B Germany Freiburg Clinical 2010 
L10-023 1 Knoxville 62 8,10,3,15,18,1,6 Gt75(49) 7,7,13,2,4,15,2,2,22,3,20,5,0 VACC1-B Germany Ulm Clinical 2010 
L10-033 1 Knoxville 62 8,10,3,15,18,1,6 Gt75(49) 7,7,13,2,4,15,2,2,22,3,20,5,0 VACC1-B Germany Ulm Clinical 2010 
L10-034 1 Knoxville 62 8,10,3,15,18,1,6 Gt67(22) 7,7,0,2,4,15,2,2,22,3,20,5,0 VACC1-B Germany Ulm Clinical 2010 
L10-069 1 Knoxville 62 8,10,3,15,18,1,6 Gt75(49) 7,7,13,2,4,15,2,2,22,3,20,5,0 VACC1-A Germany Ulm Clinical 2010 
L10-091 1 Philadelphia 435 2,10,18,15,2,1,1 Gt69(69) 7,7,10,2,4,13,4,3,18,3,30,5,8 VACC1 Germany Erlangen Clinical 2010 
L10-163 1 OLDA 1 1,4,3,1,1,1,1 Gt68(19) 7,7,10,2,4,9,2,2,17,3,14,5,5 VACC1 Germany Giessen-Marburg Clinical 2010 
L10-226 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC6 Germany München Clinical 2010 
L10-273 1 Bellingham 59 7,6,17,3,13,11 Gt22(64) 8,8,10,2,5,14,4,1,13,3,10,0,8 
 
Germany Freiburg Clinical 2010 
L10-441 1 Allentown/France 224 4,8,11,16,42,12,2 Gt83(121) 8,8,11,2,0,9,2,1,8,3,0,4,0 VACC1 Germany Ulm Clinical 2010 
L10-495 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1-B Germany Biedenkopf Clinical 2010 
L10-496 1 Philadelphia 62 8,10,3,15,18,1,6 Gt29(27) 7,7,12,2,4,15,2,2,22,3,20,5,0 
 
Germany Biedenkopf Clinical 2010 
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L10-525 1 Allentown/France 44 4,8,11,10,10,12,2 Gt77(139) 9,8,15,2,4,8,2,2,17,15,0,4,0 
 
Germany Harburg Clinical 2011 
L11-002 1 Philadelphia 23 2,3,9,10,2,1,6 Gt36(45) 8,7,11,2,4,13,4,3,26,3,20,5,0 
 
Germany Ulm Clinical 2011 
L11-078 1 Philadelphia 47 5,10,22,15,6,2,6 Gt37(46) 8,7,12,2,4,19,4,1,16,3,12,5,8 
 
Germany Heidelberg Clinical 2011 
L11-082 1 Knoxville 182 3,4,1,3,35,9,11 Gt23(71) 8,8,10,2,4,17,1,1,3,2,6,5,8 VACC3 Germany Greifswald Clinical 2011 
L11-124 1 Benidorm 42 4,7,11,3,11,12,9 Gt76(140) 7,8,9,2,0,14,3,1,12,3,0,4,8 VACC8 Germany Köln Clinical 2011 
L11-154 1 Allentown/France 62 8,10,3,15,18,1,6 Gt29(27) 7,7,12,2,4,15,2,2,22,3,20,5,0 VACC2 Germany Viersen Clinical 2011 
L11-198 1 Benidorm 8 1,4,3,1,1,1,9 Gt28(24) 7,7,11,2,4,9,4,2,17,3,14,0,5 VACC4 Germany Hannover Clinical 2011 
L11-209 1 Knoxville 62 8,10,3,15,18,1,6 Gt29(27) 7,7,12,2,4,15,2,2,22,3,20,5,0 VACC1-B Germany Hannover Clinical 
 
L11-219 1 Knoxville 182 3,4,1,3,35,9,11 Gt23(71) 8,8,10,2,4,17,1,1,3,2,6,5,8 VACC1 Germany Oderland Clinical 2011 
L11-235 1 Philadelphia 46 5,1,22,5,6,10,12 Gt37(62) 8,7,12,2,4,19,4,1,16,16,12,5,8 VACC1-B Germany Münster Clinical 2011 
L11-285 1 Philadelphia 1 1,4,3,1,1,1,1 Gt28(25) 7,7,11,2,4,9,4,2,17,3,14,5,5 VACC2 Germany Hannover Clinical 2011 
L11-413 1 Knoxville 9 3,10,1,3,14,9,11 Gt54(77) 8,8,12,2,5,16,1,1,3,3,6,4,8 VACC8 Germany Regensburg Clinical 2011 
L11-462 1 Allentown/France 82 5,1,22,10,6,10,6 Gt37(62) 8,7,12,2,4,19,4,1,16,16,12,5,8 VACC1 Germany Erlagen Clinical 2011 
L11-463 1 Allentown/France 224 4,8,11,16,42,12,2 Gt83(121) 8,8,11,2,0,9,2,1,8,3,0,4,0 VACC2 Germany Erlagen Clinical 2011 
L11-483 1 Knoxville 9 3,10,1,3,14,9,11 Gt87(120) 8,8,12,2,1,16,1,1,3,3,6,4,8 VACC8 Germany Leverkusen Clinical 2011 
L11-508 1 Philadelphia 1 1,4,3,1,1,1,1 Gt18(4) 7,7,7,2,4,9,4,2,17,3,14,5,5 
 
Germany Frankfurt/Main Clinical 2012 
L12-158 1 OLDA 1 1,4,3,1,1,1,1 Gt70(21) 7,7,10,2,2,9,4,2,17,3,14,5,5 
 
Germany Bochum Clinical 2012 
L12-230 6 Dresden 68 3,13,1,28,14,9,3 Gt24(116) 8,8,11,2,0,17,1,1,3,3,6,4,8 VACC2 Germany Lübeck Clinical 2012 
L12-284 1 Knoxville 9 3,10,1,3,14,9,11 Gt64(115) 8,8,11,2,4,17,1,1,3,3,6,4,8 VACC1 Germany Bochum Clinical 2012 
L12-296- 1 OLDA 45 5,1,22,26,6,10,12 Gt32(41) 8,7,7,2,4,19,4,1,12,3,12,5,8 VACC1 Germany Göppingen Clinical 2012 
L12-317 1 Knoxville 444 2,10,22,10,2,1,6 Gt72(66) 7,7,10,2,5,13,4,3,18,3,28,5,8 VACC2 Germany Lörrach Clinical 2012 
L12-360- 1 Allentown/France 82 5,1,22,10,6,10,6 Gt37(46) 8,7,12,2,4,19,4,1,16,3,12,5,8 VACC2 Germany Zweibrücken Clinical 2012 
L12-384 1 Allentown/France 82 5,1,22,10,6,10,6 Gt37(46) 8,7,12,2,4,19,4,1,16,3,12,5,8 VACC8 Germany Zweibrücken Clinical 2012 
L12-426 Dallas 1327 
 
Gt78(130) 8,8,0,2,7,0,2,0,8,0,6,0,0 VACC1-A Germany Oberschleißeim Clinical 2012 
L12-435 1 Knoxville 9 3,10,1,3,14,9,11 Gt88(90) 8,8,12,2,8,17,1,1,9,3,6,4,8 VACC8 Germany Mannheim Clinical 2012 
L12-480 1 Benidorm 42 4,7,11,3,11,12,9 Gt31(37) 7,8,9,2,5,12,3,1,12,3,0,4,0 VACC8 Germany Kitzingen Clinical 2012 
L12-516 1 Bellingham 
  
Gt85(138) 9,8,8,2,9,9,2,3,11,3,0,4,8 
 
Germany Heilbronn Clinical 2012 
L12-643 1 Allentown/France 788 2,6,17,14,2,8,11 Gt41(52) 8,8,9,2,4,15,3,1,5,11,9,0,8 VACC2 Germany Regensburg Clinical 2012 
L12-654 1 Allentown/France 1403 2,1,22,16,6,10,26 Gt32(70) 8,7,7,2,4,0,4,1,12,3,12,5,8 VACC4 Germany Freiburg Clinical 2013 
L13-236 1 OLDA 1 1,4,3,1,1,1,1 Gt4(59) 7,7,10,2,4,1,4,2,17,3,14,5,5 
 
Germany Stuttgart Clinical 2013 
L13-435 1 Knoxville 345 6,10,19,3,19,4,11 Gt39(48) 8,8,8,2,5,13,2,2,6,3,10,4,8 VACC10 Germany Warstein Clinical 2013 
L13-440 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC8 Germany Bochum Clinical 2013 
L13-443 3 93 3,10,1,28,14,9,13 Gt24(68) 8,8,11,2,0,16,1,1,3,0,6,4,8 VACC1 Germany Warstein Clinical 2013 
M?chen 8 1 Bellingham 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC5 Germany München Clinical 2003 
W03-279 1 Bellingham 334 2,6,17,6,13,11,11 Gt50(57) 8,8,11,2,4,14,4,1,6,3,10,0,8 VACC1 Germany Bottrop Environmental 2006 
W06-574 1 Benidorm 387 2,6,17,14,13,11,11 Gt48(60) 8,8,10,2,4,15,3,1,5,3,9,0,8 VACC2 Germany Görlitz Environmental 2006 
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W06-582 1 OLDA 387 2,6,17,14,13,11,11 Gt48(60) 8,8,10,2,4,15,3,1,5,3,9,0,8 VACC6 Germany Coswig Environmental 2006 
W06-730-1 1 Knoxville 9 3,10,1,3,14,9,11 Gt53(76) 8,8,12,2,4,16,1,1,3,3,6,4,8 VACC6 Germany Lörrach Environmental 2007 
W07-120 Stoma 1 Denver 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC10 Germany Berlin Environmental 2008 
W08-297- 1 Knoxville 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Leuna Environmental 2008 
W08-444 1 Denver 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Berlin Environmental 2008 
W08-450 1 Bellingham 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC6 Germany München Environmental 2008 
W08-452 1 Bellingham 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC6 Germany München Environmental 2009 
W09-154 1 Benidorm 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC6 Germany Birkenfeld Environmental 2009 
W09-155 1 Benidorm 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC6 Germany Birkenfeld Environmental 2009 
W09-366 1 OLDA 182 3,4,1,3,35,9,11 Gt23(63) 8,8,10,2,4,16,1,1,3,3,6,5,8 VACC2 Germany Frankfurt/Oder Environmental 2010 
W10-1075 1 Bellingham 334 2,6,17,6,13,11,11 Gt46(58) 8,8,10,2,4,14,4,0,6,3,10,4,8 VACC6 Germany Ulm Environmental 2010 
W10-403 1 Knoxville 9 3,10,1,3,14,9,11 Gt52(75) 8,8,11,2,5,16,1,1,3,3,6,4,8 VACC2 Germany Ulm Environmental 2010 
W10-921 1 OLDA 1 1,4,3,1,1,1,1 Gt4(61) 7,7,10,2,4,2,4,2,17,3,14,5,5 VACC1 Germany Biedenkopf Environmental 2011 
W11-035 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Düsseldorf Environmental 2011 
W11-038 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Düsseldorf Environmental 2011 
W11-039 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Düsseldorf Environmental 2011 
W11-046 1 Bellingham 334 2,6,17,6,13,11,11 Gt47(56) 8,8,10,2,4,14,4,1,6,3,10,0,8 VACC6 Germany Düsseldorf Environmental 2011 
W11-1006 1 OLDA 182 3,4,1,3,35,9,11 Gt54(56) 8,8,12,1,5,3,1,1,3,3,6,4,8 VACC2 Germany Frankfurt/Oder Environmental 2011 
W11-1153-2 1 Philadelphia 1 1,4,3,1,1,1,1 Gt18(5) 7,7,7,2,4,4,4,2,17,2,14,5,5 VACC1 Germany Frankfurt Environmental 2011 
W11-677-2 1 Benidorm 8 1,4,3,1,1,1,9 Gt28(24) 7,7,11,2,4,9,4,2,17,3,14,0,5 VACC1 Germany Wolfenbüttel Environmental 2011 
W11-928 1 Philadelphia 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Hannover Environmental 2012 
W12-1082 1 Benidorm 42 4,7,11,3,11,12,9 Gt31(37) 7,8,9,2,5,12,3,1,12,3,0,4,0 VACC4 Germany Kitzingen Environmental 2012 
W12-1190 1 Philadelphia 1 1,4,3,1,1,1,1 Gt18(4) 7,7,7,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Heilbronn Environmental 2012 
W12-1216 1 Allentown/France 788 2,6,17,14,2,8,11 Gt42(53) 8,8,9,2,4,15,3,1,10,11,0,0,0 VACC10 Germany Regensburg Environmental 2012 
W12-1308 1 Allentown/France 1403 2,1,22,16,6,10,26 Gt32(70) 8,7,7,2,4,0,4,1,12,3,12,5,8 VACC8 Germany Freiburg Environmental 2012 
W12-724 1 Philadelphia 1 1,4,3,1,1,1,1 Gt18(4) 7,7,7,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Kiel Environmental 2012 
W12-805 1 OLDA 45 5,1,22,26,6,10,12 Gt32(41) 8,7,7,2,4,19,4,1,12,3,12,5,8 VACC8 Germany Göppingen Environmental 2012 
W12-948 1 Allentown/France 82 5,1,22,10,6,10,6 Gt37(46) 8,7,12,2,4,19,4,1,16,3,12,5,8 VACC8 Germany Zweibrücken Environmental 2013 
W13-255 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Stuttgart Environmental 2013 
W13-845-1 1 Knoxville 600 6,10,19,28,19,14,11 Gt30(34) 7,8,8,2,5,12,2,2,11,3,0,4,8 VACC5-A Germany Warstein Environmental 2013 
W13-845-11 1 Knoxville 600 6,10,19,28,19,14,11 Gt30(33) 7,8,8,2,5,12,2,2,11,2,0,4,8 VACC5-A Germany Warstein Environmental 2013 
W13-845-13 10 
  
Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 
 
Germany Warstein Environmental 2013 
W13-845-16 Dresden 
  
Gt56(86) 10,8,8,2,4,12,3,3,18,3,10,4,8 
 
Germany Warstein Environmental 2013 
W13-870-2 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Germany Warstein Environmental 2013 
W13-872-2 1 Knoxville 600 6,10,19,28,19,14,11 Gt30(32) 7,8,8,2,5,12,2,2,11,3,15,4,8 VACC5-A Germany Warstein Environmental 2013 
W13-874-13 1 Knoxville 600 6,10,19,28,19,14,11 Gt30(35) 7,8,8,2,5,12,2,2,11,3,14,4,8 VACC5-A Germany Warstein Environmental 2013 
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O10 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O100 3 
  
Gt15(95) 9,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2013 
O101 3 
  
Gt15(96) 9,8,8,2,5,13,2,2,21,0,10,4,9 VACC5 Israel Oranim Haifa Environmental 2013 
O102 3 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O103 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O104 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O105 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O106 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O107 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O108 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O109 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O11 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O110 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O111 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O112 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O113 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O114 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O115 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O116 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O117 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O118 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O119 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O12 1 OLDA 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O120 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O121 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O122 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O123 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O124 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O125 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O126 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O127 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O128 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O129 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O13 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O130 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O131 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
153 
 
Strain Sgp, mAb ST ST profile 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
O132 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O133 1 
  
Gt58(9) 0,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O134 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O136 1 
  
Gt59(112) 0,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O138 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O139 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O14 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O140 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O141 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O142 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O144 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O145 1 
  
Gt6(13) 7,7,10,2,4,9,4,2,18,2,17,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O146 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O147 1 
  
Gt6(13) 7,7,10,2,4,9,4,2,18,2,17,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O148 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O149 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O15 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O150 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O151 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O153 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O154 1 
  
Gt27(28) 10,8,8,2,5,13,2,2,18,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2013 
O156 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O157 3 
  
Gt57(29) 10,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2013 
O159 3 
  
Gt57(29) 10,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2013 
O16 1 
  
Gt6(83) 7,7,10,2,4,9,4,2,18,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2013 
O160 3 
  
Gt57(29) 10,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2013 
O161 3 
  
Gt57(29) 10,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2013 
O165 3 
  
Gt57(44) 10,8,8,2,5,13,2,2,21,3,10,4,8 VACC5 Israel Oranim Haifa Environmental 2013 
O168 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O169 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O17 1 Oxford 1 1,4,3,1,1,1,1 Gt6(83) 7,7,10,2,4,9,4,2,18,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O170 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O171 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O172 1 
  
Gt6(13) 7,7,10,2,4,9,4,2,18,2,17,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O173 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O174 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
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O175 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O176 1 
  
Gt60(80) 7,0,7,2,0,9,4,2,30,3,14,5,0 
 
Israel Oranim Haifa Environmental 2013 
O177 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O178 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O18 1 Oxford 
  
Gt6(83) 7,7,10,2,4,9,4,2,18,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O180 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O181 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O182 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O183 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O187 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O188 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O189 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O19 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O190 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O191 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O192 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O193 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O194 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O195 NA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
O2 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O21 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O22 1 Oxford 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O23 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O24 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O25 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O26 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O28 1 OLDA 1 1,4,3,1,1,1,1 Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O29 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O3 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O30 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O32 1 Oxford 1 1,4,3,1,1,1,1 Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O33 1 Oxford 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O34 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O35 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O36 1 Oxford 1 1,4,3,1,1,1,1 Gt6(83) 7,7,10,2,4,9,4,2,18,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O37 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
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O38 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O39 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O4 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O40 1 Oxford 
  
Gt6(83) 7,7,10,2,4,9,4,2,18,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O41 1 Oxford 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O42 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O45 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O46 1 OLDA 
  
Gt4(110) 7,7,10,2,4,9,4,2,17,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O47 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O48 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O49 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O5 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O50 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O51 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O52 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O53 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O54 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O55 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O56 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O57 3 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O58 3 
  
Gt15(95) 9,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2012 
O59 3 
  
Gt15(95) 9,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2012 
O6 1 
  
Gt4(110) 7,7,10,2,4,9,4,2,17,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O60 3 
  
Gt15(95) 9,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2012 
O61 3 
  
Gt15(95) 9,8,8,2,5,13,2,2,21,0,10,4,8 VACC5 Israel Oranim Haifa Environmental 2012 
O63 3 
  
Gt17(111) 7,7,8,2,3,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O64 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O65 1 
  
Gt3(81) 7,7,10,2,4,9,4,2,0,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O66 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O67 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O68 1 
  
Gt61(82) 7,0,10,2,4,9,4,2,0,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O69 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O70 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O71 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O72 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O73 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
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O74 1 
  
Gt4(110) 7,7,10,2,4,9,4,2,17,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O75 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O76 1 
  
Gt6(83) 7,7,10,2,4,9,4,2,18,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O77 1 
  
Gt3(81) 7,7,10,2,4,9,4,2,0,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O79 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O8 1 
  
Gt4(110) 7,7,10,2,4,9,4,2,17,3,14,5,6 VACC1 Israel Oranim Haifa Environmental 2012 
O80 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O81 1 
  
Gt18(4) 7,7,7,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O82 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O83 1 
  
Gt15(97) 9,8,8,2,5,13,2,2,21,3,10,4,8 VACC5 Israel Oranim Haifa Environmental 2012 
O85 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O86 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O87 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O88 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O9 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O92 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O93 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O94 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O96 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O97 1 
  
Gt3(81) 7,7,10,2,4,9,4,2,0,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2012 
O99 3 
  
Gt3(81) 7,7,10,2,4,9,4,2,0,3,14,5,5 VACC1 Israel Oranim Haifa Environmental 2013 
OA1 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2013 
OA10 1 
  
Gt22(98) 8,8,10,2,5,14,4,1,13,3,10,4,8 VACC6 Israel Alonei Aba House Environmental 2012 
OA11 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2012 
OA12 1 
  
Gt45(107) 8,8,10,2,0,16,1,1,3,2,6,4,8 VACC2 Israel Alonei Aba House Environmental 2013 
O-A17 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Alonei Aba House Environmental 2013 
O-A19 1 
  
Gt6(13) 7,7,10,2,4,9,4,2,18,2,17,5,5 VACC1 Israel Alonei Aba House Environmental 2013 
O-A2 1 
  
Gt22(99) 8,8,10,2,5,14,4,1,13,3,10,5,8 VACC6 Israel Alonei Aba House Environmental 2013 
O-A23 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2013 
O-A27 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2013 
O-A28 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2013 
OA3 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2012 
OA4 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2012 
OA5 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2012 
OA6 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2012 
OA7 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2012 
OA9 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Alonei Aba House Environmental 2012 
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O-H1 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-H10 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-H11 1 
  
Gt20(115) 7,7,10,2,4,9,4,3,17,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-H2 1 
  
Gt24(68) 8,8,11,2,0,16,1,1,3,0,6,4,8 VACC2 Israel Rambam Hospital Clinical NA 
O-H3 1 
  
Gt19(17) 7,7,10,1,4,9,4,2,17,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-H4 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-H5 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-H6 1 
  
Gt22(99) 8,8,10,2,5,14,4,1,13,3,10,5,8 VACC6 Israel Rambam Hospital Clinical NA 
O-H7 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-H8 1 
  
Gt22(99) 8,8,10,2,5,14,4,1,13,3,10,5,8 VACC6 Israel Rambam Hospital Clinical NA 
O-H9 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Rambam Hospital Clinical NA 
O-P11 1 
  
Gt23(108) 8,8,10,2,4,16,1,1,3,3,6,4,8 VACC2 Israel Pilot Technion Environmental 2013 
O-P1B2 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Yavniel Environmental 2013 
O-P1B3 (2-14) 
  
Gt24(68) 8,8,11,2,0,16,1,1,3,0,6,4,8 VACC2 Israel Yavniel Environmental 2013 
O-P1B4 1 
  
Gt21(15) 7,7,10,1,4,9,4,2,18,2,14,5,5 VACC1 Israel Yavniel Environmental 2013 
O-P3 1 
  
Gt45(78) 8,8,10,2,0,18,1,1,3,2,6,4,8 VACC2 Israel Pilot Technion Environmental 2013 
O-P5 1 
  
Gt45(78) 8,8,10,2,0,18,1,1,3,2,6,4,8 VACC2 Israel Pilot Technion Environmental 2013 
O-P6 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Pilot Technion Environmental 2013 
O-P7 3 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Pilot Technion Environmental 2013 
OT1 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
OT2 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
OT3 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T35 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T37 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T38 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Raz House Environmental 2013 
OT4 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T41 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T42 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T43 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T44 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T45 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T46 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T47 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T48 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
O-T49 1 
  
Gt6(9) 7,7,10,2,4,9,4,2,18,2,17,4,5 VACC1 Israel Raz House Environmental 2013 
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Strain Sgp, mAb ST ST profile 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
OT5 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
OT6 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Raz House Environmental 2013 
OT7 2-14 (not 3) 
  
Gt2(89) 7,8,3,2,4,9,1,0,11,2,12,4,5 
 
Israel Tamar House Environmental 2013 
OT8 2-14 (not 3) 
  
Gt2(91) 7,8,3,2,4,9,1,0,11,3,12,5,0 
 
Israel Tamar House Environmental 2013 
OT9 2-14 (not 3) 
  
Gt1(88) 7,8,3,2,4,9,1,2,11,2,12,5,0 
 
Israel Tamar House Environmental 2013 
O-W1 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W10 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Mehanamia Environmental 2013 
O-W11 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Mehanamia Environmental 2013 
O-W12 1 
  
Gt6(13) 7,7,10,2,4,9,4,2,18,2,17,5,5 VACC1 Israel Mehanamia Environmental 2013 
O-W13 3 
  
Gt25(7) 7,8,0,2,4,8,2,1,0,3,27,0,0 
 
Israel TIiberias (Shosh) Environmental 2013 
O-W14 1 
  
Gt6(13) 7,7,10,2,4,9,4,2,18,2,17,5,5 VACC1 Israel TIiberias (Shosh) Environmental 2013 
O-W15 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W16 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W17 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W18 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W19 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W2 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W20 3 
  
Gt27(28) 10,8,8,2,5,13,2,2,18,0,10,4,8 VACC5 Israel Arbel Environmental 2013 
O-W21 3 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Arbel Environmental 2013 
O-W22 3 
  
Gt27(28) 10,8,8,2,5,13,2,2,18,0,10,4,8 VACC5 Israel Arbel Environmental 2013 
O-W24 3 
  
Gt27(2) 10,8,8,2,5,13,2,2,18,2,10,4,8 VACC5 Israel Arbel Environmental 2013 
O-W25 3 
  
Gt26(8) 7,8,8,2,4,8,2,1,3,3,14,5,5 
 
Israel TIiberias (Shosh) Environmental 2013 
O-W26 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel TIiberias (Shosh) Environmental 2013 
O-W27 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel TIiberias (Shosh) Environmental 2013 
O-W28 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W29 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W30 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 Israel Tiberias (Hila) Environmental 2013 
O-W31 3 
  
Gt25(7) 7,8,0,2,4,8,2,1,0,3,27,0,0 
 
Israel Tiberias (Hila) Environmental 2013 
O-W33 1 
  
Gt27(2) 10,8,8,2,5,13,2,2,18,2,10,4,8 VACC5 Israel Arbel Environmental 2013 
O-W4 (2-14) 
  
Gt23(108) 8,8,10,2,4,16,1,1,3,3,6,4,8 VACC2 Israel Arbel Environmental 2013 
O-W5 3 
  
Gt27(43) 10,8,8,2,5,13,2,2,18,0,11,4,8 VACC5 Israel Arbel Environmental 2013 
O-W6 3 
  
Gt27(28) 10,8,8,2,5,13,2,2,18,0,10,4,8 VACC5 Israel Arbel Environmental 2013 
O-W7 3 
  
Gt27(2) 10,8,8,2,5,13,2,2,18,2,10,4,8 VACC5 Israel Arbel Environmental 2013 
O-W8 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Mehanamia Environmental 2013 
O-W9 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 Israel Mehanamia Environmental 2013 
A1 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Ramallah Environmental 2013 
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Strain Sgp, mAb ST ST profile 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
A10 6 
  
Gt13(106) 8,8,11,1,4,16,1,1,3,3,6,4,8 VACC2 West Bank Al Quds University Environmental 2013 
A100 1 
  
Gt38(109) 8,8,6,2,4,8,1,1,3,2,6,4,8 VACC2 West Bank Hospital F Environmental 2013 
A101 1 
  
Gt63(83) 7,7,10,2,4,0,4,0,0,3,14,4,9 VACC1 West Bank Hospital H Environmental 2013 
A102 1 
  
Gt63(83) 7,7,10,2,4,0,4,0,0,3,14,4,9 VACC1 West Bank Hospital B Environmental 2013 
A103 1 
  
Gt63(83) 7,7,10,2,4,0,4,0,0,3,14,4,9 VACC1 West Bank Hospital H Environmental 2013 
A104 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2013 
A105 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2013 
A106 1 
  
Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1 West Bank Hospital G Environmental 2013 
A107 (2-14) 
  
Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital B Environmental 2013 
A108 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2013 
A109 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital F Environmental 2013 
A110 6 Dresden 
  
Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 West Bank Hospital F Environmental 2013 
A112 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2013 
A114 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2013 
A115 (2-14) 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2013 
A116 6 Dresden 
  
Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 West Bank Hospital F Environmental 2013 
A119 6 Dresden 
  
Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2 West Bank Hospital F Environmental 2012 
A12 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Al Quds University Environmental 2012 
A121 6 Dresden 
  
Gt55(94) 9,8,6,2,4,13,3,0,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A122 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A123 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2013 
A124 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A127 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A128 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A129 6 Dresden 
  
Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2 West Bank Hospital F Environmental 2012 
A13 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Al Quds University Environmental 2012 
A130 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A131 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A132 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A133 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A134 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A135 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A137 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2013 
A138 6 Dresden 
  
Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital B Environmental 2012 
A139 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A14 8 1358 5,2,22,10,6,25,203 Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8 
 
West Bank Al Quds University Environmental 2012 
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Strain Sgp, mAb ST ST profile 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
A142 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital E Environmental 2012 
A143 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital E Environmental 2012 
A144 1 
  
Gt13(72) 8,8,11,2,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital E Environmental 2012 
A148 6 Dresden 
  
Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 West Bank Hospital F Environmental 2012 
A149 6 Dresden 
  
Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 West Bank Hospital F Environmental 2012 
A15 8 
  
Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8 
 
West Bank Al Quds University Environmental 2012 
A152 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A153 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A154 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital F Environmental 2012 
A156 6 Dresden 
  
Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2 West Bank Hospital F Environmental 2013 
A157 6 Dresden 
  
Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 West Bank Hospital F Environmental 2014 
A159 6 Dresden 
  
Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 West Bank Hospital F Environmental 2014 
A16 8 
  
Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8 
 
West Bank Al Quds University Environmental 2012 
A161 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital F Environmental 2012 
A162 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A163 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A164 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A165 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A166 (2-14) 
  
Gt8(142) 10,8,8,2,4,13,2,2,18,3,10,4,8 VACC5 West Bank Hospital G Environmental 2012 
A167 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A168 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A169 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A17 8 
  
Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8 
 
West Bank Al Quds University Environmental 2012 
A170 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2013 
A171 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2013 
A172 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2013 
A173 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2013 
A174 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2013 
A175 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital C Environmental 2013 
A176 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital C Environmental 2014 
A18 8 1358 5,2,22,10,6,25,203 Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8 
 
West Bank Al Quds University Environmental 2014 
A180 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital F Environmental 2014 
A181 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital F Environmental 2014 
A182 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2014 
A183 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2014 
A184 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
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Strain Sgp, mAb ST ST profile 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
A186 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A187 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A188 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A189 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A19 (2-14) 461 6,10,14,28,21,14,9 Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A190 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A191 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A192 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2014 
A193 6 Dresden 
  
Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 VACC5 West Bank Hospital H Environmental 2012 
A194 6 Dresden 
  
Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 VACC5 West Bank Hospital H Environmental 2012 
A195 6 Dresden 
  
Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 VACC5 West Bank Hospital H Environmental 2012 
A196 (2-14) 
  
Gt13(143) 8,8,11,1,4,16,1,1,3,0,6,4,8 VACC2 West Bank Hospital E Environmental 2012 
A197 10 
  
Gt13(143) 8,8,11,1,4,16,1,1,3,0,6,4,8 VACC2 West Bank Hospital E Environmental 2012 
A198 (2-14) 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A20 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital F Environmental 2012 
A21 (2-14) 461 6,10,14,28,21,14,9 Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A22 (2-14) 461 6,10,14,28,21,14,9 Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital H Environmental 2012 
A23 (2-14) 1438 7,10,3,28,9,14,3 Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5 West Bank Hospital G Environmental 2012 
A24 (2-14) 
  
Gt8(23) 10,8,8,2,4,13,2,2,18,3,14,4,8 VACC5 West Bank Hospital G Environmental 2012 
A25 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A26 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A27 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A28 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A29 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A3 1 OLDA 1 1,4,3,1,1,1,1 Gt4(20) 7,7,10,2,4,9,4,2,17,3,14,4,5 VACC1 West Bank Al Quds University Environmental 2012 
A30 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A31 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A32 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A33 1 
  
Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1 West Bank Hospital G Environmental 2012 
A140 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A141 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A145 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A177 (2-14) 
  
Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital B Environmental 2014 
A178 6 Dresden 
  
Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital B Environmental 2014 
A179 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2014 
A2 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
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Strain Sgp, mAb ST ST profile 
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8(12) 
MLVA-8(12) profile MLVA_CC Country Location Sample type Year 
A34 (2-14) 
  
Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5 West Bank Hospital A Environmental 2012 
A35 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A36 (2-14) 
  
Gt16(6) 9,8,8,2,4,13,2,2,18,2,10,4,8 VACC5 West Bank Hospital A Environmental 2012 
A37 (2-14) 1326 3,10,1,28,14,9,207 Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital A Environmental 2012 
A38 (2-14) 
  
Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5 West Bank Hospital A Environmental 2012 
A39 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A4 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Al Quds University Environmental 2012 
A40 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A41 (2-14) 
  
Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital A Environmental 2012 
A42 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A43 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A44 (2-14) 
  
Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital A Environmental 2012 
A45 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A46 6 Dresden 
  
Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5 West Bank Hospital A Environmental 2012 
A47 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A48 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A49 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A5 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Al Quds University Environmental 2012 
A50 (2-14) 
  
Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5 West Bank Hospital A Environmental 2012 
A51 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2012 
A52 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2013 
A53 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2013 
A54 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2014 
A55 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital A Environmental 2014 
A56 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2014 
A57 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2014 
A58 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2014 
A59 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2014 
A6 1 OLDA 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A60 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A61 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A62 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A63 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A64 1 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A65 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A66 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
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A67 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital D Environmental 2012 
A68 (2-14) 
  
Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital D Environmental 2012 
A69 (2-14) 
  
Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital D Environmental 2012 
A7 8 1358 5,2,22,10,6,25,203 Gt11(87) 7,7,10,2,4,17,1,1,18,3,14,5,8 
 
West Bank Al Quds University Environmental 2012 
A70 (2-14) 
  
Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital D Environmental 2012 
A71 (2-14) 461 6,10,14,28,21,14,9 Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital C Environmental 2012 
A72 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital C Environmental 2012 
A73 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital C Environmental 2012 
A74 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A75 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A76 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A77 1 
  
Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A78 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A79 (2-14) 1326 3,10,1,28,14,9,207 Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital B Environmental 2012 
A8 6 187 3,10,1,28,14,9,3 Gt84(106) 8,8,11,1,0,16,1,1,3,3,6,4,8 VACC2 West Bank Al Quds University Environmental 2012 
A80 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A81 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2013 
A82 (2-14) 461 6,10,14,28,21,14,9 Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital B Environmental 2013 
A83 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2013 
A84 (2-14) 
  
Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital B Environmental 2013 
A85 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2013 
A86 (2-14) 
  
Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 West Bank Hospital B Environmental 2012 
A87 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A88 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A89 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A9 1 OLDA 1 1,4,3,1,1,1,1 Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Al Quds University Environmental 2012 
A90 1 
  
Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 West Bank Hospital B Environmental 2012 
A91 (2-14) 1482 7,10,3,28,9,4,207 Gt8(7) 10,8,8,2,4,13,2,2,18,2,10,4,8 VACC5 West Bank Hospital E Environmental 2014 
A92 (2-14) 1482 7,10,3,28,9,4,207 Gt8(7) 10,8,8,2,4,13,2,2,18,2,10,4,8 VACC5 West Bank Hospital E Environmental 2012 
A93 (2-14) 
  
Gt24(68) 8,8,11,2,0,16,1,1,3,0,6,4,8 VACC2 West Bank Hospital E Environmental 2012 
A94 (2-14) 
  
Gt16(3) 9,8,8,2,4,13,2,2,18,2,10,5,8 VACC5 West Bank Hospital E Environmental 2012 
A95 6 Dresden 
  
Gt13(72) 8,8,11,2,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital E Environmental 2012 
A97 (2-14) 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2012 
A98 6 Dresden 
  
Gt13(72) 8,8,11,2,4,16,1,1,3,2,6,4,8 VACC2 West Bank Hospital F Environmental 2012 
A99 6 Dresden 
  
Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 West Bank Hospital F Environmental 2013 
1Serogroup, monoclonal subtype 
         
2 ST allele order: flaA, pilE, asd, mip, mompS,  proA, neuA 
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3 MLVA allele order: Lpms1, Lpms3. Lpms13, Lpms17, Lpms19, Lpms31, Lpms33, Lpms34, Lpms35, Lpms38, Lpms39, Lpms40, Lpms44 
    
  
